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ABSTRACT 
 The low efficiency of the nuclear transfer (NT) procedure requires large number of 
oocytes to produce embryos and live offspring. A series of experiments were conducted to 
evaluate the ability of the bovine cytoplast to reprogram nuclei from horses and llamas. In a 
preliminary study, equine oocytes from small (<20mm diameter) follicles were either 
pretreated with roscovitine or placed in maturation (IVM only) prior to NT. Roscovitine 
pretreatment did not improve nuclear maturation rates (roscovitine pretreatment 57% vs. IVM 
only 66%) and no fusion was obtained from roscovitine-pretreated oocytes after NT. Another 
preliminary study was conducted with the objective to produce llama NT embryos and to 
compare their development in two in vitro culture conditions (G1.2® vs. CR1aa). No 
difference was found in the number of embryos cleaved after 2 d of culture. This resulted in 
the first scientific report of somatic cell NT, in vitro culture and transfer of NT embryos in the 
llama. In the next experiment, adult horse and llama fibroblasts were injected into enucleated 
cow oocytes. The results showed the cow cytoplasm is capable of partially reprogramming 
nuclei from other species and support a few mitotic divisions. However, this study also 
showed a consistent embryonic developmental arrest at the 8- to 16- cell stage when horse or 
llama donor cells were used as donor nuclei. When a more closely related species of donor 
cell (banteng) and recipient oocyte (domestic cattle) were used for NT, no embryonic 
developmental arrest was found. Embryos progressed to achieve high blastocyst rates 
(banteng male cell line 28% vs. banteng female cell line 15%). Two banteng interspecies NT 
pregnancies were established and subsequently lost from the banteng male cell line. In the 
final study, the effect of a mixed mitochondrial population (heteroplasmy) on early embryonic 
 xi 
 
development was investigated. Ooplasmic transfer performed in combination with NT 
procedure indicated presence of foreign mitochondria clustered in a small portion of the 
cytoplasm in early stages of embryo development. When goat ooplasm was transferred into 
interspecies (cow oocyte-goat donor cell) NT embryos, fusion and cleave rates were reduced 
suggesting an increased level of heteroplasmy or nuclear-ooplasmic incompatibilities. 
 
 1 
CHAPTER I 
INTRODUCTION 
In 1914, Hans Spemann demonstrated that salamanders had pluripotent nuclei up to the 
16-cell stage (Spemann, 1938). In this classic study, the author utilized a hair from his son to 
constrict a newly fertilized salamander zygote, isolating the nucleus on one side. It was observed 
that the nucleated side cleaved and developed to the 16-cell stage, at which time the hair was 
loosened to allow one of the nuclei to pass through the constriction and into the nonnucleated 
portion. The ligature was then completely tightened, cutting the embryo in half. Cell division 
occurred in the newly nucleated portion of the cytoplasm, eventually resulting in twin larvae 
(Spemann, 1938). Research by other groups demonstrated that nuclei from early amphibian 
embryos transferred to appropriate cytoplasm were totipotent (Briggs and King, 1952; Gurdon, 
1961, 1962; McKinnell, 1962). However, as researchers transferred nuclei from individuals more 
advanced developmentally, the success rates decreased. Nuclei from differentiated cells of adult 
frogs only supported development to tadpoles. During this time, classic research demonstrated 
that sexual reproduction could be completely replaced by defining necessary conditions for 
culturing somatic carrot cells (Steward et al., 1958, 1970). 
These impressive results were followed by a report of a successful nuclear transfer of 
embryonic nuclei in mice (Illmensee and Hoppe, 1981) by directly injecting inner cell mass 
(ICM) cell nuclei into enucleated zygotes. However, these results were followed by the reports 
that full development in mice was not possible after nuclear transfer (McGrath and Solter, 1983a, 
1983b). Their report in 1983 described the use of the cytoskeletal inhibitor cytochalasin B (CB) 
and a virus-mediated cell fusion technique that allowed efficient pronuclear transplantation and 
full-term development in the mouse (McGrath and Solter, 1983a). Although pronuclear transfer 
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in the mouse resulted in viable offspring the transfer of nuclei from 2-cell blastomeres into 
enucleated zygotes produced very few blastocysts (13%) and no development to term (McGrath 
and Solter, 1983a, 1983b). It was then concluded that the nuclei of advanced differentiated cells 
were irreversibly programmed and, in a memorable line, the authors stated: “…the cloning of 
mammals by nuclear transfer is biologically impossible…” Even with these discouraging results, 
other groups still considered this an unanswered point. It had previously been stated that failure 
to demonstrate totipotency in transplanted nuclei could be due to inadequate knowledge of the 
control of gene expression and not to a permanently altered DNA structure (McKinnell, 1962). 
The body of research in domestic animals has been driven by the economic value of farm 
animals. The first report of mammalian embryonic nuclear transfer occurred using enucleated, 
metaphase-II sheep oocytes fused with 8- or 16-cell embryonic blastomeres (Willadsen, 1981, 
1986). This landmark achievement was followed by multiple efforts to clone cattle and other 
species. Numerous examples of successful nuclear transfer using embryonic donor cells have 
been reported for sheep (Willadsen, 1986), cows (Prather et al., 1987; Bondioli et al., 1990), 
rabbits (Stice and Robl, 1988; Collas et al., 1992a), pigs (Prather et al., 1989) mice (Kono and 
Tsunoda, 1989), goats (Yong and Yuqiang, 1998) and monkeys (Meng et al., 1997). Morula and 
blastocyst stage donor cells were also shown to be totipotent and capable of being reprogrammed 
by the cytoplasmic factors in cows (Willadsen et al., 1991) and rabbits (Yang and Anderson, 
1992).   
 The first offspring produced by the transfer of a cultured cell line was reported in 1996 
(Campbell et al., 1996b).  In this study, cells were derived from the embryonic disk of an in vivo 
produced day-9 sheep embryo. The cells, which remained in culture in vitro for a prolonged 
period of time (6 to 13 subpassages) adopted an epithelial morphology prior to being used as 
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donors for the nuclear transfer procedure. The significance of this study was threefold: (1) it 
demonstrated that differentiated cells, cultured for prolonged periods of time had the ability to be 
reprogrammed and originate a new individual, (2) it proved cultured cells could be induced to 
enter and temporarily arrested at a so-called G0 or quiescent state and (3) it led the way for the 
production of Dolly, the first mammal cloned from an adult, differentiated somatic cell. 
 In 1997, the world was fascinated by the birth of Dolly, a sheep created not from the 
fertilization of an oocyte and a sperm, but by the transfer of a nucleus from a fully differentiated 
somatic cell into a mature oocyte devoid of its own nuclear DNA by the process of NT (Wilmut 
et al., 1997). In their pathway to produce Dolly, Dr. Wilmut and colleagues learned to appreciate 
the cleverness of DNA being able to remodel and reprogram itself, given the appropriate 
conditions and timing. The announcement of the birth of a healthy animal cloned from a 
differentiated adult somatic cell ignited a firestorm of public and scientific interest in the field. 
This remarkable achievement led to an explosion of studies dealing with cell-cycle regulation, 
sources of and techniques of establishing stem cell lines and on early embryo development.  
 Since Dolly, eleven other mammalian species have been cloned from differentiated so-
matic cells, including the cow (Cibelli et al., 1998; Kato et al., 1998), mouse (Wakayama et al., 
1998), goat (Baguisi et al., 1999), pig (Betthauser et al., 2000; Polejaeva, 2001), gaur (Lanza et 
al., 2000), mouflon (Loi et al., 2001), rabbit (Chesné et al., 2002), domestic cat (Shin et al., 
2002), mule (Woods et al., 2003), horse (Galli et al., 2003) and rat (Zhou et al., 2003). The 
development of this technology will have a significant impact in livestock breeding practices 
(Wilmut et al., 2000), the biotechnology and pharmaceutical industry (Ziomek, 1998; Baguisi et 
al., 1999), human medicine (Lanza et al., 1999a; Cibelli et al., 2001), the companion animal 
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market (Westhusin et al., 2001; Shin et al., 2002) and the preservation of endangered species 
(Lanza et al., 2000; Loi et al., 2001). 
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CHAPTER II 
LITERATURE REVIEW 
The birth of cloned animals from adult somatic cells provided the evidence that 
mammalian development has a far greater developmental plasticity than had been imagined years 
ago (Wilmut et al., 1997). Somatic cell nuclear transfer (NT) cloning involves removing nuclear 
DNA from a mature oocyte (enucleation) and inserting a donor cell nucleus (reconstruction) 
derived from a somatic cell. The donor nucleus is then subjected to a complete “reprogramming” 
by undetermined factors located inside the ooplasm, which enable the complete set of 
instructions that were once turned off in the differentiated donor nucleus to become active and 
commence development, not as another somatic cell, but as a 1-cell embryo (Campbell, 1999). 
Nuclear transfer is a complex procedure, and each step affects the overall efficiency. The 
unpredictability of the technology due to biological variation of the recipient oocytes and the 
donor cells is difficult to control. Therefore, standardization of the steps is important to obtain 
consistent results.  
Factors Affecting Nuclear Transfer Efficiency  
Enucleation and Reconstruction 
 The enucleation step is critical in NT. Because the chromosomes of mammalian oocytes 
are indiscernible with most light microscopy techniques, the position of the chromosomes is in-
directly determined by the location of the first polar body or directly observed under ultraviolet 
light after staining oocytes with a DNA-specific dye (e.g., Hoechst-33342). The enucleation step 
is usually accomplished by using a sharp borosilicate pipette that has been beveled and spiked to 
aid in the penetration of the zona pellucida (Nour and Takahashi, 1999). An alternative method, 
which was first developed in mice oocytes, is to make a cut in the zona pellucida directly above 
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the first polar body and then compress the oocyte by applying pressure with a glass-cutting 
needle to expel the a small portion of the ooplasm (Tsunoda et al., 1986). The expelled ooplast 
remains intact, and is therefore suitable for DNA staining to confirm the removal of metaphase 
spindle without subjecting the oocyte to the harmful effects of ultraviolet light. The detrimental 
effects of DNA dyes and ultraviolet light exposure on oocytes and their developmental potential 
have been documented in the past (Smith et al., 1993a, 1993b; Dominko et al., 2000). Although 
this technique eliminates the use of ultraviolet light, it has been documented that first polar 
bodies of a metaphase-II oocyte often migrate and do not always remain in proximity to the 
chromosomes in the metaphase-II spindle (Bordignon and Smith, 1998; Dominko et al., 2000; 
Liu et al., 2000).  
 These obstacles have determined the advent of alternative approaches to the enucleation 
of oocytes. Pretreatment of mouse oocytes with 3% sucrose was effective in aiding the 
visualization of the metaphase spindle and chromosomes with standard light microscopy (Wang 
et al., 2001) and a 0.3 M sucrose treatment was found to be effective in facilitating the 
localization of the bovine chromosomes (Liu et al., 2002). Because the enucleation step requires 
a high degree of visual and manual control, other methods of enucleation have also been 
explored. Cloned piglets were born after chemically assisted enucleation of the oocytes (Yin et 
al., 2002). In this study, a brief treatment of the metaphase-II porcine oocytes in demecolcine and 
sucrose resulted in a membrane protrusion that contained the condensed chromosomes, which 
were easily visualized and aspirated into a pipette without the need of staining. Although the 
mechanisms of action of demecolcine are not clear, the appearance of the protrusion might be 
related to the condensation of maternal chromosomes (Yin et al., 2002). Recently, a handmade 
somatic cell cloning was reported for cattle (Oback et al., 2003; Vajta et al., 2003). Mature, 
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metaphase-II oocytes were stripped of their zonae pellucidae using 1.5 mg/ml of pronase and 
manually bisected using an Ultra Sharp splitting blade (AB Technologies, Pullman, WA). The 
demi-oocyes were then stained for nuclear DNA and only those without a metaphase spindle 
were selected for fusion with donor somatic cells. An individual donor cell was attached to an 
ooplast using phytohemagglutinin and ooplast-somatic cell pairs were fused using standard 
electrofusion protocols (Vajta et al., 2003). More recently, this handmade technique (with 
variations) was used by a group in Italy to produce the world’s first horse cloned by somatic cell 
NT (Galli et al., 2003). 
 In the mouse, cow and horse, improved results have been achieved with Piezo-driven 
enucleation and reconstruction (Choi et al., 2002a, 2002b; Galli et al., 2002). Because the Piezo 
drill generates mechanical pulses that travel longitudinally along the microinjection pipette and 
vibrate the pipette tip, drilling through the zona pellucida and the oolema are facilitated without 
producing any net forward movement of the pipette. This is especially useful in species with 
fragile oocytes or hard zonae pellucidae, such as the mouse and the horse (Choi et al., 2002a). 
Because the pipette used for Piezo-driven injection (7 to 10 µm) is smaller than those used in 
traditional NT (20 to 25 µm), it also allows for the direct injection of donor cells or nuclei into 
the cytoplasm without the need for electrofusion (Wakayama et al., 1998; Lee et al., 2003).  
Activation 
 During fertilization, the sperm entry triggers a series of intracellular short-lived calcium 
oscillations critical to oocyte activation. Calcium is released in a pulsatile manner from internal 
stores, including the endoplasmic reticulum and mitochondria (Yanagimachi, 1994) and this 
elevation in intracellular Ca2+ can persist for several hours (Carroll and Swann, 1992; Kline and 
Kline, 1992; Miyazaki et al., 1993). These calcium oscillations are responsible for the cascade of 
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events that follow, including the cortical granule reaction (Miyazaki et al., 1990), zona pellucida 
reaction (Yanagimachi, 1994) and the escape from the metaphase-II arrest (Whitaker and Irvine, 
1984). However, this is not the case after NT, where the lack of sperm-induced fertilization steps 
requires the use of artificial activation in order to trigger nuclear reprogramming and further 
embryonic development (Wells et al., 1999). Different artificial protocols have been developed 
to activate mammalian oocytes by simulating the biochemical and physiological events that 
normally occur during sperm-oocyte interaction. Maturation promoting factor (MPF) and 
mitogen-activated protein (MAP) kinase are the most likely targets of calcium-stimulated events, 
because inactivation of these kinases is a prerequisite to the resumption and completion of 
meiosis, subsequent pronuclear formation and DNA synthesis (Collas et al., 1993; Verlhac et al., 
1994; Moos et al., 1996).  
 Maturation promoting factor was first described as a complex of two subunits: a catalytic 
subunit, p34cdc2 and a regulatory subunit, cyclin B. p34cdc2 is a protein kinase regulated by 
changes in its phosphorylation state and by its association with cyclin. Throughout the cell cycle, 
the level of p34cdc2 remains constant but the level of cyclin varies. Maturation promoting factor 
peaks at metaphase in association with nuclear envelope breakdown, chromatin condensation, 
reorganization of the cytoskeleton and the formation of the mitotic spindle (Doree and Galas, 
1994; Moos et al., 1996). Maturation promoting factor inactivation, which is necessary for the 
cell to exit the metaphase-II arrest, involves cyclin proteolysis by the proteosome system 
(Glotzer et al., 1991).  
 In vertebrates, mature oocytes are arrested at metaphase-II of the meiotic division, with 
elevated MPF activity maintained by a cytostatic factor (CSF), which prevents the ubiquitin-
dependent degradation of cyclin B and thus, inactivation of MPF. Intracellular Ca2+ oscillations 
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triggered by sperm down-regulate CSF activity and allow for the degradation of cyclin. 
Proteolytic degradation of cyclin B and subsequent MPF inactivation releases oocytes from 
metaphase arrest and allows the beginning or resumption of mitotic cycles (Lorca et al., 1993). 
In NT procedures, enucleated oocytes fused with a diploid donor cell must be artificially 
activated to continue development, since somatic cell nuclei cannot initiate activation (Campbell, 
1999). Different artificial activation treatments attempt to mimic sperm-triggered events and 
induce parthenogenic development in metaphase-II oocytes. Some of these treatments, such as 
ethanol, electrophoration, calcium ionophore, ionomycin or inositol 1,4,5 triphosphate induce 
calcium oscillations and release mitotic arrest (Presicce and Yang, 1994; Soloy et al., 1997; Liu 
et al., 1998; Mitalipov et al., 1999;). However, the activity of MPF is quickly restored with 
recondensation of chromosomes and re-entry of activated oocytes into a new M-phase arrest, 
also known as metaphase-III.  
To prevent this premature restoration of MPF activity, additional treatments that non-spe-
cifically inhibit protein synthesis such as (cycloheximide, CHX) or that inhibit protein 
phosphorylation (6-dimethylaminopurine, DMAP) (Soloy et al., 1997; Liu et al., 1998) must be 
used in the activation protocol. Therefore, sequential activation approaches with ionomy-
cin/DMAP, calcium ionophore/CHX, or inositol 1,4,5-triphosphate/DMAP that result in high 
activation and parthenogenic rates (Barcroft et al., 1998; Mitalipov et al., 1999) have been 
reported. DMAP acts by blocking the second reduction division preventing karyokinesis of the 
newly transferred diploid nucleus, thus allowing diploid development to proceed (Susko-Parrish 
et al., 1994). CHX does not interfere with the spindle apparatus and results in haploid 
development if cytochalasin is not added to depolymerize the actin microfilaments (Booth et al., 
2001). 
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 In addition, detrimental effects of these non-specific, broad spectrum protein synthesis 
and/or kinase inhibitors are suspected during later embryonic development. In the cow, 
developmental competence of oocytes was compromised after blocking maturation at the 
germinal vesicle stage for 24 hour with CHX or DMAP (Lonergan et al., 1997). In contrast, 
purine derivatives such as roscovitine, butyrolactone-I or olomoucine, which specifically inhibit 
MPF and MAP kinase, have been used to delay meiotic progression of bovine oocytes without 
affecting their subsequent developmental potential to the blastocyst stage (Mermillod et al., 
2000). This also suggests that these components might have a potential application not only in 
oocyte maturation (nuclear and cytoplasmic) but to promote parthenogenic activation as well.  
Selection of Donor Cells 
 Various cell types, such as embryonic cells (Campbell et al., 1993), fibroblasts (Kato et 
al., 1998), mammary gland cells (Wilmut et al., 1997), cumulus granulosa cells (Wakayama et 
al., 1998), oviduct cells (Kato et al., 2000), leukocytes (Galli et al., 1999), mural granulosa cells 
(Wells et al., 1999), germ cells (Bordignon et al., 2003), embryonic stem cells (Eggan et al., 
2001) and liver cells (Brem and Kuhholzer, 2002a) have been used as donor cells for production 
of cloned animals. However, it is still unclear which type is the most efficient for nuclear transfer 
into oocytes (Kato et al., 2000). When the efficiency of various cell types from adult, newborn 
and fetal male and female donor cells was compared, the percentage of blastocysts produced 
from each cell type was found not to be significantly different (Kato et al., 2000). Similar results 
were obtained using various cell types derived from mice of different strains, sexes and ages 
(Wakayama and Yanagimachi, 2001). 
 Initially, all cloned animals derived from adult somatic cells were produced using cells 
from the female reproductive system, such as mammary gland (Wilmut et al., 1997), oviduct 
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(Kato et al., 1998), cumulus and mural granulosa cells (Wakayama et al., 1998; Wells et al., 
1999; Kato et al., 2000) raising the question of whether male individuals could be cloned. 
However, male mice were cloned from tail skin cells (Wakayama and Yanagimachi, 1999) and 
no significant differences were found in the developmental rates of embryos reconstituted with 
male or female nuclei in cattle (Kato et al., 2000) and mice (Wakayama and Yanagimachi, 
2001). 
 Because fetal cells are believed to have less genetic damage and more proliferative ability 
(as measured by cell doublings) than adult somatic cells, they have been the cell type of choice 
as nuclear donors (Hill et al., 2000a). However, this presents a limitation in that the individual 
the donor cells are derived from (a fetus) has not had the chance to demonstrate its genetic merit 
(an adult) prior to somatic cell nuclear transfer. No significant differences were found in bovine 
embryo developmental rates to the blastocyst stage with adult, newborn, or fetal cell nuclei; 
however, abortion in later stages of pregnancy were higher for cloned fetuses derived from adult 
cells (Kato et al., 2000). Similarly, no differences among embryos derived from fetal and adult 
bovine fibroblasts with regard to fusion, cleavage and blastocyst formation were detected 
(Niemann et al., 2002). However, more fetal losses after transfer into recipients were noted with 
embryos reconstructed with adult bovine donor cells (Hill et al., 2000c; Niemann et al., 2002). 
 Genetic damage may occur during the in vitro culture of donor cells prior to NT.  Cells 
cultured for prolonged periods of time are known to increase in their levels of aneuploidy over 
time (Freshney, 2000). Therefore, fresh or short-term cultured (<10 subpassages) donor cells 
have been the cell type of choice for the production of cloned embryos. In contrast, one study re-
ported higher developmental rates to the blastocyst stage for embryos reconstituted with adult 
somatic cells that had been subpassaged 10 to 15 times compared with that of embryos recon-
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stituted from cells with a lower number of subpassages (Kubota et al., 2000). In addition, cloned 
calves were obtained from embryos reconstituted with high-subpassaged cells, with all cloned 
fetuses derived from low-subpassaged donor cells aborting during pregnancy (Kubota et al., 
2000). Similar results were obtained using enhanced green fluorescent protein gene transfected 
and nontransfected bovine granulosa cell donor cells where in vitro developmental rates of 
cloned embryos derived from cells at passage 15 were higher that those for embryos derived 
from cells at lower subpassages (Arat et al., 2001). Results within and among various research 
laboratories are often conflicting due to procedural effect, oocyte variability, inherent differences 
among donor cell lines, age of donor animals or to effects of in vitro culture conditions..   
Stages of Donor Cell Cycle 
 Understanding the cell cycle synchrony requirements in an NT scenario was a major 
contributing factor to the success of the first somatic cell NT (Campbell et al., 1996b). Studies 
aimed at understanding the regulation of the cell cycle indicated that the use of G0 cells could be 
beneficial for the success of NT procedures (Wilmut et al., 1997). In the scientific literature, G0 
and G1 cells are often grouped together as G0/G1, although these phases are quite distinct. G0 
cells exit the normal cell division cycle and enter a quiescent state, whereas, G1 is a transient 
stage between M-phase and S-phase in proliferating cells. Currently, there is no clear molecular 
correlation between cell quiescence and defined differences in chromatin structure. In addition, 
using the terms ‘serum-starved’ and ‘quiescent’ interchangeably should be avoided when 
referring to in vitro cell cultures for nuclear transfer, as quiescence is a state that cells can enter 
spontaneously while serum-starvation can cause a state of stress with potentially more profound 
implications within the cells (Wells et al., 2003).   
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 Quiescent cells presumably arrested in G0 phase of the cell cycle have commonly been 
used to produce cloned animals (Campbell et al., 1996b; Wilmut et al., 1997; Baguisi et al., 
1999; Kues et al., 2000; Reggio et al., 2001; Gibbons et al., 2002; Wells et al., 2003; Yu et al., 
2003) and the specific method used to arrest donor cells can markedly affect fetal survival to 
term and neonatal survival (Gibbons et al., 2002). However, proliferating cells have also been 
successfully used for NT (Cibelli et al., 1998), although the exact stage of the donor cell cycle 
was never verified. Thus far, only statistical probabilities on cell stage percentages in G0/G1, G2, 
M and S-phases have been provided as evidence of the cell cycle stage (Boquest et al., 1999). 
 Most oocytes from amphibians and mammals become developmentally arrested at the 
germinal vesicle stage in prophase of the first meiotic division. After an appropriate stimulation, 
meiosis resumes, the germinal vesicle breaks down, the first meiotic division is completed and 
the oocyte becomes arrested at metaphase of the second meiotic division. During the fertilization 
process, the second meiotic division is completed and the second polar body is extruded. This is 
followed by male and female chromatin decondensation and pronuclei formation. After DNA 
replication, equal segregation of the genetic material occurs by mitosis and the zygote cleaves to 
form two daughter blastomeres (Campbell et al., 1996a). 
 Maturation/meiosis/mitosis-promoting factor (MPF) is of critical importance during 
activation (Masui and Markert, 1971). MPF has been identified as a complex of two proteins, 
cyclin and p34cdc2, a protein kinase regulated by changes in its phosphorylation state and by its 
association with cyclins (Nurse, 1990). Throughout the cell division cycle, the concentration of 
p34cdc2 remains constant, whereas, the concentration of cyclin varies (Masui, 1992). The 
activation of p34cdc2 kinase triggers entry of the cell into mitosis or meiosis and results in 
breakdown of the nuclear envelope, chromosome condensation, reorganization of the cy-
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toskeleton and changes in cell morphology (Nurse, 1990). MPF activity during oocyte 
maturation is maximal in metaphase of both first and second meiotic divisions. When the oocyte 
becomes arrested at metaphase-II, MPF activity remains high, then following fertilization or 
chemical activation, MPF activity rapidly declines.  
 During the cell cycle, chromosomal DNA is replicated only once. The mechanisms by 
which a cell coordinates this event and prevents re-replication still remain unclear, although 
maintenance of an intact nuclear envelope appears to be of utmost importance (Blow and 
Laskey, 1988). The development of reconstructed embryos following nuclear transfer appears to 
be dependent upon a variety of factors and cell cycle synchrony appears to be a critical aspect. 
The donor nucleus must be in G1 or G0 when transferred to fresh oocytes with high levels of 
MPF to condense normally and maintain correct ploidy of subsequent embryos at the end of the 
first cell cycle (Campbell et al., 1996a). The high levels of MPF in the mature, metaphase-II 
oocyte cause nuclear envelope breakdown (NEBD) and chromosome condensation of the 
transferred nucleus, irrespective of the cell cycle stage of the donor cell. Subsequently, the 
exposure of the chromosomes to the licensing factors in the oocyte cytoplasm leads to the 
replication of DNA following the decay of MPF activity and the reformation of the nuclear 
membrane (Campbell et al., 1996a, 1993; Dinnyés et al., 2002).  
 Primarily, two types of cytoplasts have been used as hosts for NT: (1) the enucleated and 
activated metaphase-II cytoplast (low MPF) and (2) the enucleated but not activated cytoplast 
(high MPF) (Campbell et al., 1996a; Dinnyés et al., 2002). When nuclei are transplanted to 
metaphase-II arrested cytoplasts, high levels of MPF lead to premature chromatin condensation 
(PCC) and NEBD. In contrast, when nuclei are transferred to previously activated cytoplasts, 
NEBD and PCC do not occur because the MPF activity has already declined. 
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 The response of the introduced donor nuclei is quite different for these two scenarios (Dinnyés 
et al., 2002). In the metaphase-II cytoplast, donor chromatin immediately condenses, in 
conjunction with the breakdown of the nuclear envelope (Collas and Robl, 1991). Spindle 
microtubules then form in association with condensed chromatin (Pinto-Correia et al., 1993). 
When the embryo karyoplast is activated, causing a decrease in MPF, a nucleus forms and 
acquires the morphology of a large pronucleus (Collas and Robl, 1991). If DNA synthesis has 
commenced prior to NEBD, then DNA replication will take place, resulting in abnormal ploidy 
and a defective embryo. Furthermore, the progression of DNA synthesis in the donor nucleus is 
not compatible with normal chromatin condensation, which also results in a defective embryo. 
Consequently, only nuclei that have not entered the S-phase (G1 or alternatively G0 nuclei) 
produce normal embryos when transplanted to a non-activated cytoplast (Collas et al., 1992b). 
 Early studies in bovine NT embryos reconstructed by transfer into metaphase-II cyto-
plasts showed that all nuclei underwent NEBD and DNA synthesis after reformation of the nu-
clear envelope, regardless of their cell cycle stage (Campbell et al., 1993). Thus, it was 
hypothesized that only G1 nuclei should be used when transferring to metaphase-II cytoplasts. 
During NT procedures, all nuclei transferred into a cytoplasm with high MPF activity undergo 
NEBD and chromatin condensation. As chromosome condensation is induced prematurely in the 
donor nucleus, this event has been referred to as PCC. The degree of PCC appears to vary with 
the MPF activity and the duration of exposure and, in addition, the cell cycle of the transferred 
nucleus has profound implications on the outcome (Campbell et al., 1996a). Observations in both 
somatic cell hybrids (Johnson and Rao, 1970) and NT embryos (Collas and Robl, 1991) showed 
that the chromatin of S-phase nuclei induced to undergo PCC by exposure to MPF has a typical 
pulverized appearance and chromosome analysis showed a high incidence of abnormalities in 
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such nuclei (Collas et al., 1992a). In contrast, when G1 or G2 phases undergo PCC, the chroma-
tin condensed to form elongated chromosomes with single-chromatids and double-stranded 
chromatids, respectively (Collas et al., 1992a). In contrast, when the activated cytoplast is used, 
little change is noted in the transplanted nucleus. DNA synthesis, if initiated, is completed or, if 
not initiated, progresses normally. This type of recipient cytoplast is compatible with both G1 and 
S-phase stages of the donor cycle (Collas et al., 1992a). Morphologically, little change is 
observed in the nucleus following the transfer to activated cytoplasts. This type of cytoplast has 
also been termed a ‘Universal Recipient’ (Campbell et al., 1993) and although blastocysts have 
been produced, no pregnancy has developed to term suggesting incomplete or inappropriate 
nuclear reprogramming (Dinnyés et al., 2002).  
Cell Line Cloning Efficiency 
 The developmental capacity of bovine cloned embryos differs among donor cell lines, 
even if they are derived from the same tissue or organ (Kato et al., 2000). Results obtained from 
NT using four primary cell lines of adult bovine somatic cells indicated that the primary donor 
cell culture has a significant impact on in vitro development, initial pregnancy rates and 
percentage of live births (Dinnyés et al., 2002; Miyoshi et al., 2003). In addition, similar results 
were obtained from pig cloning studies, in which nine different somatic cell cultures used in NT 
procedures resulted in 10 initial pregnancies from four of the cell lines. However, development 
past 90 days of gestation was achieved with only one cell line (Kuhholzer et al., 2001). It has 
been hypothesized that the differences among cell lines for both cattle and pigs may be due to 
epigenetic effects, because even within a primary cell culture, the generation of cell lines shows 
that some lines are more suitable than others as nuclear donors for NT (Kuhholzer et al., 2001; 
Miyoshi et al., 2003). 
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Nuclear Reprogramming and Genomic Activation 
 Reports of successful generation of cloned animals by NT of somatic cells indicated that 
somatic nuclei could reverse their developmental block to recover totipotency when introduced 
into appropriate cytoplasmic environments (Kim et al., 2002). The early stages of normal 
embryogenesis are regulated by maternally inherited gene products stored in the oocyte 
cytoplasm. As development proceeds and maternally inherited informational molecules decay, 
the process of early embryogenesis then becomes dependent on the expression of genetic 
information derived from the embryonic genome. There are species-specific differences in the 
developmental period at which the transition from control by maternally inherited molecules to 
that of embryonic genome-derived transcription products occurs (Table 2.1). The major features 
that characterize the timing of the switch from maternal to embryonic genome control include: 
(1) loss or decay of mRNA molecules of maternal origin, (2) activation of transcription of the 
embryonic genome, (3) developmental arrest in the presence of transcriptional inhibitors and 4) 
marked qualitative changes in protein synthetic patterns. The switch is also often associated with 
a so-called critical or developmental block stage during in vitro culture of preimplantation 
embryos (Telford et al., 1990).  
 The most detailed information on embryonic genome activation has been obtained from 
the mouse embryos. It the murine species, the transition period between development dependent 
on maternally derived gene transcripts and the initiation of transcriptional activity by the em-
bryonic genome occurs around the 2-cell stage (Schultz, 1986; Telford et al., 1990). It was 
shown that mouse embryos cultured from the 1-cell stage in presence of transcriptional inhibitors  
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Table 2.1. Summary of stage of transition from maternal to embryonic control in embryos from several mammalian species  
(Telford et al., 1990) 
 
   
           Cell stage when characteristic feature is observed 
    
 
Feature 
 
Mouse 
 
Rabbit 
 
Pig 
 
Sheep 
 
Cow 
 
Human 
 
Developmental arrest in α-amanitin culture 
 
2 
 
8-16 
 
NRa 
 
8-16 
 
NR 
 
4-8 
RNA synthesis from embryonic genome is initiated 1-2 1-2 4 NR 8 4 
Change in qualitative pattern of protein synthesis 1-2 2-16 NR 8-16 8-16 4-8 
In vitro developmental culture block 2 NR 4-8 8-16 8-16 4-8 
aNR: not reported 
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do not develop beyond the 2-cell stage and it was shown that there is a major turnover in mRNA 
during the 1-cell to 2-cell stage that involves both the degradation of preexisting maternal mRNA 
and the beginning of synthesis of new mRNA from the embryonic genome (Golbus et al., 1973).  
 Additionally, another component that is likely associated with the maternal-embryonic 
genome switch in the mouse embryo is the 2-cell in vitro block. Most random-bred strains 
produce embryos that, when removed at the 1-cell stage and cultured under conventional 
conditions, arrest at the G2 phase of the second cell cycle (Muggleton-Harris et al., 1982; 
Goddard and Pratt, 1983; Pratt and Muggleton-Harris, 1988). The reasons for this in vitro 
phenomenon are not clear. The effects of the 2-cell block have been shown to be reversible by 
transfer of cytoplasm from the oocytes of nonblocking mouse strains (Muggleton-Harris et al., 
1982) and can be circumvented by improved in vitro culture conditions (Chatot et al., 1989). 
Nonetheless, the in vitro block has been shown to coincide with the time of transition from 
maternal to embryo genomic control. Embryos appear to be particularly sensitive to culture 
conditions during this critical phase of their development (Chatot et al., 1989; Telford et al., 
1990).  
 In the cow and the sheep, the timing of the switch from maternal to embryo genomic 
control has been reported to occur at the 8- to 16-cell stage (Camous et al., 1984), though others 
have reported it to occur as early as the 8-cell stage (Kopency et al. 1989a, 1989b). When the 
qualitative patterns of protein synthesis were examined at different stages of development, 
marked changes were detected in 8- to 16-cell stage embryos (Frei et al., 1989). The quantitative 
and qualitative changes in protein synthesis and the late onset of new RNA synthesis in bovine 
embryos is consistent with the hypothesis that maternal messages are gradually degraded from 
fertilization through the 8-cell stage, at which time control of transcription shifts from the 
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maternal to the embryonic genome. As in mouse embryos, the shift from maternal to embryonic 
control of transcription in the cow is temporally associated with the developmental block found 
in cultured embryos.  
 Recent studies using long term exposure of 2-cell to 4-cell stage embryos to [3H] uridine 
followed by autoradiography have revealed that transcriptional activity can be detected early in 
the development of bovine embryos and treatment with the transcriptional inhibitor α-amanitin 
blocked incorporation (Plante et al., 1994; Viuff et al., 1996; Liu and Foote, 1997; Memili et al., 
1998). In addition, bovine embryos labeled at the 2-cell stage with 35S methionine revealed 
transcriptional and translational activity (Memili et al., 1998). Together, these findings suggest 
that there may be a low level of transcriptional activity between the 2- and the 4-cell stage 
bovine embryos. 
 A critical period in the culture of pig embryos, analogous to the 2-cell block in mice and 
the 8- to 16-cell block in sheep and cows, has been reported to occur at the 4-cell stage (Davis, 
1985), as determined by [3H] uridine incorporation and autoradiography (Kopecny et al., 1989a). 
Interestingly, NT experiments have also suggested the time of in vitro arrest as a possible 
indicator for the timing of maternal-embryonic transition in pig embryos (Prather et al., 1989). 
The period of maternal-embryonic transition in rabbit embryos appears to be somewhat different 
from other species (Telford et al., 1990). There is no measurable loss of mRNA during early 
cleavage as occurs in the mouse and the developmental arrest after in vitro culture in α-aminitin 
was observed at the 8- to 16-cell stage (Manes, 1973).  
 In the human, the difficulty of obtaining human preimplantation embryos precludes 
extensive studies of the biochemical changes that occur during early development. However, one 
study showed that qualitative changes in protein synthesis were detected at the 4-cell stage 
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(Braude et al., 1979b) and these changes coincided with the 4-cell block observed in the presence 
of  α-aminitin (Braude et al., 1979a). Together, these observations suggested that the maternal 
genome controls development up to the 4-cell stage, at which time expression of the embryonic 
genome is necessary for further development. 
 For this embryonic takeover to occur in the NT scenario, the transferred nucleus must 
change its gene expression pattern to that of an early embryonic nucleus. This process is 
generally termed nuclear reprogramming, and is generally preceded by the altering of chromatic 
configuration or chromatin remodeling. Early studies demonstrated that the metaphase-II 
arrested, non-activated oocytes were more effective in supporting development of embryos 
reconstructed with differentiated nuclei than activated oocytes (Kim et al., 2002). This 
demonstrated that the success in chromatin remodeling, from differentiated nuclei to totipotent 
ones, was dependent of the cell cycle stage of the recipient ooplasm (Campbell et al., 1993, 
1996a).  
 With the objective of describing the molecular/biochemical nature of chromatin 
remodeling, NT embryos were produced by injection of cumulus cells into either nonactivated or 
activated enucleated oocytes. More than half (56.1%) of the embryos transferred to the 
nonactivated cytoplasts developed to the morula or blastocyst stage, whereas, very few (1%) of 
the embryos reconstructed with preactivated cytoplasts developed to advanced stages (Kim et al., 
2002). Results from this experiment indicated that the successful remodeling of somatic nuclei is 
brought about by a process similar to that of normally fertilized embryos and failure of pre-
activated cytoplasts to remodel somatic nuclei was attributed to the inability of the ooplasmic 
environment to trigger obligatory events in chromatin remodeling, such as silencing of 
transcription and loosening of the chromatin structure (Kim et al., 2002). 
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Epigenetic Effects 
 It has been estimated that 0.1 to 1% of all mammalian genes are repressed on a single 
chromosome (Surani, 2001). This phenomenon, termed ‘genomic imprinting’, causes some genes 
to be expressed according to their parental origin and results in a developmental asymmetry in 
the function of parental genomes (Ferguson-Smith and Surani, 2001). This explains why, in 
mammals, parthenogenic development to live offspring is not possible (Reik et al. 2001a, 
2001b). Imprinted genes are generally implicated in the regulation of fetal growth, development 
and function of the placenta, as well as, postnatal behavior (Reik and Walter, 2001). The two 
parental genomes are formatted during gametogenesis to respond to the oocyte environment and 
proceed during development.  
 The zygote biochemically remodels the paternal genome shortly after fertilization and 
before embryo genomic activation through epigenetic modifications (Rideout et al., 2001). These 
epigenetic modifications include DNA methylation, assembly of histones into nucleosomes and 
the remodeling of chromatin-associated proteins and X-chromosome inactivation (Rideout et al., 
2001). Epigenetic changes affect the local structure, composition and remodeling of chromatin, 
which in turn defines and maintains the accessibility and transcriptional competence of the 
nucleosomal DNA template (Wolffe and Matzke, 1999). 
DNA Methylation 
 DNA methylation takes place mainly on the 5’–cytosine residues at CpG dinucleotides. 
Of the normal 30,000-40,000 genes in the human genome, approximately 29,000 are linked to 
CpG islands (Bestor, 2000). These CpG islands are normally found unmethylated in at least four 
cases: imprinted genes, X-linked genes in females, germline-specific and tissue-specific genes. 
Therefore, DNA methylation plays a critical role in the determination of cell fate and cell type-
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specific gene expression (Shi et al., 2003). DNA methylation is catalyzed by enzymes of the 
cytosine methyltransferases group (Dnmts). Targeted Dnmt 1 disruption in mice was shown to be 
lethal in mid gestation (Li et al., 1992). Dnmt 3a and Dnmt 3b have been proposed as de novo 
methyltransferases potentially involved in the set up of the initial patterns of methylation during 
embryogenesis (Okano et al., 1999). 
 Most of the imprinted genes have differentially methylated regions. After fertilization, 
differential methylation of imprinted genes needs to be maintained. However, it has been shown 
that during preimplantation development there is genome-wide demethylation. The biological 
reason and mechanisms for this genome-wide demethylation is still unknown, although it has 
been proposed that it might prime the genome for widespread transcriptional activation (Walsh 
and Bestor, 1999). 
 DNA methylation has been extensively described in the mouse. Two major waves of 
demethylation and remethylation have been described, the first occurring in the fetus during 
germ cell development and the second after fertilization during early embryonic development 
(Shi et al., 2003). The paternal genome undergoes major transformations within the cytoplasm of 
the oocyte during fertilization, including remodeling of sperm chromatin by replacement of 
protamines with histones followed by genome-wide demethylation (Perreault, 1992). The active 
demethylation of the paternal genome was shown to occur a few hours after fertilization and 
before the first cell division in mice (Mayer et al., 2000; Santos et al., 2002), whereas, the 
genome-wide demethylation of maternal genome occurs gradually (Rougier et al., 1998; Santos 
et al., 2002). Genome-wide de novo methylation occurs at the blastocyst stage in mice, 
preferentially in the inner cell mass (Dean et al., 2001). The basic events of DNA demethylation 
are conserved to some extent in the rat, pig and cow (Shi et al., 2003). In the bovine 
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preimplantation embryo, considerable de novo methylation has been detected from the 8- to 16-
cell stage (Dean et al., 2001). The process of DNA methylation has been proposed to have an 
important role in imprinting, both in silencing genes like H19 (Reik and Walter, 2001b) and 
activating others, such as IGF2 and IGF2r (Sleutels and Barlow, 2002). However, the role of 
methylation in genomic stability is still a matter of debate. The mechanisms by which deficient 
methylation leads to aberrant regulation of a substantial proportion of endogenous genes are still 
unclear (Okano et al., 1999).  
 The successful cloning of mammals by the transfer of embryonic or somatic cell nuclei 
into an enucleated oocyte demonstrated that the genetic and epigenetic programs can be reversed 
and that nuclear totipotency can be restored (Gurdon and Colman, 1999; Shi et al., 2003).  
However, the nucleus of the cell transferred to an enucleated oocyte must be quickly 
reprogrammed to express the genes needed for normal early embryonic development. 
Experimental evidence indicates that the abnormalities observed in cloned animals are due, at 
least in part, to the faulty or incomplete establishment, maintenance and resetting of epigenetic 
states during and after nuclear transfer (Dean et al., 2001; Young et al., 2001). Several studies 
have reported anomalies in the methylation patterns of early preimplantation cloned embryos.  
 Dean et al. (2001) reported that the initial demethylation appeared to be conserved in 1-
cell cloned bovine embryos. However, it was found that the further passive demethylation 
appeared to be absent in those embryos, and a precocious de novo methylation was described at 
the 4- to 8-cell stage. In contrast, other studies failed to find any demethylation in cloned bovine 
embryos (Bourc'his et al., 2001).  
 The demethylation/remethylation waves generally appear to coincide with the activation 
and transcription of the embryonic genome. In mammals, it is well known that the onset of ge-
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nomic activation differs between species, occurring at the 2-cell stage in mice, 4-cell stage in 
pigs, and the 8- to 16-cell stage in cows (Campbell, 1999). It has been proposed that the delayed 
or aberrant demethylation/remethylation wave observed in preimplantation cloned embryos may 
impair the normal progression towards the activation of the genome (Shi et al., 2003). Overall, 
these studies demonstrated that incomplete or aberrant methylation patterns occur during 
reprogramming of the donor genome in cloned embryos. 
Genomic Imprinting 
 Among the abnormalities observed in cloned animals are placental abnormalities (Hill et 
al., 2001a), fetal overgrowth and perinatal death (Hill et al., 2000c). Increased fetal and placental 
weights were reported in cloned mice produced from ES cells. These abnormalities were not 
reported in pups derived from tetraploid aggregation, suggesting abnormalities resulted from the 
nuclear transfer procedure (Eggan et al., 2001). In contrast, no abnormalities have been reported 
in placentae of cloned goats and pigs (Keefer et al., 2001; Polejaeva, 2001).  
 In mammals, both maternal and paternal genomes are needed for normal development. 
By the mechanisms of genomic imprinting, specific genes are allowed to express dependent on 
their parental origin (Surani et al., 1984). Therefore, functional differences between maternal and 
paternal genome are present during early embryo development. The paternal genome exerts its 
effects in the extraembryonic tissues, whereas the maternal genome will have influence in the 
development of the embryo (McGrath and Solter, 1984; Surani et al., 1984). Imprinted genes 
have been proposed to have a key role in processes; such as placentation, homeostasis, lactation 
(Lefebre et al., 1998) and many of these processes have been reported to be deficient in cloned 
animals. Both DNA methylation and chromatin packaging have been implicated as imprinting 
marks. However, little is known how they are established and maintained (Shi et al., 2003). It has 
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been proposed that when a somatic nucleus is introduced into an enucleated oocyte, the 
methylation of imprinted genes needs to be protected from genome-wide demethylation so that 
imprints are maintained intact in the cloned organism. In this case, reprogramming could 
interfere with proper maintenance of imprints and this could explain, at least in part, the low 
efficiency of animal cloning (Shi et al., 2003).  
 Various cell types have been used as nuclear donors. Nuclear reprogramming involves 
structural and functional modifications associated with the acquisition of pluripotency or 
totipotency of embryonic and somatic nuclei transplanted to enucleated oocytes (Gurdon et al., 
1975). Two approaches have been used to induce the reprogramming of the donor nucleus. The 
first focuses on exposing the transplanted nucleus for prolonged periods of time to the oocyte 
ooplasmic environment during the M phase with the corresponding high levels of MPF 
(DiBernardino et al., 1984; Wakayama et al., 1998). The second approach involves inducing 
nuclear quiescence in cultured cells before they are used as nuclear donors (Wilmut et al., 1997).  
Both approaches attempt to modify the structure and function of donor chromatin to render it 
more accessible to the reprogramming factors present in the ooplasm.  
 The efficiency of reprogramming by the cytoplast varies considerably among different 
types of cells or even different lines of the same type of cells. It has been proposed that 
epigenetic differences could be a major reason for this underlying variability (Shi et al., 2003). 
However, cell viability does not seem to be a prerequisite for effective nuclear reprogramming.  
 In a recent study, Loi et al. (2002) produced live cloned lambs from the injection of 
nonviable, heat-treated granulosa cells into enucleated sheep oocytes demonstrating that 
denatured somatic cells can be reactivated after nuclear transfer and develop to blastocysts in 
vitro and subsequently to viable offspring. In this study, cells were denatured by incubation at 55 
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or 75°C. No live offspring were produced from the 75°C treatment group, and 4 cloned lambs 
were born from the 55°C treatment group. Of these four, only one was surviving at the time the 
study was published.  
X-chromosome Inactivation 
 During early development of eutherian mammals, one of the chromosomes is inactivated 
to ensure compensation for X-linked products. The inactivated X chromosome (Xi) is 
characterized by late DNA replication and epigenetic chromatin modifications. CpG islands of 
many X-linked genes are methylated on Xi but not on the active chromosome (Xa) (Shi et al., 
2003). Dosage compensation for X-linked genes between males and females is achieved by 
transcriptional inactivation of one of the two X chromosomes (Lyon, 1961). An untranslated 
RNA, encoded by the Xist (X-inactive specific transcript) gene that is expressed only from Xi, is 
necessary for the initiation of inactivation (Li et al., 1992; Penny et al., 1996). Continuous 
presence of Xist RNA acts together with DNA methylation and histone hypoacetylation to 
accomplish high fidelity inheritance of the inactive form (Park and Kuroda, 2001). In the female 
nucleus, one X chromosome is inactivated because it expresses the Xist RNA. The other X 
chromosome escapes silencing and remains active.  
 On the other hand, in somatic cell nuclear transfer the recipient oocyte receives one Xi 
and one Xa from the donor cell. In bovine cloned embryos, aberrant patterns of X-chromosome 
inactivation have been noted (Xue et al., 2002). The abundance of Xist transcripts was 
significantly higher in bovine cloned embryos produced from adult somatic cells than in those 
produced from fetal cells (Wrenzycki et al., 2002). Another study showed aberrant patterns of X-
linked genes, as well as, hypomethylation of Xist in the organs of deceased cloned calves (Xue et 
al., 2002). 
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Long-lasting Effects of Epigenetic Alterations 
 Many cloned offspring exhibit abnormal phenotypes and some of these carry subtle 
epigenetic changes. Although some groups have claimed that no obvious abnormalities were 
found in mature cloned animals from somatic cells (Lanza et al., 2001; Heyman et al., 2002), a 
multitude of researchers have observed various long-term abnormalities in cloned animals, which 
varied with type of donor cell and species used for NT (Hill et al., 2000a, 2002; Eggan et al., 
2001; Brem and Kuhholzer, 2002b; Ogonuki et al., 2002; Miyoshi et al., 2003; Wells et al., 
2003). The majority of cloned mice in one study were found to suffer from pneumonia, hepatic 
failure, obesity and impaired immune functions (Ogonuki et al., 2002). Some cloned calves and 
goats have also shown malfunction of the immune system (Renard et al., 1999; Bourc'his et al., 
2001). The long-lasting effect of somatic cell cloning is currently an active area of research and 
the effects of abnormal epigenetic reprogramming on preimplantation development are currently 
under investigation. 
Mitochondria 
 Mitochondria are complex, semi-autonomous organelles found in the cytoplasm of all 
aerobic eukaryotic cells, except mature red blood cells and some protozoans. The double 
membranes of mitochondria regulate transport of molecules and these organelles are the site of 
most of the metabolic reactions that produce adenosine triphosphate (ATP). Large molecules 
transit the outer membrane through nonspecific porin channels; the inner membrane, heavily 
invaginated and forming cristae, is where the enzymes of the electron transfer chain are located. 
It is also within this inner membrane that the Krebs cycle and β-oxidation take place (Hutchinson 
et al., 1974). The metabolic requirement of a cell for oxygen reflects its metabolic activity and 
the levels of ATP produced in the mitochondria are often reflective of cell function (Moyes et al., 
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1998). Cells with a larger oxidative capacity, such as those found in the liver, heart, muscle and 
neural tissue, generally have large numbers of mitochondria per cell (Brown and Wallace, 1994).  
 The number of mitochondria present in gametes is a matter of controversy, mainly due to 
the methods used for counting and reporting these organelles. Confusion over the number of 
mitochondria and mitochondrial DNA (mtDNA) copy number are spread throughout the 
scientific literature. In humans, the mtDNA is a closed circular molecule of 16,500 nucleotides 
located within the inner mitochondrial membrane (Shoffner and Wallace, 1990). Mammalian 
mtDNA codes for 13 enzymes used in the mitochondrial energy-generating pathway, 22 tRNAs 
and 2 rRNAs (Smith and Alcivar, 1993b).  
 It has been reported that the typical mammalian sperm midpiece contains a range of 50 to 
75 mitochondria (Bahr and Engler, 1970; DeMartino et al., 1979; Hecht et al., 1984). However, 
Pikó and Matsumoto (1976) have reported in the mouse a mtDNA copy number of 1,000 to 
10,000 for most of the body cells and an even higher (100,000) mtDNA copy number in mature 
oocytes (Pikó and Matsumoto, 1976; Michaels et al., 1982; Gyllensten et al., 1985; Gyllensten et 
al., 1991). It was proposed that the higher copy number present in mature oocytes is due to the 
fact that no mtDNA replication is observed during early embryogenesis, and therefore a larger 
number of copies might be needed to support the energy demands of the cells during this period 
(Pikó and Matsumoto, 1976). 
Mitochondrial Inheritance 
 Mitochondrial inheritance is also still a subject of much debate. For many years it was 
assumed that mitochondrial genes, in contrast to nuclear genes, have an exclusively maternal 
mode of inheritance in mammals (Hutchinson et al., 1974; Giles et al., 1980; Hayashi et al., 
1983). Mitochondria from the sperm tail have been shown to be carried into the oocyte at 
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fertilization in numerous studies (Szöllösi, 1965; Hiraoka and Hirao, 1988). The absence of 
paternal mitochondria was in part explained by the 1:1000 ratio between paternal and maternal 
mtDNA molecules (Pikó and Matsumoto, 1976; Michaels et al., 1982; Gyllensten et al., 1985; 
Gyllensten et al., 1991). However, in a classical study conducted by Gyllensten et al. (1991) 
using polymerase chain reaction (PCR), paternally inherited mtDNA molecules were detected at 
a frequency of 10-4 relative to maternal contributions in inbred mice backcrossed for 26 
generations.  
 Although most of the evidence indicating leakage of paternal transmission of mtDNA 
derives from interspecific crosses, some researchers suggested paternal mitochondria might be an 
artifact. A nested PCR assay was used to detect sperm mtDNA in individual mouse embryos 
(Kaneda et al., 1995). In embryos produced by IVF of Mus musculus oocytes with the same 
strain spermatozoa, paternal mtDNA could only be detected in zygotes at the pronuclear stage 
and its disappearance coincided with the loss of membrane potential in sperm-derived 
mitochondria, as measured by Rhodamine-123 fluorescence. In contrast, when Mus spretus 
spermatozoa were used to fertilize Mus musculus oocytes, paternal mtDNA was detected at the 
pronuclear stage, 2-cell stage and in the resulting neonates. Kaneda et al. (1995) proposed that an 
underlying mechanism in the cytoplasm of the zygote may allow for the recognition and 
elimination of sperm mitochondria on the basis of nuclear encoded proteins, and that this 
mechanism might be species-specific.  
 The results of the work conducted by Gyllensten et al. (1991) has been questioned by 
other researchers, who have suggested that the congenic strains of mice used in detecting 
paternal leakage may have retained a stable level of heteroplasmy and this heteroplasmy could 
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have arisen from mitochondrial fusion as was previously proposed to have occurred in a least 
one strain of mice produced by ooplasmic transfer (Meirelles and Smith, 1998). 
Nuclear-mitochondrial Interactions 
 Little is known about the coordination of expression between nuclear and mitochondrial 
genomes. Any alterations that arise in the components of the mtDNA or RNA that recognize and 
bind to nuclear-encoded regulatory elements must be balanced by compensatory mutations in the 
nuclear genes, as the mitochondrial genome mutates much more rapidly than the nuclear genome 
(Cummins, 1998). This interdependence is believed to drive the species-specificity previously 
observed in nuclear-mitochondrial interaction (Kenyon and Moraes, 1997).  
 In 1998, a study reported decreased physical and growth performance of congenic mice 
with mismatch between the nuclear and mitochondrial genomes (Nagao et al., 1998a). The type 
of mtDNA was also shown to affect the developmental ability of preimplantation congenic 
mouse embryos (Nagao et al., 1998b). In this study, the mtDNA-congenic strain was established 
from backcrossing Mus musculus female mice to B6 male mice for 20 generations and it was 
shown that the percentage of embryos reaching the blastocyst stage was reduced from 94 to 35% 
depending on their mtDNA composition. It was concluded that since in early embryonic 
development mitochondria contribute to the energy production in preimplantation embryos, their 
developmental ability may be influenced by the type of maternally derived mtDNA and possible 
incompatibilities among nuclear and mitochondrial genomes could impair early embryonic 
development.  
 In addition, the ubiquitin system has been implicated in the early degradation of 
paternally inherited mitochondria and ubiquitin-dependent proteolysis has been proposed to have 
a role in the recognition and selective elimination of paternal mitochondria and mtDNA after 
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fertilization in mammals (Smith and Alcivar, 1993b; Hiendleder et al., 2003; Nagao et al., 
1998b). 
Heteroplasmy 
 Most organisms seem intolerant of heteroplasmy for mtDNA, even though stable 
heteroplasmic lineages can be created artificially (Jenuth et al., 1996; Jenuth et al., 1997). When 
it occurs, it generally arises from de novo mutation during oogenesis and in humans is frequently 
associated with progressive mitochondrial bioenergetic diseases in the offspring (Cummins, 
1998). It is suspected that many homoplastic mutations are probably lethal in early 
embryogenesis, due to oxidative phosphorylation insufficiency (Shoffner and Wallace, 1990). 
 Ooplasm transfer (OT) is a technique that involves the transfer of a small amount 
(generally 5 to 15%) of foreign ooplasm into a recipient oocyte (Barritt et al., 2001a). The 
transfer of small amounts of donor ooplasm likely includes mRNAs, various proteins, mitochon-
dria, as well as, other factors and organelles (Barritt et al., 2001a) and it opens the possibility for 
the mixing of two different maternal mtDNA sources (heteroplasmy). Early studies in the animal 
field lead to the ultimate implementation of the ooplasmic transfer technique in humans. In 1996, 
work conducted by Levron et al. provided the basis for the first attempts of OT in humans, by 
obtaining mouse zygotes after fusion with synchronous and asynchronous cytoplasts. 
Heteroplasmic mice were produced after transfer of cytoplasts followed by electrofusion and 
demonstrated that mitochondrial genotypes in cytoplast- and karyotyped-reconstructed embryos 
were segregated during the preimplantation period (Meirelles and Smith, 1998).  
 Since the birth of a child was announced after OT (Cohen et al., 1997), the technique has 
become the subject of debate in the human field. Its application to overcome fertilization failures 
in older women has become a matter of concern due to the possibility of heteroplasmy of 
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mitochondrial DNA and related mitochondrial diseases, such as mitochondrial cytopathy, 
Kearns-Sayre Syndrome, Barth Syndrome, Alpers disease and mitochondrial encephalopathy. 
 Subsequently, researchers attempted to determine if active mitochondria were transferred 
from human donor oocytes to recipient oocytes, and if these mitochondria could persist in 
preimplantation embryos. Observations after 48 hours of transfer showed segregation of labeled 
mitochondria to some, but not to all, blastomeres and demonstrated the recipient oocyte 
contained a heteroplasmic population of mitochondria after ooplasmic transfer (Barritt et al., 
2001b). In addition, heteroplasmy was identified in 2 of 15 ooplasm transfer children using direct 
PCR (Brenner et al., 2000).  
 Although the underlying mechanisms of OT in the human are not known, it has been 
proposed that the injection of healthy donor mitochondria may give an additional ‘boost’ to 
compromised oocytes from infertile patients (Van Blerkom et al., 1995) and also may inhibit 
apoptotic mechanisms (Van Berklom et al., 1998). However, children born by this approach are 
potentially recipients of two nuclear DNA genomes, one from each parent; and two mito-
chondrial genomes, one from the mother and one from the ooplasm donor. The implications of 
the levels of heteroplasmy seen in these children are still under investigation.  
Interspecies Nuclear Transfer 
 There are basically two approaches to the success of the application of NT technology in 
any given species: (1) to adjust the multiple parameters that affect the overall efficiency of the 
NT procedure and (2) to explore the use of a more readily available, universal recipient ooplasm 
for NT in species were the availability of oocytes is restricted. 
 The bovine ooplasm has been shown to be able to reprogram somatic cell nuclei from 
other species. After transfer into enucleated, metaphase-II bovine oocytes, nuclei from sheep, 
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pig, monkey and rat skin cells underwent nuclear swelling. It was reported that cell division and 
formation of an embryonic blastocele cavity occurred at the time characteristic of embryos from 
the species of the donor nuclei (Dominko et al., 1999a). It must be noted, however, that no 
parthenogenically activated control was run in this study, as well as no pregnancies were 
reported. 
 Successful interspecies NT, either giving birth to live offspring or producing nearly 
termed fetuses, has been achieved by several groups concerned with the preservation of 
endangered species. When dermal fibroblasts of an endangered bovid, the gaur (Bos gaurus) 
(Lanza et al., 2000), granulosa cells from an endangered sheep, the mouflon (Ovis orientalis 
musimon) (Loi et al., 2001) and fetal fibroblasts from water buffalo (Bublaus bubalis) 
(Kitiyanant et al., 2001) were introduced into enucleated oocytes of cow, sheep and cow, 12%, 
30% and 33% of the reconstructed embryos developed to the blastocyst stage, respectively.  
 The first interspecies NT offspring was reported for the gaur by Lanza et al., (2000) but 
unfortunately died within the first 48 hours. Using domestic sheep (Ovis aries) as recipient 
cytoplasts two pregnancies were established after interspecies NT using an exotic argali (Ovis 
ammon) for donor karyoplasts, however both of these pregnancies were reported to have been 
lost by 59 days of gestation (White et al., 1999). More recently, domestic sheep (Ovis aries) 
enucleated oocytes used as cytoplasts for adult mouflon cells (Ovis orientalis musimon) resulted 
in one live offspring (Loi et al., 2001). 
 Other interspecies NT studies using the bovine cytoplast as a universal recipient included 
the injection of somatic cells from pigs (Yoon et al., 2001), saolas (Bui et al., 2002), elands 
(Damiani et al., 2003), horses (Li et al., 2002a; Sansinena et al., 2002), bears (Ty et al., 2003) 
and humans (Cibelli et al., 2001), however no confirmed pregnancies have been reported. In 
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addition, equine enucleated oocytes have been used as recipients for somatic cells from a mule 
fetus producing pregnancies (Woods et al., 2002) and three live offspring have been born 
(Woods et al., 2003) at the time of writing this literature review. 
 The use of alternative NT techniques, such as interspecies NT, is an exciting possibility 
for species with limited availability of oocytes and recipients as well as for endangered or exotic 
species. Although some studies have shown promising results initially, the mechanisms of 
nuclear reprogramming by the oocyte are still unknown and the extent of the ‘universality’ of the 
bovine cytoplast remains under investigation. 
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CHAPTER III 
EFFECT OF DIFFERENT PRETREATMENTS ON IN VITRO 
MATURATION OF EQUINE OOCYTES AND SUBSEQUENT  
SOMATIC CELL NUCLEAR TRANSFER EFFICIENCY 
 
Introduction 
 Somatic cell nuclear transfer (NT) has been accomplished in several species, including 
the sheep (Campbell et al., 1996b; Wilmut et al., 1997), cow (Cibelli et al., 1998; Kato et al., 
1998), mouse (Wakayama et a., 1998), goat (Baguisi et al., 1999), pig (Betthauser et al., 2000; 
Onishi et al., 2000; Polejaeva et al., 2000), gaur (Lanza et al., 2000), mouflon (Loi et al., 2001), 
rabbit (Renard et al., 2002), mule (Woods et al., 2003b), horse (Galli et al., 2003) and domestic 
cat (Shin et al., 2002). To date, NT in the horse has only been met with limited success. Because 
cloning is still an unpredictable and inefficient procedure, particularly if the end point is live 
offspring, the effect of the numerous variables on the overall outcome is difficult to separate. Of 
these variables, oocyte maturation, the source of nuclei used for NT, the fusion and the activation 
methods are among the most important aspects to be considered when comparing results among 
different laboratories (Galli et al., 2002).  
 Several cell types have been used successfully in bovine NT experiments, such as mural 
granulosa (Kato et al., 1998; Wells et al., 1999), leukocytes (Galli et al., 1999), cumulus 
granulosa (Alberio et al., 2001) and fetal and adult fibroblasts (Cibelli et al., 1998; Hill et al., 
2000c; Zakhartchenko et al., 2001; Galli et al., 2002). In the horse, sources of nuclei previously 
used for NT include cumulus (Hinrichs et al., 2000b), fetal and adult fibroblasts (Reggio et al., 
2000; Li et al., 2002b; Choi et al., 2003).  
 High fusion rates of equine adult somatic cells with equine oocytes have been previously 
reported form several laboratories. One of the early attempts of NT in the horse reported fusion 
 37 
rates of 81% for quiescent and 52% for proliferating adult equine fibroblasts (Reggio et al., 
2000). The same year, a fusion efficiency of 48% was reported for equine oocytes with equine 
somatic cells (Hinrichs et al., 2000b). More recently, greater fusion rates were reported when 
combining electrofusion with Sendai virus (82%) compared with the electrofusion technique 
alone (57%) (Li et al., 2002b). Although the fusion efficiencies reported by different laboratories 
for the horse are comparable to those previously reported for the cow (Cibelli et al., 1998; 
Campbell, 1999; Colman, 2000), this step is still a source of variability in the outcome of the NT 
procedure. To by-pass the necessity for fusion, Piezo-driven injection of equine somatic cells in 
combination with activation using equine sperm cytosolic factor were used for NT, reporting a 
cleavage rate as high as 51% (Choi et al., 2002a). Although an acceptable cleavage was obtained, 
only 11% of these embryos revealed the presence of normal nuclei after Hoechst-33342 staining.  
 Activation is another important component in the NT procedure. During the process of 
fertilization, sperm entry triggers a series of intracellular calcium oscillations critical to oocyte 
activation. Maturation promoting factor (MPF) and mitogen-activated protein (MAP) kinase are 
the most likely targets of calcium-stimulated events because inactivation of these kinases is a 
prerequisite to the resumption and completion of meiosis, subsequent pronuclear formation and 
the synthesis of DNA (Collas et al., 1993; Verlhac et al., 1994; Moos et al., 1996). Maturation 
promoting factor is a complex of two subunits: a catalytic subunit, p34cdc2 and a regulatory 
subunit, cyclin B (Doree and Galas, 1994). Association of these subunits and the subsequent 
activation of MPF occur in a specific order by dephosphorylation of the p34cdc2 subunit at 
threonine-14 and tyrosine-15, and by phosphorylation at threonine-161 (Schultz and Kopf, 
1995). Maturation promoting factor peaks at metaphase of the mitotic cycles in association with 
nuclear envelope breakdown, chromatin condensation, and the formation of the mitotic spindle 
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(Doree and Galas, 1994; Moos et al., 1996). Maturation promoting factor inactivation, which is 
necessary for the cell to exit mitosis, involves cyclin proteolysis by the proteosome system 
(Glotzer et al., 1991).  
 In vertebrates, mature oocytes are arrested at metaphase-II of the meiotic division, with 
elevated MPF activity maintained by a cytostatic factor (CSF), which prevents ubiquitin-
dependent degradation of cyclin B and thus, inactivation of MPF (Yanagimachi, 1994). 
Intracellular Ca2+ oscillations triggered by sperm down-regulate CSF activity and allow 
degradation of cyclin. Proteolytic degradation of cyclin B and subsequent MPF inactivation 
releases oocytes from metaphase arrest and allows the beginning or resumption of mitotic cycles 
(Lorca et al., 1993).  
 Different artificial activation treatments attempt to mimic sperm-triggered events and 
induce parthenogenic development in metaphase-II oocytes. Some of these treatments, such as 
ethanol, electroporation, calcium ionophore, ionomycin or inositol 1,4,5 triphosphate induce 
calcium oscillations and release the mitotic arrest (Presicce and Yang, 1994; Soloy et al., 1997; 
Liu et al., 1998; Mitalipov et al., 1999). However, the MPF activity is quickly restored with 
recondensation of chromosomes and the re-entry of activated oocytes into a new M-phase arrest, 
also known as metaphase-III. To prevent this, additional treatments that inhibit protein synthesis 
(cycloheximide, CHX) or protein phosphorylation (6-dimethylaminopurine, DMAP) must be 
used (Soloy et al., 1997; Liu et al., 1998). This has led to the use of sequential approaches with 
ionomycin/DMAP, calcium ionophore/CHX or inositol 1,4,5-triphosphate/DMAP that result in 
high activation and parthenogenic rates (Barcroft et al., 1998; Mitalipov et al., 1999). However, 
detrimental effects of the use of these non-specific, broad spectrum protein synthesis and/or 
kinase inhibitors are suspected.  
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 In the cow, the developmental competence of oocytes was compromised after blocking 
maturation at the germinal vesicle stage for 24 h with CHX or DMAP (Lonergan et al., 1997). In 
contrast, purine derivative compounds such as roscovitine, butyrolactone I or olomoucine, which 
specifically inhibit MPF and MAP kinase, have been used to delay meiotic progression of bovine 
oocytes without affecting their subsequent potential for development to the blastocyst stage in 
cattle (Mermillod et al., 2000; Lonergan et al., 2000). This also suggests that these components 
might have a potential application not only in the process of oocyte maturation (nuclear and 
ooplasmic) but also in promoting parthenogenic activation. 
 A small number of reports of oocyte activation have been published for the horse, either 
parthenogenically (Choi et al., 2001b; Hinrichs et al., 2002), after the use of cytoplasmic sperm 
injection (Grøndahl et al., 1997; Kato et al., 1997; Galli et al., 2000; Li et al., 2000; Hinrichs et 
al., 2002; Dell'Aquila et al., 2003) or somatic cell NT (Hinrichs et al., 2000; Reggio et al., 2000; 
Choi et al., 2002a; Li et al., 2002b; Li and Allen, 2002a; Choi et al., 2003; Lagutina et al., 2003; 
Li et al., 2003).  Recently, sperm cytosolic extract has gained attention as an alternative for the 
artificial activation of oocytes. A maximum of 49% cleavage rate was reported after 
parthenogenic activation of horse oocytes injected with various concentrations of stallion 
cytosolic sperm extract (Choi et al. 2002a, 2002b).  
 Even with numerous efforts, cleavage and blastocyst production after NT in the horse are 
still poor. Cleavage rates of 22% were reported after NT with a combination of Piezo-driven cell 
injection and activation using stallion cytosolic sperm extract (Choi et al. 2002a, 2002b), 
however, none of the embryos developed past the 10-cell stage in vitro. Recently, a novel 
approach to the NT procedure was described, in which horse oocytes were stripped of their zona 
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pellucidae prior to enucleation (Lagutina et al., 2003). Using this procedure, this group achieved 
an impressive 85% cleavage rate.  
 Only a few groups have produced in vitro cultured blastocysts after somatic cell NT in 
the horse (Li et al., 2002b; Lagutina et al., 2003). In an experiment comparing the development 
of horse oocytes reconstructed with nuclei of either fetal (FFC) or adult (SFC) equine fibroblasts, 
cleavage rates were 53% for FFC and 35% for SFC  and blastocyst rates were 4% for FFC and 
7% for SFC (Li et al., 2002b). Using the zona-free technique, a 4% blastocyst rate was obtained 
after 8 d of in vitro culture with SOFaa medium (Lagutina et al., 2003). 
 Although a few groups have produced cloned embryos in vitro, only one reported the 
establishment of an equid pregnancy in the scientific literature. Recently, several pregnancies 
were reported from mule fetal fibroblasts electrofused with in vivo matured equine oocytes and 
transferred immediately to the oviduct of synchronized recipient mares (Woods et al., 2002). 
Seven of the 195 (3.6%) transferred cloned mule embryos resulted in embryonic vesicles. 
Although only one vesicle developed into an embryo proper detectable by ultrasonography, all 
seven pregnancies were spontaneously resorbed between d 27 and 61 of gestation. It was this 
group that reported the live birth of two cloned, healthy mules at the time of writing this 
literature review (Woods et al., 2003). Following the announcement of the first two cloned 
equids, the live birth of a cloned horse was announced (Galli et al., 2003). Prometea, a healthy 
filly, was carried to term by the same mare that originated the donor cell line, making the first 
cloned horse born from its twin dam. 
The low efficiency of the somatic cell NT procedure requires that large numbers of 
meiotically competent equine oocytes be available for maturation. In vitro maturation rates of 
equine oocytes have been reported by several laboratories, and are generally lower and more 
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variable than those of other domestic species (Hinrichs et al., 1993; Del Campo et al., 1995; 
Squires, 1996; Alm and Hinrichs, 1996; Choi et al., 1993; Hinrichs and Schmidt, 2000a; Franz et 
al., 2001; Hinrichs et al., 2002; Dell'Aquila et al., 2003; Marchal et al., 2003;). Although the 
source of this variability is still unknown, it has been attributed in part to the selection of oocytes 
for in vitro culture. A recent study evaluated oocyte meiotic competence as related to granulosa 
cell apoptosis reported that, although follicle size was not significantly correlated to apoptosis, 
the proportion of oocytes maturing in vitro was significantly greater in oocytes issuing from 
apoptotic follicles than in those issuing from healthy ones (Dell'Aquila et al., 2003). In addition, 
it was found that significantly more oocytes with expanded cumulus (Exp) than compact 
cumulus (Cp) originated from apoptotic follicles. This supports previous studies that reported the 
Cp oocytes having a lower meiotic competence (Alm and Hinrichs, 1996; Hinrichs and 
Williams, 1997) and slower maturation rate (Hinrichs et al., 1993; Zhang et al., 1989; Alm and 
Hinrichs, 1996) than Exp oocytes. 
The method of oocyte collection has also been proposed to have a significant impact on 
the outcome of in vitro oocyte maturation. Using abattoir-derived ovaries, aspiration of follicles 
resulted in a lower oocyte recovery rate and higher prevalence of oocytes with partial cumulus 
when compared to follicle scraping (Dell'Aquila et al., 2001). Although these results may 
indicate differences in collection techniques, the fact that transvaginal ultrasound-guided aspi-
ration (TUGA) allows repeated collection of equine oocytes without the need of a surgical 
procedure often makes it the only alternative to obtain equine oocytes for research or clinical 
procedures. Previous observations at this laboratory suggested that the oocyte recovery rate from 
small follicles (<20 mm) was higher than from larger follicles, and a larger pool of small follicles 
was available for TUGA at any given time (Hylan, personal communication). Although other 
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laboratories (Hinrichs et al., 1990) have reported lower meiotic competence of the oocytes from 
small (<20 mm) follicles, an effort was made to study the proportion of those maturing in vitro 
and determine if oocytes from small follicles would be suitable for NT procedures.  
Oocyte maturation, both nuclear and ooplasmic, is an important aspect in the 
development of somatic cell NT procedures for the horse. Ooplasmic oocyte maturation involves 
the synthesis of proteins from nuclear and mitochondrial transcripts used during early embryonic 
development. Recently, purine derivatives directed toward the inhibition of MPF have gained 
attention as a way to maintain oocytes at the GV stage, while allowing ooplasmic maturation to 
take place in vitro. With the overall objective of increasing the number of mature, metaphase-II 
oocytes available for NT, a first experiment was conducted to evaluate the nuclear status of 
equine oocytes matured in vitro using a sequential maturation medium. A second study was 
conducted to evaluate the effect of roscovitine prematuration in oocytes from small equine 
ovarian follicles and to use these in vitro matured oocytes for equine NT procedures. 
Materials and Methods 
Experiment 3.1 
Oocyte Collection 
 Twenty-nine normally cycling, mixed-breed mares of good body condition scores (body 
condition scores ranged from 6 to 8 on a scale of 1 to 9) were selected for a single aspiration 
after ≥28 d of no stimulation during the 2002 breeding season. Oocytes were aspirated using the 
ultrasound-guided follicular aspiration technique previously reported by this laboratory (Cochran 
et al., 1998, 2000). All follicles >5 mm of diameter were aspirated. Briefly, a 12-gauge double-
lumen stainless steel needle (Cook® Veterinary Products, Inc., Bloomington, IN) was inserted 
through the vaginal wall via a transvaginal ultrasonic transducer attached to a needle guide. 
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Negative pressure (~90 mm Hg) was constantly applied using a vacuum pump while oocyte 
collection medium (phosphate-buffered solution, 2% calf serum (HyClone, Logan, UT), 2 USP 
units of heparin and 100 units of penicillin-G/mL) was flushed into the follicle cavity at least 8 
times, while the follicle was massaged rectally. Sufficient pressure was applied by the incoming 
oocyte collection medium to expand the follicle wall and to allow detachment of the cumulus-
oocyte complex (COC). The aspirate was collected in autoclaved glass 500 mL bottles. No 
attempt was made to separate aspirates by follicular size and contents were searched for COC 
under a dissecting microscope. 
Oocyte Maturation 
 Cumulus-oocyte complexes were randomly allocated to one of five treatments (Table 
3.1). Oocytes were exposed to pre-maturation medium consisting of 100% preovulatory 
follicular fluid supplemented with 75 µM of roscovitine. Pre-maturation was allowed for 0 to    
24 h, followed by a 24- to 36-h exposure to the maturation medium. The maturation medium was 
the same for all the treatment groups, and consisted of TCM-199, 10% FBS, 5 µg/mL of FSH,  
10 µg/mL of LH, 1 µg/mL of E2, 100 ng/mL of EGF and 100 ng/mL of IGF-1. At the end of 
maturation, oocytes were denuded of cumulus by vigorous pipetting for 2 to 3 min in TL-HEPES 
containing 100 units/mL of hyaluronidase (Sigma, St. Louis, MO). Oocytes were labeled with    
2 µg/mL of Hoechst-33342 for 3 min and then observed with epifluorescent illumination to 
visualize the metaphase plate and assess nuclear status. 
Experiment 3.2 
Oocyte Collection and Maturation 
Twenty-nine mixed-breed, cycling mares of good body condition score (body condition 
scores ranged from 6 to 8 on a scale of 1 to 9) were aspirated for 6 consecutive times during the  
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Table 3.1. Sequential prematuration and maturation of equine in vivo-harvested oocytes  
 
   Treatment No. oocytes Time in pre-maturation 
medium (h) 
Time in maturation 
medium (h) 
Total time in vitro (h) 
   A 7 12-13 24 36-37 
   B 16 14-17 24 38-41 
   C 27 18-20 25 43-45 
   D 21 22-24 26 48-50 
   E 36 0 36 36 
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2002 breeding season. The mares were treated daily with 0.444 mg of altrenogest (Regumate®, 
Hoechst Roussel Vet., Warren, NJ) per kg of body weight for a total period of 91 d (d 1 = first 
day of treatment) for the duration of the experiment.  
During periods of progesterone dominance such as pregnancy, both cattle (Ginther et al., 
1989) and mares continue to show follicular wave emergence and growth (Ginther and Bergfelt, 
1992). Oral altrenogest, a synthetic progestin, has been shown to reduce the occurrence of 
follicular dominance in mares (Lofstedt et al., 1989). Since previous studies have shown that 
oocytes collected from pregnant donor mares are viable and capable of producing live foals 
(Cochran et al., 1998; Meintjes et al., 1995), the altrenogest treatment used in our study aimed at 
inducing a pseudopregnant state in the mares in which follicular dominance would be minimized 
and large numbers of follicles could be aspirated.    
Seven days after the initiation of altrenogest treatment, all mares were subjected to a 
follicle ablation procedure, during which all ovarian follicles >5 mm in diameter were punctured 
and follicular fluid was collected via TUGA. The objectives of performing follicular ablation 
were (1) to remove all atretic follicles present and (2) to induce a new wave of follicular growth 
for subsequent oocyte collection procedures.  
After the follicle ablation procedure, all mares were aspirated for oocyte collection at   
14-d intervals. Ultrasound-guided oocyte collection was performed as described in Experiment 
3.1. At the time of aspirations, follicles were classified as pre-ovulatory (>35 mm diameter, not 
used in this experiment), subordinate (20-35 mm diameter) or small (<20 mm diameter). The 
oocytes recovered from subordinate follicles were subjected to in vitro maturation (IVM) in 
TCM-199, 15% estrous mare serum, 5 µg/mL of FSH, 10 µg/mL of LH and 1 µg/mL of E2 for 
36 h.  Oocytes aspirated from small follicles were randomly allocated to IVM only or pre-treated 
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for 48 h prior to IVM in roscovitine (50 µM) prepared in TCM-199. At the end of treatment, 
oocytes were stripped of cumulus by pipetting in TL-HEPES containing 100 units/mL of 
hyaluronidase. Nuclear maturation was assessed by visualization of first polar body using a 
dissecting scope and NT procedure was performed on metaphase-II oocytes. 
Nuclear Transfer 
 Only mature, metaphase-II oocytes with intact membrane and good ooplasmic mor-
phology were used for NT. Oocytes were labeled with 3 µg/mL of Hoechst-33342 for 3 min to 
allow observation of nuclear DNA under UV illumination. The oocytes were then washed in 
modified TL-HEPES (mTLH; TL-HEPES supplemented with 10% FBS and 0.1% gentamicin) 
and placed in an elongated 150-µL micromanipulation droplet containing 0.2 µg/mL of 
cytochalasin D (Sigma). The micromanipulation droplet was overlaid with mineral oil (Sigma, 
embryo tested). All micromanipulations of equine oocytes were conducted on the stage of an 
inverted microscope (Nikon Diaphot) equipped with Hoffman Modulation Contrast objectives, 
Narishige micromanipulators, Uniblitz VMM-D1 shutter system (Vincent Associates, Rochester, 
NY) and epifluorescent illumination. A 120-µm diameter (o.d.) pipette was used to hold the 
oocytes by negative pressure.  
 After a brief exposure (<5 s) to ultraviolet light to visualize nuclear DNA, the metaphase 
spindle with a small amount of surrounding ooplasm was removed by negative pressure applied 
to a 15-µm enucleation pipette. Because of the inherent fragility of equine oocytes, no attempt 
was made to remove the first polar body. Once enucleated, the cytoplasts were held in modified 
TCM (mTCM; TCM-199 supplemented with 10% FBS and 0.1% gentamicin) at 38.5ºC and    
5% CO2 in humidified air.  
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 Female adult equine fibroblasts used as nuclear donors were at passage three of culture. 
Donor cells were serum starved (0.5% FBS) for 3 to 5 d to induce presumptive quiescence prior 
to NT procedures. Reconstruction was performed in a 200-µL elongated droplet of mTLH     
containing 0.2 µg/mL of cytochalasin D overlaid with mineral oil (Sigma, embryo tested). A sin-
gle adult fibroblast was inserted into the perivitelline space of an enucleated oocyte. Fusion of 
karyoplast-cytoplast couplets was performed in a microslide fusion chamber with stainless steel 
electrodes separated by a 1-mm gap. The chamber was filled with fusion buffer (0.3 M mannitol, 
0.1 mM MgSO4⋅7H2O, 0.05 mM CaCl2, 0.5 mM HEPES and 4 mg/mL of BSA (Fraction V, 
Sigma). The couplets were then fused by two consecutive DC pulses (3.0 kV/cm for 30 µs) 
delivered by a BTX Electrocell Manipulator 200 (Genetronics, San Diego, CA). Couplets were 
evaluated for fusion by microscopic examination within a 1-h period. Chemical activation was 
performed with a 5-min exposure to 5 µM of ionomycin (Sigma) and 6 min in TL-HEPES with 
30 mg/mL of BSA (Fraction V, Sigma) followed by a 3-h incubation period in 10 µg/mL of 
cycloheximide (Sigma) with 6 µg/mL of cytochalasin D prepared in CR1aa medium (Rosenkrans 
et al., 1993).  
 After micromanipulation, embryos were cultured for 48 h in 35-µl droplets of CR1aa 
medium in a modular incubator chamber (Billups-Rothenberg, Del Mar, CA) at 38.5ºC and 5% 
O2, 5%CO2 and 90% N2. 
Results 
Experiment 3.1 
 A total of 192 follicles were punctured in 29 cycling mares in a single aspiration and a 
total of 115 oocytes were recovered (60% recovery), yielding a mean of 3.96 oocytes/mare. A 
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total of 107 of these oocytes were classified as non-degenerate and randomly allocated to five 
treatments.  
 Nuclear status results are summarized in Table 3.2. Of the 7 oocytes allocated to 
Treatment A (12 to 13 h of prematuration + 24 h of maturation), 1 (14%) was found to be in the 
germinal vesicle (GV) stage, 1 (14%) was in the germinal vesicle breakdown (GVBD) stage,      
1 (14%) was in metaphase-I (M I) stage, 1 (14%) was in metaphase-II (M II) stage and 3 (43%) 
were degenerate. Of the 16 oocytes allocated to Treatment B (14 to 17 h of prematuration + 24 h 
of maturation), 3 (19%) were found to be in GV stage, 2 (12%) were in GVBD stage, 7 (44%) 
were in M I stage, none (0%) were in M II stage and 4 (25%) were degenerate. Of the 27 oocytes 
allocated to Treatment C (18 to 20 h prematuration + 25 h maturation), 3 (11%) were found to be 
in GV stage, 2 (7%) were in GVBD stage, 13 (48%) were in M I stage, 1 (4%) was in M II stage 
and 8 (30%) were found to be degenerate. Of the 21 oocytes allocated to Treatment D (22 to 24 h 
prematuration + 26 h maturation), 3 (11%) were found to be in the GV stage, none (0%) were in 
the GVBD stage, 11 (52%) were in the M I stage, 4 (19%) were in M II stage and 3 (14%) were 
found to be degenerate. Of the 36 oocytes allocated to Treatment E (0 h prematuration + 26 h 
maturation), 2 (5%) were found to be in the GV stage, none (0%) were in GVBD stage, 6 (17%) 
were in M I stage, 22 (61%) were in M II stage (Figure 3.1) and 6 (17%) were degenerate.  
Experiment 3.2 
 Of a total of 346 ovarian follicles collected in 6 aspirations, 71 (20%) were classified as 
subordinate (20-35 mm) and 275 (80%) follicles were classified as small (<20 mm) at the time of 
TUGA. A total of 217 oocytes were recovered from 346 follicles for an overall recovery rate of 
63%. When classified according to follicular size, 71 subordinate follicles yielded 24 oocytes 
(34% recovery), whereas, 275 small follicles wielded 193 oocytes (70% recovery rate). 
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Table 3.2. Nuclear status of in vitro matured equine oocytes after sequential prematuration and 
maturation treatments 
 
Treatment No. oocytes GV (%)a GVBD (%)b MI (%)c MII (%)d Degenerate (%) 
 
A 
 
7 
 
1 (14) 
 
1 (14) 
 
1 (14) 
 
1 (14) 
 
3 (43) 
B 16 3 (19) 2 (12)  7 (44) 0 (0) 4 (25) 
C 27 3 (11) 2 (7) 13 (48) 1 (4) 8 (30) 
D 21 3 (11) 0 (0) 11 (52) 4 (19) 3 (14) 
E 36 2 (5) 0 (0) 6 (17) 22 (61) 6 (17) 
aGerminal vesicle. 
bGerminal vesicle breakdown. 
cMetaphase I. 
dMetphase II. 
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Figure 3.1. Equine oocytes allocated to Treatment E (Experiment 3.1). (a) Prior to IVM, 20 X objective. (b) After 26 h of IVM, 
10 X objective. (c) Metaphase-II oocyte, 40 X objective. 
 
a b c
40 µm 
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 Results of this experiment are summarized in Table 3.3. Of a total of 24 oocytes 
recovered from subordinate follicles, 12 (50%) reached metaphase-II stage after 36 h of in vitro 
maturation. Of these mature oocytes, 9 (75%) were successfully enucleated, as evidenced by 
intact oolema after removal of first polar body, 7 (78%) survived reconstruction without lysing 
and 5 (71%) were fused.  
 A total of 193 oocytes were recovered from small follicles, and these were randomly 
allocated to IVM (n = 100) or roscovitine pre-maturation followed by IVM (n = 93). Of the 100 
oocytes allocated to IVM, 66 (66%) reached the metaphase-II, 30 (45%) were successfully 
enucleated, 22 (73%) were reconstructed and 12 (55%) fused. Of the 93 oocytes allocated to 
roscovitine pre-maturation followed by IVM, 53 (57%) reached the metaphase-II, 30 (57%) were 
successfully enucleated, 20 (67%) were reconstructed and none (0%) fused. However, signifi-
cantly more (P<0.05) couplets fused with ova from subordinate and small (IVM) treatments 
compared with the small (roscovitine + IVM) treatment (71%, 55% and 0%, respectively). 
Discussion 
 One of the largest obstacles in establishing a repeatable protocol for NT for the horse is 
the inability to collect and mature large numbers of good quality oocytes from donor mares. The 
low follicle number per ovary (Hinrichs, 1991; Hinrichs et al., 1993; Del Campo et al., 1995), the 
difficulty recovering oocytes from follicles (Hawley et al., 1995) and the scarce information 
regarding the process of selection of oocytes for optimal meiotic and developmental competence 
(Dell'Aquila et al., 2001) are key factors contributing to the overall inefficiencies.   
 Although transvaginal aspiration of follicles has been reported to yield lower recovery 
rates than follicle scraping (Dell'Aquila et al., 2003), the lack of abattoir-derived ovaries has 
made TUGA the only alternative for oocyte collection in this laboratory.  In the past, oocyte  
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Table 3.3.  Effect of oocyte source (by follicle size) and roscovitine pretreatment on in vitro 
maturation and nuclear transfer efficiency 
 
 
Treatment  
No. 
oocytes 
No. (%)  
Mature 
No. (%)  
enucleated
No. (%)  
reconstructed 
No. (%)  
fused 
 
Subordinate (IVM only) 
 
24 
 
12 (50) 
 
9 (75) 
 
7 (78) 
 
5 (71)a 
Small  (IVM only) 100 66 (66) 30 (45) 22 (73) 12 (55)a 
Small (Roscovitine + IVM) 93 53 (57) 30 (57) 20 (67) 0 (0)b 
Total 217 131 (60) 69 (53) 49 (71) 17 (35) 
 abValues in columns with different superscripts are different (Chi square, P<0.05). 
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recovery rates for small, unstimulated follicles have been reported to be lower than those from 
larger, preovulatory follicles (Hinrichs et al., 1990) and recovery rates were reported to increase 
with follicular size, which also reflected increased oocyte maturity and tendency toward 
expanded cumuli. However, results from this laboratory (Hylan, personal communication) 
revealed there is a larger number of small (<20 mm) than large (>20 mm) follicles present in the 
ovary at any given time, regardless of the stimulation protocol. 
 In this study, treatment with oral altrenogest in combination with follicle reduction after  
7 d of initiation of treatment resulted in a larger (80%) population of small ovarian follicles at the 
time of TUGA. Interestingly, the oocyte recovery rate according to follicular size was also higher 
for small follicles than for follicles larger than >20 mm (70 vs. 34% recovery). This observation 
is consistent with previous results for this laboratory, but is not in agreement with results 
previously reported by other groups. Previously, oocyte recovery from small, immature follicles 
has been reported to be as low as 1 to 16% (Vogelsang et al., 1983; Palmer et al., 1987). It was 
proposed that the close attachment of the immature COC to the follicular wall might make the 
oocytes from small oocytes less likely to be aspirated. It must be noted, however, that this 
recovery rate was obtained using the technique of puncturing the follicle with a needle through 
the flank while the ovary was manipulated per rectum and not using TUGA. In our study, every 
follicle is flushed, the follicular wall is stretched and massaged numerous times, which may have 
made the COC more likely to detach after repeated flushes and aspirations. 
 Oocyte maturation and differentiation is a complex process starting during fetal life and 
culminating in a preovulatory follicle as the oocyte reaches its full competence to resume meiosis 
and successfully accomplish both nuclear and ooplasmic aspects of maturation (Mermillod et al., 
2000). Nuclear maturation is characterized by chromatin condensation, disappearance of the 
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nucleolus and disassembly of the nuclear membrane, leading to GVBD (Krischek and Meinecke, 
2001). The GV stage is an important stage for the transcription and translation, not only for 
stage-specific molecules needed for GVBD, but also for synthesis and storage of transcripts and 
proteins that play an important role in further embryo development (Khatir et al., 1998).  
 The importance of terminal oocyte differentiation during late folliculogenesis was 
demonstrated by comparing maturation and developmental potential of oocytes harvested from 
follicles of different sizes in various species (Mermillod et al., 2000). When a meiotically 
competent oocyte is removed from its follicular environment, it spontaneously resumes meiosis. 
This meiotic resumption involves condensation of chromosomes, which results in the block of 
the transcription process (Lonergan et al., 1994; Wu et al., 1996). Therefore, an oocyte that is re-
moved from the follicular environment in the early stages, such as oocytes from smaller size 
follicles, is deprived of important steps in its differentiation.  
 Early attempts to maintain oocytes at the GV stage to allow further ooplasmic maturation 
included prematuration in follicular fluid (Tsafriri and Channing, 1975; Aguilar et al., 2001), co-
culture with mural granulosa (Van Tol et al., 1996) or theca cells (Richard and Sirard, 1996) 
cells, although these treatment showed only a temporary arrest of the oocyte in GV stage. 
Because resumption of meiosis is highly dependent on the MPF activation, chemical approaches 
such as the inhibition of protein synthesis with cycloheximide (Lonergan et al., 1997; Saeki et 
al., 1997) or the inhibition of phosphorylation with 6-DMAP (Saeki et al., 1997) have previously  
been attempted. However, the nonspecific nature of these compounds resulted in the loss of 
developmental potential at the end of the prematuration treatments. Recently, the use of more 
specific inhibitors to maintain oocytes at the GV stage has gained considerable attention. 
Specific cdc-kinase inhibitors; such as butyrolactone I (Lonergan et al., 2000), roscovitine 
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(Mermillod et al., 2000; Krischek and Meinecke, 2001; Marchal et al., 2001; Franz et al., 2002; 
Lagutina et al., 2002) or their mixture (Ponderato et al., 2001) have been used to prevent meiotic 
resumption without compromising further developmental potential.   
 In our study (Experiment 3.1), the prematuration of oocytes pooled from all follicle sizes 
in roscovitine with follicular fluid did not improve nuclear maturation rates obtained after per-
missive maturation. In fact, the highest maturation rate was obtained when oocyte maturation 
was conducted in maturation medium alone (Treatment 5), indicating the incubation in follicular 
fluid with roscovitine for a prolonged period of time may have negatively affected not only 
ooplasmic maturation, but also the ability of the chromosomes to condense and resume the 
normal steps of nuclear maturation.  
 Studies conducted previously with the bovine model reported that follicular fluid from 
both small and medium follicles had the greatest ability to keep oocytes in GV stage, however, 
follicular fluid from large follicles at estrus had less ability to inhibit GVBD (Ayoub and Hunter, 
1993). It is possible that the preovulatory equine follicular fluid used in this study was ineffective 
in arresting equine oocytes at the GV stage, although assessment of the nuclear status of the 
oocytes at the end of the in vitro prematuration and prior to maturation should have been 
conducted to support this statement.  
 In our study (Experiment 3.2), the pretreatment of oocytes from small follicles in 
roscovitine did not have a significant effect on the proportion of oocytes reaching the metaphase-
II stage after maturation. This is in agreement with previous studies that have shown that, 
although roscovitine was effective in maintaining the oocytes in meiotic arrest, the nuclear 
maturation rates were not significantly affected by the preincubation treatment (Khatir et al., 
1998; Mermillod et al., 2000; Ponderato et al., 2001; Franz et al., 2002). Although roscovitine, 
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butyrolactone and other purine derivatives have been shown to be effective in maintaining 
meiotic arrest for prolonged periods of time, the beneficial effects of the permissive ooplasmic 
maturation on oocyte maturation and embryo development still remain to be demonstrated. 
Numerous studies in different species, such as the cow (Lonergan et al., 1997; Mermillod et al., 
2000; Ponderato et al., 2001), pig (Krischek and Meinecke, 2001; Marchal et al., 2001) and horse 
(Franz et al., 2002; Franz et al., 2003) have achieved effective arrest in a dose-dependent manner 
and have shown the arresting effect to be fully reversible. However, roscovitine was recently 
shown to increase developmental potential of Cp equine oocytes but not of Ex oocytes after ICSI 
(Franz et al., 2003).  
 Interestingly, our study (Experiment 3.2) showed that none of the roscovitine-treated 
oocytes from small follicles fused after NT. A previous study in the cow had also reported a 
significantly lower cleavage rate after NT with oocytes pretreated with roscovitine for 24 h 
(Lagutina et al., 2002). Because in our study the roscovitine-treated oocytes remained in culture 
for approximately 84h (48 h roscovitine + 36 h IVM), it is possible that membrane stability 
might have been compromised. This would explain the lack of fusion in that treatment, and more 
research is needed to clarify this point.  
 In conclusion, our study showed that it is possible to obtain acceptable maturation rates in 
oocytes from small follicles and use these oocytes in NT procedures. Although at this point the 
value of the roscovitine treatment remains questionable, compounds that inhibit the meiotic 
resumption of oocytes could potentially be used to pool equine oocytes in larger groups before 
entering in vitro maturation, thus facilitating the subsequent procedure of NT. 
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CHAPTER IV 
PRODUCTION OF NUCLEAR TRANSFER LLAMA (Lama glama) 
EMBRYOS FROM IN VITRO MATURED LLAMA OOCYTES 
 
Introduction 
 The Camelidae family consists of two genera: Camelus and Lama. The genus Lama is 
comprised of four species: the llama (Lama glama), the alpaca (Lama pacos), the guanaco (Lama 
guanicoe) and the vicuña (Lama vicugna). These four species are collectively known as the 
South American or New World camelids (Bravo et al., 2000). During the last two decades the 
worldwide demand for domestic South American camelids has increased mainly due to their 
value as exotic pets. However, the application of assisted reproductive technologies has proven 
difficult in these species due to inherent characteristics of their reproductive physiology.  
 Llamas are induced ovulators; therefore, they do not exhibit a typical estrus but rather 
prolonged periods of receptivity followed by brief episodes of anestrous behavior (San-Martin et 
al., 1968; England et al., 1969). Ovarian follicles develop in waves with an interval of 15 to 20 d 
(Adams et al., 1990) and in the absence of pregnancy the corpus luteum declines approximately 
10 d after infertile copulation (Sumar, 1983; Aba et al., 1995). Consequently, these animals have 
a shorter luteal phase than spontaneously ovulating ruminants. The absence of a spontaneously 
occurring luteal phase during which traditional superovulatory agents are normally administered, 
in addition to the presence of a dominant follicle that prevails for an extended period of time in 
pregnant females, makes the synchronous stimulation of small follicles difficult to achieve. 
Several approaches have been attempted, including the administration of 1,000 IU of equine 
chorionic gonadotropin (eCG) given to females during an induced luteal phase (Bourke et al., 
1992, 1995), treatment with 500 IU of eCG, 220 mg of FSH in descending doses over 4 d or a 
combination of both during estrus (Correa et al., 1997). More recently, a 52% oocyte recovery 
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was achieved by transvaginal ultrasound guided follicular aspiration (TUGA) in females that 
were superstimulated with a combination of 100 IU of eCG and 400 mg of FSH (Follitropin®) 
over a 6-d period (Brogliatti et al., 2000).  
 In vitro maturation (IVM) and in vitro fertilization (IVF) have also been attempted in 
South American camelids (Del Campo et al., 1992, 1994). Abattoir-derived oocytes matured in 
TCM-199 plus gonadotropins and fetal calf serum at 38°C and 5% CO2 under humidified 
atmosphere achieved a 62% nuclear maturation rate (metaphase-II stage). In another study, 
nuclear maturation of 30% was reported after 30 h of in vitro maturation (Del Campo et al., 
1994). This was also the first report of IVF-derived embryos produced in the llama, produced 
with epididymal spermatozoa and co-cultured in medium with llama oviduct epithelial cells 
(LOEC) for 9 d.  
 Since Wilmut et al., (1997) announced the birth of the first mammal cloned by the 
procedure of somatic cell nuclear transfer (NT) other species have been produced by the transfer 
of a differentiated somatic cell into an enucleated oocyte, namely the cow (Cibelli et al., 1998; 
Kato et al., 1998), mouse (Wakayama et a., 1998), goat (Baguisi et al., 1999), pig (Betthauser et 
al., 2000; Onishi et al., 2000; Polejaeva et al., 2000), gaur (Lanza et al., 2000), mouflon (Loi et 
al., 2001), rabbit (Renard et al., 2002), domestic cat (Shin et al., 2002), mule (Woods et al., 
2003) and horse (Galli et al., 2003). This technology has potential applications in livestock 
breeding (Wilmut et al., 2000), biotechnology and the pharmaceutical industry (Ziomek, 1998), 
human medicine (Lanza et al., 1999a, 1999b), companion animals (Westhusin et al., 2001) and 
endangered species (Lanza et al., 2000).  
 To date, there have been no reports of somatic cell NT in llamas. The application of this 
technique to the llama industry could be helpful in the propagation of genetically valuable 
 59 
animals. Also, future experiments in interspecies NT using llama oocytes as hosts and vicuña 
donor cells could potentially aid in the conservation and propagation of endangered species. 
Such applications of the NT technology will be feasible once the basic procedure has been 
established for the llama. Therefore, the main objective of this study was to perform somatic cell 
NT in the llama. In addition, two different NT embryo culture protocols for this species were 
compared.  
Materials and Methods 
Preparation of Adult Llama Fibroblast Donor Cells 
 All skin biopsies (Figure 4.1) were obtained from a llama herd located in Bozeman, 
Montana (Genesearch, Inc., Bozeman, MT). To obtain primary cultures, the skin biopsy was 
placed in a 35 x 10-mm Falcon™ petri dish (Becton and Dickinson, Lincoln Park, NJ). Using 
sterile curved scissors, dermal tissue was finely minced to a smooth consistency. Culture 
medium consisting of TCM-199 (Gibco, Grand Island, NY), 15% fetal bovine serum (FBS, 
HyClone, Logan, UT) and gentamicin (Gibco) was added. Tissue suspension was transferred to a 
15-mL centrifuge tube using a sterile transfer pipette, and washed by swirling the tube and 
allowing the tissue to settle in the bottom. Supernatant was discarded and 3 mL of new culture 
medium was added. This process was repeated three times, after which tissue was transferred to 
a 35-mm petri dish. Excess medium was aspirated leaving 500 to 700 µl to ensure good oxygen 
tension over the tissue. All cultures were conducted at 38.5ºC and 5% CO2 in humidified 
atmosphere. Once a fibroblast cell layer was established, the cells were grown in 25-cm2 tissue 
culture flasks (Costar™, Cambridge, MA) until they reached 95% confluency. Cells were then 
trypsinized (Sigma, St. Louis, MO) counted in a hemacytometer, and re-seeded at a density of 
100,000 cells in 25-cm2 tissue culture flasks. After two subpassages, the cultured cells were      
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Figure 4.1.  Donor llama used for nuclear transfer. (a) Pure Argentine female llama used 
as karyoplast donor (picture courtesy of Paul and Sally Taylor, Bozeman, MT). (b) Adult 
female llama fibroblasts (Rebaño Escondido Querencia) after three subpassages prior to 
nuclear transfer procedure, 40 X objective.  
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exposed to a cryoprotectant solution consisting of TCM-199, 20% calf serum, 5% dimethyl-
sulfoxide (DMSO) and frozen in aliquots of 500,000 cells per vial. To prepare adult fibroblasts 
as donors for NT, cells were thawed and cultured in TCM-199 containing 15% FBS and 
gentamicin in 25-cm2 tissue culture flasks.   
Superstimulation, Oocyte Recovery and Maturation  
 Llama superstimulation was conducted in Bozeman, MT during the month of September.  
Fourteen adult female llamas (ages 2 to 16 years) with good body condition (scores 6 to 8 on a 1 
to 9 scale) were available for superstimulation. The superstimulation protocol (Figure 4.2) 
consisted of an initial dominant follicle removal (DFR) on the morning of d 0. Dominant follicle 
removal and manual rupture of the follicle was performed by rectal manipulation, followed by 
confirmation with ultrasonography. A second DFR was performed 12 d later, after which 
gonadotropin stimulation was immediately initiated. Gonadotropin stimulation consisted of a 
total dose of 200 mg of FSH (Follitropin-V, Vetrepharm, Ontario, CA) in twice daily (i.m.) doses 
(50, 30, 20 mg) over a 3-d interval.  
 Llamas were ultrasounded for ovarian structures on d 15 after initiation of stimulatory 
treatment and classified as good (>15 ovarian follicles), medium (10 to 15 ovarian follicles) or 
poor (<10 ovarian follicles) responders. Only those llamas classified as good and medium res-
ponders were selected for ovary recovery. Ovariectomies were performed by flank laparotomy 
on d 16 after initiation of the superstimulation protocol. Excised ovaries were rinsed with 
phosphate-buffered solution (PBS) and oocytes were aspirated using a 20-g needle attached to a 
10-ml syringe. Once aspirated, the follicles were sliced and walls were scraped with a scalpel 
blade into a search dish. Recovered cumulus-oocyte complexes (COC) were evaluated as 
follows: grade 1 (denuded), grade 2 (corona radiata only), grade 3 (multiple layers of compact  
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Figure 4.2.  Llama superstimulation protocol using porcine follicle stimulating hormone (pFSH). 
Dominant follicle reduction (DFR) was performed on d 0 (a.m.) and d 12 (a.m.) of treatment.  
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cumulus), grade 4 (expanded cumulus layer) and degenerate. All COC (except degenerate 
oocytes) were included in the study. Groups of 100 COC were rinsed and placed in maturation 
medium in sterile 5-ml culture test tubes (Fisherbrand, Pittsburgh, PA). The maturation medium 
consisted of TCM-199, 5 µg/mL of FSH (F-2293 Sigma), 10 µg/mL of LH (L-9773 Sigma),       
1 µg/mL of estradiol 17β (E-2758 Sigma) and 10% FBS. Tubes were placed in a portable 
incubator at 39ºC and transported to the LSU Embryo Biotechnology Laboratory at Louisiana 
State University, Baton Rouge, Louisiana for nuclear transfer procedures. After 30 h of 
maturation, oocytes were stripped of their cumulus investments by pipetting repeatedly in       
TL-HEPES (BioWittaker, Walkersville, MD) supplemented with 210 units/mL of hyaluronidase 
(Sigma). The oocytes were washed in modified TL-HEPES (mTLH; TL-HEPES supplemented 
with 10% FBS and gentamicin) and nuclear maturation was established by visualization of the 
first polar body under a dissecting microscope.  
Nuclear Transfer 
 Groups of 25 metaphase-II llama oocytes were labeled with 2 µg/mL of Hoechst-33342 
for 3 min to allow visualization of the metaphase plate. Micromanipulation was performed in a 
180-µL elongated droplet of mTLH containing 6 µg/mL of cytochalasin D (Sigma) overlaid with 
mineral oil (Sigma). All micromanipulations were conducted on an inverted microscope (Nikon 
Diaphot) equipped with Hoffman Modulation Contrast objectives, a pair of Narishige 
micromanipulators and epifluorescent illumination. Oocytes were held by negative pressure 
applied to a holding pipette (120 µm outside diameter). After brief (<20 s) exposure to ultraviolet 
light to visualize nuclear DNA, the metaphase plate and polar body with a small amount of 
surrounding ooplasm were removed by negative pressure applied to an enucleation pipette       
(20 µm outside diameter, 35º bevel, spiked). Once enucleated, the cytoplasts were held in 
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modified TCM (mTCM; TCM-199 supplemented with 10% FBS and gentamicin) at 38.5ºC and 
5% CO2.  
 Donor cells prepared for use as nuclear donors for NT were at passage three of culture. 
Prior to NT procedures the donor cells were serum starved (0.5% FBS) for 3 to 5 d to induce 
quiescence. A single cell suspension was prepared by trypsinization and cells were immediately 
used for transfer into cytoplasts. Reconstruction was performed in groups of 30 cytoplasts. 
Micromanipulation was performed in a 180-µL elongated droplet of mTLH containing 6 µg/mL 
of cytochalasin D (Sigma) overlaid with mineral oil. A single adult llama fibroblast (15 to 20 µm 
diameter) was inserted into the perivitelline space of an enucleated oocyte and close contact 
between the donor cell membrane and oolema was visually confirmed.  
 Fusion of karyoplast-cytoplast couplets was performed in a microslide fusion chamber 
with stainless steel electrodes separated by a 1-mm gap. The chamber was filled with fusion 
buffer (0.3 M mannitol, 0.1 mM MgSO4.7H2O, 0.05 mM CaCl2, 0.5 mM HEPES and 4 mg/mL 
of BSA) and couplets were manually aligned and fused by two consecutive DC pulses (1.4 
kV/cm for 25 µs) delivered by a BTX Electrocell Manipulator 200 (Gentronics, San Diego, CA). 
Couplets were evaluated for fusion by microscopic examination within a 1-h period and 
activation was immediately performed on the fused couplets. Chemical activation was performed 
by a 5-m exposure to 5 µM ionomycin (Sigma) followed by a 3-h incubation in 10 µg/mL of 
cycloheximide (Sigma) prepared in either in CR1aa medium (Rosenkrans et al., 1993) or G1.2™ 
(Vitrolife, Vero Beach, FL) medium.  
 Embryos were cultured in 35-µL droplets of CR1aa medium (Treatment A) or G1.2™ 
medium (Treatment B) at 38.5ºC and 5% O2, 5%CO2 and 90% N2 humidified atmosphere and 
cleavage was assessed on d 2 of culture.  
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Transfer of NT Llama Embryos  
 All the embryo transfers to recipient llamas (surgical and nonsurgical) were performed 4 
to 5 d after gonadotropin releasing hormone (GnRH) analog administration. Recipients were 
administered 40 µg of gonadorelin diacetate tetrahydrate (Cystorelin®, Merial, Duluth, GA) i.m. 
when a follicle of 9 to 13 mm was present in the ovary. Transfers to recipient llamas coincided 
with 4 d of embryo in vitro culture.  
 For the surgical transfers, llamas were placed in dorsal recumbency position and a 
standard mid-ventral laparotomy procedure was performed. The uterus and uterine tubes were 
exteriorized and embryos were transferred to the left oviduct, irrespective of the side of ovu-
lation. A small plastic Embryon catheter (Rolon Medical, UK) was inserted through the ostium 
advancing the catheter as far as possible into the infundibulum of the oviduct and embryos        
(2 per female) were transferred (range = 8- to 32-cell stage). One embryo (morula stage) was 
transferred nonsurgically. Using a Cassou artificial insemination (AI) apparatus and a 0.25-mL 
plastic semen straw the embryo was transferred into the left uterine horn of a synchronized 
recipient.  
 Pregnancy status was verified on d 14 and 21 post-transfer by ultrasonography. Although 
one female that received embryos from Treatment A exhibited a small amount of uterine fluid, 
no pregnancies were confirmed.  
Statistical Analysis 
 Mean cleavage rate of NT llama embryos and embryo development rate were compared 
by Chi-square analysis. The differences between groups were considered to be statistically 
significant when P<0.05. 
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Results 
Superstimulation, Oocyte Aspiration and Maturation 
 Of a total of 14 superstimulated females, 7 (50%) were classified as good responders as 
determined by presence of ovarian follicles, 2 (14%) were classified as medium responders and  
5 (36%) were classified as poor responders (Figure 4.3).  
 A total of 307 follicles were aspirated from both good and medium responders, and a 
total of 298 (97%) oocytes were recovered. There was a significant difference in the number of 
oocytes recovered from good (261/264) compared with the medium (37/43) responders (P<0.05). 
The mean (± SEM) number of ovarian follicles per aspirated female was 37.7 ± 3 and 21.5 ± 2.5 
for good and medium responders, respectively. The mean number of oocytes recovered was   
37.3 ± 5.6 and 18.5 ± 3.5 for good and medium responders, respectively (Table 4.1).  
 In vitro maturation results are presented in Table 4.2. Of a total of 298 oocytes aspirated, 
69 were damaged during transport or subsequent stripping; therefore they were not included in 
the group evaluated for nuclear maturation. Of the 229 remaining oocytes, 52% reached nuclear 
maturation (metaphase-II stage) and 48% were classified as immature oocytes. Of these 
immature oocytes, 16% were at the germinal vesicle (GV) stage, 8% had germinal vesicle 
breakdown (GVBD) and 23% were in metaphase-I (M I) stage.  
Nuclear Transfer 
 Of a total of 120 metaphase-II oocytes (Figure 4.4), 84 (70%) were successfully 
enucleated, 80 (95%) were reconstructed with female adult llama fibroblasts and 50 (62.5%) 
fused. The fused couplets were randomly allocated (25 per treatment) to culture in CR1aa 
medium (Treatment A) or G1.2 medium (Treatment B).  
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Figure 4.3.  Ovarian response to stimulation protocol. (a) Ultrasound image of 
ovary from female classified as good responder. (b) Excised ovaries from FSH-
stimulated female llama.  
 
 
 
 
 
 
 
 
 
a b 
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Table 4.1. Number of follicles aspirated and oocytes recovered from superstimulated female llamas 
 
Ovarian   
response 
No. of 
llamas 
No. follicles 
aspirated 
No. (%) oocytes 
recovered 
 
Good  7 
 
264 
 
261 (99)a 
Medium 2 43 37 (86)b 
Total 9 307 298 (97) 
a,bValues with different superscripts within a column are significantly different (Chi square analysis, P<0.05). 
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Table 4.2. Nuclear status of llama oocytes after 30 h of in vitro maturation 
   Immature   Mature 
No. oocytes 
aspirated 
No. oocytes 
strippeda 
 
GVb 
 
GVBDc 
 
M Id  
 
M IIe 
298 229 37 (16%) 19 (8%) 53 (23%)  120 (52%) 
aTotal oocytes not damaged during transport. 
bGerminal vesicle. 
cGerminal vesicle breakdown. 
dMetaphase-I. 
eMetaphase-II. 
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Figure 4.4.  Metaphase-II llama oocytes prior to enucleation. (a) At metaphase-II selection, 40 X objective. (b) Prior to enucleation,  
40 X objective. 
a b40 µm 
40 µm 
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 Cleavage and transfer results are shown in Table 4.3. There was no effect of culture 
treatments on the number of couplets cleaved (d 2) or transferred (d 4). Cleavage rate was 32 % 
for Treatment A and 40 % for Treatment B (Fig. 4.5). There were no significant difference in 
cleavage rate between treatments (P<0.05).  
 Four 8- to 16-cell stage embryos from Treatment A and six 8- to 16-cell stage embryos 
from Treatment B were surgically transferred to the left oviduct of five synchronized recipients 
(2 embryos per female). One morula-stage embryo from Treatment A was nonsurgically 
transferred to the uterus of one synchronized recipient. Labeling of the remaining nontransferred 
embryos with Hoechst-33342 revealed presence of nuclei in the blastomeres (Figure 4.6). 
Ultrasonography at 14 d post-transfer verified that no pregnancies were established. 
Discussion 
 In previous studies, superstimulation was used mainly for embryo production and embryo 
transfer (Taylor et al., 2001). The ovarian response in past studies was variable and in most cases 
it was measured in terms of number of ovulations and embryo recovery rates (Correa et al., 1997; 
Ratto et al., 1997, 2002), not in terms of oocyte production. Only one study (Brogliatti et al., 
2000) reported the use of superstimulation followed by TUGA in llamas with the objective of 
oocyte collection, producing a 52% oocyte recovery rate. Our present study resulted in a 64% 
ovarian response, yielding a 97% oocyte recovery rate and a mean of 33 recovered oocytes per 
animal. These results are comparable with those obtained by Del Campo et al. (1994), who used 
nonstimulated, abattoir ovaries, reporting a mean oocyte recovery of 27 oocytes per llama. Their 
study also reported 26 degenerate oocytes unsuitable for IVM, which indicates some oocytes 
likely came from regressing or atretic follicles. Interestingly, oocytes examined in our study did 
not reveal signs of degeneration. A possible explanation is that two DFR procedures prior to the  
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Table 4.3. Cleavage and embryo transfer results from two in vitro culture treatmentsa 
Treatment 
group 
No. fused 
couplets 
No. (%) 
cleaved 
No. (%) 
transferredd 
No.  
pregnant 
 
A (CR1aa) mediumb 
 
25 
 
8 (32) 
 
5 (62.5) 
 
0 
B (G1.2) mediumc 25 10 (40) 6 (60) 0 
aNo significant differences between treatment groups. 
bRosenkrans et al. (1993). 
cVitrolife, Vero Beach, FL. 
dTen 8- to 16-cell stage embryos were surgically transferred to 5 recipients, 1 morula-stage embryo was nonsurgically 
transferred to one synchronized recipient. 
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Figure 4.5. Llama embryos (d 2) produced by somatic cell nuclear transfer (40X objective). (a) A 2-cell NT llama embryo (Treatment 
A). (b) A 3-cell NT llama embryo (Treatment A). (c) An 8-cell NT llama embryo (Treatment B).  
a b c
40 µm 40 µm 40 µm 
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Figure 4.6. A 2-cell llama NT embryo labeled with Hoechst-33342 to 
visualize nuclei in blastomeres (40 X objective). 
 
 
 
 
 
 
 
40 µm 
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initiation of superstimulation were effective in ensuring the start of a new cohort of follicles that 
were in the growing phase at the time of ovariectomy. In addition, there have been few reports of 
IVM of llama oocytes. Del Campo et al. (1994) have reported a 30.4% nuclear maturation which 
was lower than the 52% achieved in the present study.  
 To our knowledge, this is the first report of somatic cell NT, in vitro culture and transfer 
of NT embryos in the llama. Although llama oocytes appeared darker than goat oocytes, the 
micromanipulation protocol previously used for the goat in our laboratory (Reggio et al., 2001) 
was effective in the enucleation and reconstruction of llama oocytes. This study has shown that 
serum-starved llama adult fibroblasts nuclei can be activated by ooplasmic factors and are 
suitable donor karyoplasts for NT in the llama. Exposure of presumably quiescent nuclei to 
ooplasmic factors for a 3-h period resulted in 32% and 40% of cleaved embryos from Treatments 
A and B, respectively.  
 In the present study, activation of reconstructed couplets was accomplished using 
ionomycin prior to inhibition with cycloheximide (CHX), a nonspecific inhibitor of protein 
synthesis. Ionomycin increases free cytosolic calcium resulting in decreased maturation pro-
moting factor (MPF) levels. However, no single activation agent available is known to induce 
physiological calcium oscillations capable of supporting development. Therefore, compounds 
such as CHX or dimethylaminopurine (DMAP) are used to prevent calcium levels from dropping 
before MPF inactivation takes place. Studies completed in mice (Gordo et al., 2000), pigs (Knott 
et al., 2002) and horses (Choi et al., 200a, 2002b) have suggested that certain species may heed 
on the injection of sperm cytosolic factor to induce adequate calcium oscillations and trigger the 
initiation of development of reconstructed NT embryos. It is possible that the microinjection of 
sperm cytosolic factor might be beneficial in the llama.  
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 We have demonstrated that llama NT transfer embryos can be produced from traditional 
NT protocols. These results have implications not only in the conservation of superior genetics in 
the llama, but also in future applications of NT technology for the conservation of endangered 
species. In the future, interspecies NT using llama oocytes and vicuña karyoplasts could apply to 
the conservation of the vicuña. Further research should focus on developing protocols to improve 
NT efficiency in the llama, as well as basic research on cell cycle characteristics of the llama and 
the vicuña. 
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CHAPTER V 
 
INTERSPECIES NUCLEAR TRANSFER IN THE HORSE AND THE 
LLAMA USING BOVINE RECIPIENT CYTOPLASTS 
 
Introduction 
 Even though numerous improvements made since the announcement of Dolly’s birth, the 
efficiency of the nuclear transfer (NT) procedure remains low, and the percentage of live 
offspring obtained after the transfer of embryos usually does not exceed 3% (Wilmut et al., 1997; 
Cibelli et al., 1998; Wakayama et al., 1998; Campbell, 1999; Dominko et al., 1999b; Colman, 
2000). In addition, the high embryonic loss and perinatal mortality observed with the NT 
procedure requires that large number of oocytes must be available for the numerous attempts 
needed to establish pregnancies and produce live offspring (Colman, 2000; Hill et al., 1999, 
2000a, 2000b, 2001a, 2001b). 
 In several domestic and exotic species, the low numbers of animals available for oocyte 
collection and embryo transfer, coupled with the low rates of oocyte recovery and maturation 
preclude the use of traditional NT protocols. Several studies have demonstrated that the bovine 
cytoplast is capable of reprogramming somatic cell nuclei from other species including the horse 
(Hinrichs et al., 2000b; Reggio et al., 2000; Li et al., 2002), pig (Yoon et al., 2001), tiger (Hwang 
et al., 2001), Korean cattle (Roh and Yoon, 2001), human (Cibelli et al., 2001), buffalo 
(Kitiyanant et al., 2001; Saikhun et al., 2002), saola (Bui et al., 2002), bongo (Lee et al., 2002), 
goat (Park et al., 2003), mouse (Koo et al., 2003), black bear (Ty et al., 2003) and eland 
(Damiani et al., 2003). In one of the first studies exploring the potential of the bovine oocyte as a 
universal recipient for NT, skin fibroblast cells from cows, sheep, pigs, monkeys and rats were 
used as sources of nuclei while undergoing progression through the cell cycle to achieve various 
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degrees of development (Dominko et al., 1999a). Although no pregnancies were established, this 
study speculated that the mechanisms involved in regulating early embryonic development might 
be conserved among mammalian species. Even though many studies have been conducted, only 
2 live offspring have been reported to date in the scientific literature. A live birth was produced 
using gaur (Bos gaurus) somatic cells nuclei transferred into readily available domestic cow 
cytoplasts (Lanza et al., 2000). Also, a cloned endangered sheep was produced by injecting 
mouflon (Ovis orientalis musimon) somatic cells obtained from a deceased animal into the 
enucleated cytoplasts of domestic sheep (Loi et al., 2001).  
 Both the horse and the llama are species that could clearly benefit from the use of an 
alternative source of cytoplast for NT procedures. The low number of oocytes available for 
research (Cochran et al., 2000; Brogliatti et al., 2000; Brown, 2000; Hylan et al., 2002; Ratto et 
al., 2002), the variable oocyte maturation rates reported by several laboratories (Choi et al., 
1993; Del Campo et al., 1994; Correa et al., 1997; Hinrichs and Schmidt, 2000a; Tremoleda et 
al., 2001), the lack of understanding of the optimal in vitro conditions required for embryo 
culture and blastocyst production (Dell'Aquila et al., 2003; Vanderwall, 1996) and the need to 
perform cumbersome oviduct transfers to recipients to avoid prolonged periods in culture would 
make interspecies NT a valuable tool in the study of the factors that affect the development of 
cloned embryos in both species.  
 Therefore, the main objective of this study was to evaluate the ability of the bovine 
cytoplast to reprogram nuclei from horse and llama donor cells. Additionally, an effort was made 
to use the development of interspecies NT embryos to compare donor cells used as karyoplast 
donors. The specific objectives of Experiment 5.1 were (a) to use the in vitro development of 
horse interspecies NT embryos as a tool for screening cell line cloning efficiency and (b) to 
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compare the early development of horse interspecies NT embryos produced with either 
proliferating or serum-starved donor cells. In Experiment 5.2, the objective was to compare 
female and male adult llama fibroblast cell lines by monitoring in vitro embryo development. 
Materials and Methods 
Experiments 5.1(a) and 5.1(b) 
Preparation of Horse Donor Cells 
 Skin biopsies (6 mm2) were taken from two adult mares (Experiment 1a, Treatments A 
and B) of similar age (14 to 16 years), body weight (500 to 600 kg) and body condition score (8 
to 8.5, on scale 1 to 9) using a 6-mm diameter biopsy punch (Miltex Instrument Co, Bethphage, 
NY). One adult female bovine cell line (Treatment C) was obtained from a 7-year old Angus 
cow. All skin samples were obtained from the epidermal and dermal layer overlaying the 
serratus cervicis muscle, and all samples were processed identically on the same day, using the 
same medium, by the same technician. Briefly, the epidermal layer and fat were trimmed and 
discarded. The remaining tissue was minced finely and washed three times, placed in 35-mm 
tissue culture plates, covered with 1 mL of tissue culture media consisting of TCM-199, 10% 
FCS (HyClone, Logan, UT) and 1% genatmicin, and incubated at 38.5ºC in humidified 
atmosphere of 5% CO2.  
 After a fibroblast monolayer had formed around the tissue explants, cells were allowed to 
reach 95% confluency at which time they were trypsinized and re-seeded into 25 cm2 flasks. All 
cell lines used in the study were between the 3rd and 4th subpassage. Experimental designs for 
Experiments 5.1(a) and 5.1(b) are shown in Tables 5.1 and 5.2, respectively. Treatment groups 
for Experiment 5.1(a) consisted of enucleation and reconstruction with two adult female equine 
fibroblast cell lines (Treatments A and B), one adult female bovine fibroblast cell line         
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Table 5.1. Experimental design for Experiment 5.1(a): Equine cell line A vs. equine cell line B 
 
Treatment group                                                           Source of cells/gametes 
 
Treatment A Adult female equine fibroblasts (cell line A)a 
Treatment B Adult female equine fibroblasts (cell line B)b 
Treatment C Adult female bovine fibroblastsc 
Treatment D Enucleated / activated bovine oocytesd 
Treatment E Parthenogenically activated bovine oocytesd 
a,bAdult equine fibroblast cells derived from skin biopsies obtained from two cycling mares of similar age and body weight. 
   cAdult bovine fibroblast cells derived from a skin biopsy obtained from an Angus cow. 
   dBovine oocytes were obtained from abattoir. 
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Table 5.2. Experimental design for Experiment 5.1(b): Serum starved vs. proliferating equine 
donor cells 
 
Treatment group                                                           Source of cells/gametes 
 
Treatment A Serum-starved adult female equine fibroblastsa  
Treatment B Proliferating female equine fibroblastsb 
Treatment C Enucleated / activated bovine oocytesc 
Treatment D Parthenogenically activated bovine oocytesc 
aAdult equine fibroblasts serum-starved (0.5% FBS) for 3 to 5 consecutive days prior NT. 
bAdult equine fibroblasts allowed to proliferate (10% FBS) in culture. 
cBovine oocytes were obtained from abattoir. 
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(Treatment C), an enucleation/activation bovine oocyte control group (Treatment D) and 
parthenogenically activated bovine oocytes (Treatment E). Treatment groups for Experiment 
5.1(b) consisted of enucleation and reconstruction with either proliferating or serum-starved 
(serum concentration of the cell culture medium was reduced from 10% to 0.5% FBS 3 to 5 d 
prior to the NT procedure to induce presumptive quiescence) equine fibroblast cells from a single 
mare (Treatments A and B), an enucleation/activation bovine oocyte control group (Treatment 
C) and parthenogenically activated bovine oocytes (Treatment D). To avoid bias, the cell line 
identity was coded randomly blinded until the culmination of the experiment. Unless otherwise 
stated, experimental procedures for Experiments 5.1(a), 5.1(b) and 5.2 were identical. 
Nuclear Transfer 
 Abattoir-derived oocytes were obtained (Ovagenix, San Angelo, TX), matured overnight 
and shipped by air courier. Cumulus-oocyte complexes (COC) were denuded after 18 to 22 h of 
maturation by vortexing in 1.2 mg/mL of hyaluronidase (Sigma). Mature, metaphase-II oocytes 
were selected under a dissecting scope based on the visualization of a first polar body, and 
randomly assigned to treatment groups. Nuclear DNA was labeled with 3 µg/mL of Hoechst-
33342. Bovine oocytes were enucleated in an elongated 150-µL micromanipulation droplet 
containing 6 µg/ml of cytochalasin D (Sigma) overlaid with embryo tested mineral oil (Sigma) 
on the stage of an inverted microscope (Nikon Diaphot) equipped with Hoffman Modulation 
Contrast objectives, Narishige micromanipulators, Uniblitz VMM-D1 shutter system (Vincent 
Associates, Rochester, NY) and epifluorescent illumination. Enucleated bovine cytoplasts were 
reconstructed by the injection of a single donor cell into the perivitelline space. To improve 
membrane contact prior to electrofusion, a small amount of ooplasm was aspirated into the 
injection pipette and expelled along with the donor cell. 
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 Fusion of the interspecies couplets was performed in a microslide fusion chamber with 
stainless steel electrodes separated by a 1-mm gap. The fusion medium consisted of 0.3 M 
mannitol, 0.1 mM MgSO4⋅7H2O, 0.05 mM CaCl2, 0.5 mM HEPES and 4 mg/mL of BSA 
(Fraction V, Sigma). The couplets were fused by two consecutive DC pulses (1.9 kV/cm for     
25 µs) delivered by a BTX Electrocell Manipulator 200 (Genetronics, San Diego, CA). At this 
time, the bovine oocytes allocated to the parthenogenic activation treatment group were placed in 
the microslide fusion chamber and pulsed once (1.9 kV/cm for 25 µs) to initiate activation.  
 All treatment groups were chemically activated by a 4-min exposure to 5 µM of 
ionomycin (Sigma) followed by 5 min in TL-HEPES with 30 mg/mL BSA (Fraction V, Sigma) 
and 3-h incubation in 10 µg/mL of cycloheximide (Sigma) with 6 µg/mL of cytochalasin D 
prepared in CR1aa medium (Rosenkrans et al., 1993) and cultured in 35-µl droplets of CR1aa 
medium in a modular incubator chamber (Billups-Rothenberg, Del Mar, CA) at 38.5ºC and 5% 
O2, 5%CO2 and 90% N2 in humidified atmosphere. Embryos were evaluated for cleavage after 2 
d of in vitro culture and the medium was then replaced with CR1aa with 5% FBS and allowed to 
proceed in culture for 5 more days.  
Embryo Transfers - Experiment 5.1(a) 
 After 3 days of in vitro culture, quality grade-1 embryos were selected and transferred 
surgically to the oviduct of synchronized recipient mares (n=2). Embryos (all quality grade-1) 
were transferred (4 embryos per recipient mare) to the oviduct ipsilateral to the corpus luteum. A 
plastic Embryon catheter (Rolon Medical, UK) was inserted through the ostium advancing the 
catheter as far as possible into the infundibulum of the oviduct and interspecies equine NT em-
bryos (4 embryos from Treatment A and 4 embryos from Treatment B) were gently expelled 
along with 30 to 50 µL of transfer medium (TL-HEPES supplemented with 10% FBS and 1% 
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gentamicin). All recipient mares were treated with oral altrenogest (Regumate® Hoechst Roussel 
Vet., Warren, NJ; 0.444 mg altrenogest/kg body weight) daily, beginning on the day of embryo 
transfer and continuing until pregnancy status was determined by rectal ultrasonography (Aloka 
500, 5 MHz transducer, Aloka Co., Tokyo, Japan) on d 14 d post-transfer.  
Experiment 5.2 
Preparation of Llama Donor Cells and Nuclear Transfer 
 Skin biopsies were obtained from animals in a llama herd located in Bozeman, Montana 
(Genesearch, Inc., Bozeman, MT). Two healthy adult llamas (one male and one female) were 
sampled. Animals were led into a palpation chute and allowed to spontaneously adopt sternal 
recumbency position. Fiber from the hip area was clipped and scrubbed with povidone, cleansed 
with 70% ethanol and allowed to air-dry. A 6-mm biopsy of the epidermal and dermal layer 
overlaying the gluteus superficialis muscle was taken using a biopsy punch tool (Miltex 
Instrument Co, Bethphage, NY) and placed in TCM-199 supplemented with 1% v/v gentamicin. 
Tissue samples were kept refrigerated (4˚C) until processed (within 24 h of collection). All skin 
samples were processed on the same day using the same medium, by the same technician. 
Primary cell cultures and establishment of cell lines were prepared as described in Experiment 
5.1.  
 For NT procedures, both male and female cell cultures were between the 2nd and 3rd 
subpassage and were serum-starved (0.5% FBS, 3 to 5 d prior to NT procedure). To avoid bias, 
cell line identity was randomly coded until the culmination of the experiment. Treatment groups 
for Experiment 5.2 consisted of enucleation and reconstruction with either male or female adult 
llama fibroblasts, which had been serum-starved (0.5% FBS) for 3 to 5 d prior to NT (Treatments 
A and B), one adult female bovine fibroblast cell line (Treatment C), an enucleation/activation 
 85 
bovine oocyte control (Treatment D) and parthenogenically activated bovine oocytes (Treatment 
E) (Table 5.3). Nuclear transfer procedure was conducted in a similar manner to that described in 
Experiment 5.1. 
Statistical Analysis 
 Mean cleavage rates on d 3 of in vitro culture were compared across treatment groups by 
Chi-square analysis (SAS Institute, 1995). Different mean values between treatment groups were 
considered statistically significant at the P<0.05 level. 
Results 
Experiment 5.1(a) 
 This experiment was conducted in replicates to evaluate the development of NT embryos 
reconstructed with two equine cell lines. Four replicates consisted of interspecies nuclear transfer 
using equine cell line A (Treatment A), 4 replicates consisted of interspecies nuclear transfer 
using equine cell line B (Treatment B) and 4 replicates consisted of nuclear transfer using a 
bovine cell line (Treatment C). In addition, bovine oocytes were enucleated and activated as a 
control to ensure effective removal nuclear DNA from the oocyte (Treatment D) and 
parthenogenic activation of bovine metaphase-II oocytes was included to control for activation 
protocol and in vitro culture conditions (Treatment E).  Replicates using equine cell lines A 
(Treatment A), B (Treatment B), or bovine cell line (Treatment C) were performed in alternate 
order, with both Treatments D and E included in each one of the treatment replicates. 
 The development of interspecies horse embryos in vitro is summarized in Table 5.4. Of a 
total of 146 bovine cytoplasts reconstructed with equine cell line A (Treatment A), 54% were 
fused following two electrical pulses. Of fused couplets, 70% of the embryos cleaved but none 
reached the blastocyst stage, with all the embryos arresting between the 8- to 16-cell stage.  Of a  
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Table 5.3. Experimental design for Experiment 5.2: Female vs. male llama cell lines 
 
Treatment group                                                           Source of cells/gametes 
 
Treatment A Adult female llama fibroblastsa 
Treatment B Adult male llama fibroblastsb 
Treatment C Adult female bovine fibroblastsc 
Treatment D Enucleated/activated bovine oocytesd 
Treatment E Parthenogenically activated bovine oocytesd 
aAdult female llama fibroblast cells derived from a skin biopsy obtained from a female llama in Bozeman, MT. 
bAdult male llama fibroblast cells derived from a skin biopsy obtained from a male llama in Bozeman, MT. 
cAdult bovine fibroblast cells derived from a skin biopsy obtained from an Angus cow. 
dBovine oocytes were obtained from abattoir. 
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Table 5.4.  Development of interspecies equine embryos reconstructed with adult equine female cell lines A and B 
 
Treatment 
group 
Cell 
donor 
No. of M II1 
oocytes 
No. (%) 
fused 
No. (%) 
cleaved 
No. (%) 
BLST 
No. 
transferred 
No. 
recipients 
No. 
pregnant 
 
Treatment A 
 
Equine 
 
146 
 
79 (54) 
 
55 (70)a 
 
 0 
 
4 
 
1 
 
0 
Treatment B Equine 134 80 (60) 40 (50)b 0 4 1 0 
Treatment C Bovine 138 70 (51) 36 (51)b 18 (26) -  - - 
Treatment D Enucleated/activated 154 154 (100)@ 97 (63)b 0 - - - 
Treatment E Parthenogenic 136 136 (100)@ 84 (62)b 40 (29) - - - 
abValues with different superscripts in the same column are significantly different (Chi square; P<0.05). 
    1M II = metaphase-II spindle. 
  @Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation. 
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total of 134 bovine cytoplasts reconstructed with equine cell line B (Treatment B), 60% were 
fused following two electrical pulses. Of the fused couplets, 50% of the embryos cleaved but 
none reached the blastocyst stage, with all the embryos arresting between the 8- to 16-cell stage.  
 Of a total of 138 bovine cytoplasts reconstructed with a bovine cell line (Treatment C), 
51% were fused following two electrical pulses. Of fused couplets, 51% of the embryos cleaved 
and 26% of the fused couplets reached the blastocyst stage after 168 h of in vitro culture. Of a 
total of 154 enucleated and activated bovine cytoplasts (Treatment D), 63% of the embryos 
cleaved but none reached the blastocyst stage, with all the embryos arresting between the 8- to 
16-cell stages.   
 A total of 136 parthenogenically activated bovine oocytes (Treatment E), 62% cleaved 
and 29% reached the blastocyst stage after 168 h of in vitro culture. There was no significant 
difference in the number of fused couplets among treatment groups. However, the equine cell 
line A used as karyoplast donor (Treatment A) had a significantly greater (P<0.05) cleavage rate 
than the rest of the treatments. No pregnancies resulted from the 8 embryos transferred to two 
synchronized recipient mares.  
Experiment 5.1(b) 
 This experiment was conducted in replicates to compare the development of NT embryos 
reconstructed with either proliferating or serum-starved equine donor cells. Four replicates 
consisted of interspecies nuclear transfer using serum-starved adult equine fibroblasts (Treatment 
A) and 4 replicates consisted of interspecies nuclear transfer using proliferating equine 
fibroblasts (Treatment B). In addition, bovine oocytes were enucleated and activated as a control 
to ensure effective removal of nuclear DNA from the oocyte (Treatment C) and parthenogenic 
activation of bovine metaphase-II oocytes was included to control for activation protocol and in 
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vitro culture conditions (Treatment D).  The replicates using serum-starved (Treatment A) or 
proliferating (Treatment B) equine donor cells were performed in alternate order, with both 
Treatments C and D included in each of the replicates as in-house controls.   
 Development of interspecies horse embryos reconstructed with proliferating or serum-
starved donor cells is summarized in Table 5.5. Of a total of 103 bovine cytoplasts reconstructed 
with serum-starved horse fibroblasts (Treatment A), 79% were fused following two electrical 
pulses. Of fused couplets, 80% of the embryos cleaved but none reached the blastocyst stage, 
with all the embryos arresting at the 8- to 16-cell stage in vitro. Staining with Hoechst-33342 at 
the end of in vitro culture revealed that 89% of the embryos had nuclei in all blastomeres (Figure 
5.1). Of a total of 102 bovine cytoplasts reconstructed with proliferating horse fibroblasts 
(Treatment B), 63% were fused after two electrical pulses. Of fused couplets, 66% of the 
embryos cleaved but none reached the blastocyst stage, with all the embryos arresting between 
the 8- to 16-cell stage. Of these embryos, 71% revealed nucleated blastomeres after Hoechst-
33342 staining.  
 Of a total of 105 enucleated and activated bovine cytoplasts (Treatment C), 74% of the 
embryos cleaved but none reached the blastocyst stage. As expected, staining revealed that none 
of these embryos had nuclei in any of the blastomeres. Of a total of 101 parthenogenically 
activated bovine oocytes (Treatment D), 84% cleaved and 28% reached the blastocyst stage after 
168 h of in vitro culture.  
 Embryos reconstructed with serum-starved (Treatment A) donor cells had a significantly 
higher (P<0.05) fusion rate than those reconstructed with proliferating (Treatment B) donor cells. 
The number of embryos from proliferating donor cells that cleaved after two days of culture was  
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Table 5.5.  Development of interspecies equine embryos reconstructed with serum-starved or proliferating adult equine fibroblasts  
 
Treatment 
group 
Cell 
donor 
No. of M II1 
oocytes 
No. (%) 
fused 
No. (%) 
cleaved 
No. (%) 
BLST 
No. (%) 
nucleated blastomeres 
 
Treatment A 
 
Equine serum-starved 
 
103 
 
81 (79)a 
 
65 (80)a 
 
0 
 
58 (89)a 
Treatment B Equine proliferating 102 64 (63)b 42 (66)b 0 30 (71)b 
Treatment C Enucleated/activated 105 105 (100)@ 78 (74)a 0 0 (0) 
Treatment D Parthenogenic 101 101 (100)@ 85 (84)a 28 (28) 85 (100) 
abcValues with different superscripts in the same column are significantly different (Chi square; P<0.05). 
    1M II = metaphase-II spindle. 
  @Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation. 
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  Figure 5.1. Eight-cell interspecies horse NT embryos (a) With Hoechst-33342 staining. (b) Without Hoechst-33342 staining, 40 X    
objective.              
a b
40 µm 40 µm 
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significantly lower (P<0.05) than the number of cleaved embryos in the rest of the treatments. 
Nuclei staining revealed a higher (P<0.05) number of embryos with non-nucleated blastomeres 
in those reconstructed with proliferating donor cells than in those reconstructed with serum-
starved cells.  
Experiment 5.2 
 This experiment was conducted in replicates to evaluate the development of NT embryos 
reconstructed with male and female llama cell lines. Three replicates consisted of interspecies 
nuclear transfer using an adult female llama cell line A (Treatment A), 3 replicates consisted of 
interspecies nuclear transfer using an adult male llama cell line B (Treatment B) and 3 replicates 
consisted of nuclear transfer using a bovine cell line (Treatment C). In addition, bovine oocytes 
were enucleated and activated as a control to ensure effective removal of the nuclear DNA of the 
oocyte (Treatment D) and parthenogenic activation of bovine metaphase-II oocytes was included 
to control for activation protocol and in vitro culture conditions (Treatment E).  Replicates using 
llama female (Treatment A), male (Treatment B), or bovine fibroblast cell lines (Treatment C) 
were performed in alternate order, with both Treatment D and E included in each one of the 
replicates. Cell line identity was randomly coded throughout the experiment to avoid bias.   
 Development of interspecies llama embryos is summarized in Table 5.6. Of a total of 164 
bovine cytoplasts reconstructed with an adult female llama cell line (Treatment A), 63% were 
fused following two electrical pulses. Of fused couplets, 53% of the embryos cleaved but none 
reached the blastocyst stage, with all the embryos arresting between the 8- to 16-cell stage.  Of a 
total of 150 bovine cytoplasts reconstructed with an adult male llama cell line (Treatment B), 
51% were fused following two electrical pulses. Of fused couplets, 51% of the embryos cleaved  
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Table 5.6.  Development of interspecies llama embryos reconstructed with either female or male llama donor cells 
 
Treatment 
group 
Cell 
donor 
No. of M II1 
oocytes 
No. (%) 
fused 
No. (%) 
cleaved 
No. (%) 
BLST 
 
Treatment A 
 
Llama female 
 
164 
 
104 (63) 
 
55 (53) 
 
0 
Treatment B Llama male 150 76 (51) 39 (51) 0 
Treatment C Bovine 121 68 (56) 39 (57) 14 (20) 
Treatment D Enucleated/activated 124 124 (100)@ 77 (62) 0 
Treatment E Parthenogenic 130 130 (100)b@ 87 (67) 15 (11) 
1M II = metaphase-II spindle. 
@Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation. 
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but none reached the blastocyst stage, with all the embryos arresting between the 8- to 16-cell 
stage.  
 Of a total of 121 bovine cytoplasts reconstructed with a bovine cell line (Treatment C), 
56% were fused following two electrical pulses. Of fused couplets, 57% of the embryos cleaved 
and 20% of the fused couplets reached the blastocyst stage after 168 h of in vitro culture. Of a 
total of 124 enucleated and activated bovine cytoplasts (Treatment D), 62% of the embryos 
cleaved but none reached the blastocyst stage, with all the embryos arresting between the 8- to 
16-cell stage.  Of a total of 130 parthenogenically activated bovine oocytes (Treatment E), 67% 
cleaved and 11% reached the blastocyst stage after 168 h of in vitro culture. No significant 
differences were found in fusion and cleavage rates among treatment groups. 
Discussion 
 The series of events that take place after the fusion of the recipient ooplasm and the donor 
cell have been poorly described in the scientific literature. The nuclear remodeling and 
reprogramming that enables a newly introduced genome to recall its embryonic characteristics 
depends, among other factors, on the cell cycle stage of the recipient ooplasm and the donor cell.  
 The early stages of normal embryogenesis are regulated by maternally inherited gene 
products stored in the oocyte cytoplasm. As development proceeds and maternally inherited 
informational molecules decay, the process of early embryogenesis becomes dependent on the 
expression of genetic information derived from the embryonic genome. There are species-
specific differences in the developmental period at which the transition from control by mater-
nally inherited molecules to that of embryonic genome-derived transcription products occurs. 
The loss or decay of mRNA of maternal origin, the initiation of embryonic transcription, the 
developmental arrest in presence of transcriptional inhibitor and the changes in protein synthesis 
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pathways are the main characteristics of the events during embryo genome activation (Telford et 
al., 1990).  
 The results of this study showed that the bovine recipient ooplasm is capable of 
reprogramming somatic nuclei from other species. The fact that horse and llama interspecies NT 
embryos progressed through a few mitotic divisions and nuclei were present in the blastomeres 
indicates that the factors contained in the bovine ooplasm were capable of at least partially 
reprogramming the foreign nucleus and driving cell division. In contrast, oocytes that were 
enucleated and activated without the injection of a donor cell progressed only through one or two 
mitotic divisions, showing high degrees of fragmentation and poor quality blastomeres.  
 In our study, however, neither of the horse nor llama interspecies NT embryos progressed 
to the blastocyst stage and all embryos arrested consistently at the 8- to 16-cell stage in vitro. Al-
though blastocyst stage interspecies sheep NT embryos have been reported in the past (Dominko 
et al., 1999b), other groups have also reported a consistent in vitro developmental block in 
interspecies horse, bear and goat NT embryos (Hamilton et al., 2003; Koo et al., 2003; Yoon et 
al., 2001), which is supported by the findings in our present study.  
 In the cow, the timing of the switch from maternal to embryonic genome control appears 
to occur at the 8- to 16-cell stage (Camous et al., 1984), although others have reported it to occur 
as early as the 8-cell stage (Kopency et al., 1989a). When the qualitative patterns of protein 
synthesis were examined at different stages of development, marked changes were detected in 8- 
to 16-cell stage embryos (Frei et al., 1989). The quantitative and qualitative changes in protein 
synthesis and the late onset of new RNA synthesis in bovine embryos is consistent with the 
hypothesis that maternal messages are gradually degraded from fertilization through the 8-cell 
stage, at which time control of transcription shifts from the maternal to the embryonic genome. 
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As in mouse embryos, the shift from maternal stores to embryonic control of transcription in the 
cow is associated with the in vitro developmental block observed in cultured embryos. 
 To date, the timing of genomic activation has not been described for the horse or the 
llama. Recent evidence from equine NT experiments may indicate that the transition from ma-
ternal to genomic control occurs earlier in the horse that in the cow. Nuclear transfer experiments 
conducted in the horse (using equine donor cells and recipient oocytes) have shown that high 
proportions of reconstructed embryos arrested at the 2- to 4-cell stage (Choi et al., 2002a; Li et 
al., 2002b; Choi et al., 2003; Li et al., 2003).  Because maternally stored products in the bovine 
cytoplast may last up to the 8- to 16-cell stage, it is possible that the arrest observed in our 
interspecies study using horse and llama donor cells could be attributed to a lack of shift from the 
maternal to embryonic control, thus resulting in the observed in vitro developmental block at the 
time corresponding to the depletion of active maternal mRNA for the cow cytoplast. 
 The reasons for the lack of embryonic takeover in interspecies NT embryos still remain 
unclear. Successful interspecies NT, either giving birth to live offspring or producing nearly 
termed fetuses, has been achieved by several groups concerned with at the preservation of en-
dangered species. When dermal fibroblasts of a gaur bull (Lanza et al., 2000), granulosa cells 
from a deceased mouflon (Loi et al., 2001) and fetal fibroblasts of a water buffalo (Kitiyanant et 
al., 2001) were introduced into enucleated oocytes from cow, sheep and cow, respectively, 12%, 
30% and 33% of the reconstructed embryos developed to the blastocyst stage in vitro. One 
cloned gaur was recovered after a late-term abortion and one mouflon was spontaneously de-
livered. The birth of live interspecies NT offspring suggests that the nuclear reprogramming 
mechanisms among different species are conserved, in particular in closely related species. In 
contrast, when nuclei from human somatic cells were transferred into enucleated bovine oocytes, 
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only 6 of the 56 interspecies NT embryos produced developed to the 4- to 16- cell stage (Lanza 
et al., 1999b). It is important to note that in all the live offspring produced to date by interspecies 
NT all the recipient oocytes were recovered from a species closely related to the one providing 
the donor somatic nuclei. It is possible that incompatibilities between nuclear and ooplasmic 
components from more distant species are responsible for the limited success of other 
interspecies NT experiments and also for the in vitro developmental block found in this 
experiment.  
 Further research using serial nuclear transfer could be used in an attempt to overcome the 
in vitro developmental block found in interspecies NT embryos. The technique of serial nuclear 
transfer involves conducting a first NT procedure using somatic cells as nuclear donors and a 
second NT procedure, this time using the blastomeres of the previously obtained NT embryos as 
source of nuclei. This procedure has been reported to improve blastocyst rates in the rabbit 
(Piotrowska et al., 2000), mice (Ono et al., 2001; Heindryckx et al., 2002), goats (Yong et al., 
1998) and this approach could be used in the interspecies model, in an attempt to overcome 
nuclear-ooplasmic incompatibilities. A first interspecies NT procedure could be conducted using 
a somatic donor cell and the bovine enucleated oocyte as Universal Recipient. The second NT 
could be conducted using blastomeres from the interspecies NT embryos as nuclei donors. 
 The use of alternative NT techniques, such as interspecies NT, is an exciting possibility 
for species with limited availability of oocytes and recipients. This study has demonstrated that 
the interspecies model could be used to study events occurring during early embryonic 
development. Although the bovine cytoplast seems capable of supporting a few mitotic divisions, 
it is possible that heteroplasmy, mitochondrial incompatibilities or epigenetic effects may affect 
nuclear-ooplasmic events occurring at the time of genomic activation.  
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CHAPTER VI 
 
BANTENG (Bos javanicus) EMBRYOS AND PREGNANCIES PRODUCED 
BY INTERSPECIES NUCLEAR TRANSFER 
 
Introduction 
 The banteng (Bos javanicus), a member of the bovidae family, was first characterized by 
d’Alton in 1823 (Gotch, 1979). This unique bovid is mainly found in South-East Asia (below 
2000 m), Java and Kalimantan. Today, the survival of the banteng is seriously threatened. The 
species is extinct in India, Bangladesh and West Malaysia and the population is in decline on the 
Asian mainland (IUCN/SCC, 1995). The number of banteng present in Thailand decreased by 
approximately 80% during the past 25 years, and it is estimated that the total world population is 
fewer than 10,000 animals (Srikosamatara and Suteethorn, 1995). The banteng is currently listed 
as threatened by the IUCN Red List (2002), and a recent petition suggested it was included in 
CITES list of endangered species (Duckworth and Hedges, 1998). Hunting, habitat degradation, 
changes in the dynamics of the native species, hybridization and diseases from domestic 
livestock have been the major reasons for the reduction in the wild banteng population 
(IUCN/SCC, 1995). 
 Advanced reproductive technologies such as in vitro fertilization (IVF), artificial insemi-
nation (AI) and embryo transfer (ET) are becoming increasingly important tools in the 
conservation and management of endangered species. Somatic cell nuclear transfer (NT) has 
been successfully applied in Bos taurus and Bos indicus cattle using homologous oocytes, 
resulting in the establishment of pregnancies and the production of live offspring. (Cibelli et al., 
1998; Galli et al., 1999; Shiga et al., 1999; Wells et al., 1999; Hill et al., 2000c; Kubota et al., 
2000). Also, the use of somatic cell NT has been suggested for the preservation of species 
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threatened with extinction (Dominko et al., 1999a). The current low efficiencies of the NT 
procedure, in addition to the high perinatal mortality, demand that numerous attempts are needed 
to produce live offspring (Colman, 2000; Hill et al., 2000b, 2000c). In exotic or endangered 
species, the lack of oocytes and recipients precludes the use of traditional somatic cell NT, and 
an approach such as interspecies NT may be the only alternative to produce embryos and 
offspring. 
 One of the first attempts of interspecies NT using the enucleated bovine oocyte as 
recipient cytoplast was reported by (Dominko et al., 1999a). Monkey, sheep, pig and rat somatic 
cells were used as donor karyoplasts, resulting in various degrees of early in vitro development, 
however, no pregnancies were reported in this study. Further interspecies NT attempts using the 
bovine cytoplast and the karyoplasts from other species include somatic cells from pigs (Yoon et 
al., 2001), saolas (Bui et al., 2002), elands (Damiani et al., 2003), horses (Li et al., 2002a; 
Sansinena et al., 2002), bears (Ty et al., 2003) and humans (Cibelli et al., 2001) .  
 Recently, a cloned gaur (Bos gaurus) was born after interspecies NT using bovine 
oocytes but unfortunately died within the first 48 h (Lanza et al., 2000). In another study, two 
pregnancies were established after interspecies NT using the domestic sheep (Ovis aries) as 
recipient cytoplasts and an exotic argali (Ovis ammon) as donor karyoplasts. Both of these 
pregnancies were then lost by 59 d of gestation (White et al., 1999). Also, domestic sheep (Ovis 
aries) oocytes used as recipients for mouflon (Ovis orientalis musimon) cells resulted in one live 
offspring (Loi et al., 2001) and enucleated oocytes of a mare used as recipients for somatic cells 
of a mule have produced pregnancies (Woods et al., 2001) and two live offspring (Woods et al., 
2003) at the time of writing this literature review.  
 100 
 Therefore, the objectives of this study were to evaluate the bovine oocyte as cytoplast 
recipient of interspecies NT in the banteng. In addition, an effort was made to compare male and 
female banteng cell lines by monitoring development of interspecies NT embryos. 
Materials and Methods 
Preparation of Banteng Donor Cells 
 Adult fibroblasts were isolated from 6-mm skin biopsies taken from one mature male 
(726 kg) and one mature female (499 kg) adult bantengs (Peace River Refuge, Zolfo Springs, 
FL). Primary cultures were obtained by mincing dermal tissue using sterile curved scissors in a 
35 x 10-mm Falcon™ petri dish (Becton and Dickinson, Lincoln Park, NJ). The culture medium 
consisting of TCM-199 (Gibco, Grand Island, NY) with 10% fetal bovine serum (FBS, HyClone, 
Logan, UT) and 0.1% gentamicin (Gibco).  
 Tissue samples were washed by swirling the tissue suspension in a 15-mL centrifuge tube 
and allowing the tissue to settle to the bottom. Supernatant was discarded and 3 mL of fresh 
culture medium was added to the tube. This process was repeated three times, after which tissue 
was transferred to a 35-mm petri dish. All but 500 to 700 µL of excess medium was aspirated to 
allow oxygen tension over the tissue. All cultures were conducted at 38.5ºC and 5% CO2 in 
humidified atmosphere.  
 Once a fibroblast cell layer was established (7 to 10 d), cells were grown in 25-cm2 tissue 
culture flasks (Costar™, Cambridge, MA) until they reached 95% confluency. Cells were then 
trypsinized (Sigma, St. Louis, MO), counted with a hemocytometer and re-seeded at a density of 
100,000 cells in 25-cm2 tissue culture flasks. After two subpassages, cultured cells were exposed 
to a cryoprotectant solution consisting of TCM-199, 20% calf serum, 5% dimethylsulfoxide 
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(DMSO) and frozen in aliquots of 500,000 cells/mL of cryoprotectant in CryoTubes™ (Nunc, 
Fisher Scientific, Pittsburgh, PA).  
 To prepare adult fibroblasts as donors for NT, the cells were thawed and cultured in 
TCM-199 containing 10% FBS and 0.1% gentamicin in 25-cm2 tissue culture flasks.  
Nuclear Transfer 
 Abattoir-derived oocytes were collected (Ovagenix, San Angelo, TX), matured overnight 
and shipped by air courier. At 18 to 22 h of maturation, cumulus-oocyte complexes were 
exposed to vortexing for 2 min in TCM containing 1.2 mg/mL of hyaluronidase (Sigma) to 
remove cumulus investments. After removal of cumulus investments, all mature, metaphase-II 
oocytes were selected, based on the visualization of a first polar body, and randomly assigned to 
treatment groups. Treatment groups (Table 6.1) consisted of enucleation and reconstruction with 
male adult banteng fibroblasts (Treatment A), female adult banteng fibroblasts (Treatment B) 
and parthenogenically activated oocytes served as laboratory control (Treatment C).  
 Nuclear DNA was labeled with 3 µg/mL of Hoechst-33342 for 3 min. Oocytes were then 
washed in modified TL-HEPES (mTLH; TL-HEPES supplemented with 10% FBS and 0.1% 
gentamicin) and placed in groups of 25 oocytes in an elongated 150-µL micromanipulation 
droplet containing 6 µg/mL of cytochalasin D (Sigma) overlaid with embryo tested mineral oil 
(Sigma). All micromanipulations were conducted on the stage of an inverted microscope (Nikon 
Diaphot) equipped with Hoffman Modulation Contrast objectives, Narishige micromanipulators, 
Uniblitz VMM-D1 shutter system (Vincent Associates, Rochester, NY) and epifluorescent 
illumination. A 120-µm diameter (o.d.) borosilicate pipette was used to hold the oocytes by 
negative pressure. After a brief exposure (<5 s) to ultraviolet light to visualize nuclear DNA, the  
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Table 6.1. Interspecies nuclear transfer (NT) in the banteng using male and female cell lines 
 
Treatment group                                               Source of cells/gametes 
 
Treatment A Interspecies NT using male adult banteng fibroblastsa 
Treatment B Interspecies NT using female adult banteng fibroblastsb 
Treatment C Parthenogenically activated bovine oocytesc 
aMale adult banteng (Bos javanicus) fibroblast cells derived from a skin biopsy obtained from a male banteng in  
 Peace River Refuge, Zolfo Springs, FL. 
bMale female adult banteng (Bos javanicus) fibroblast cells derived from a skin biopsy obtained from a female 
 banteng in Peace River Refuge, Zolfo Springs, FL. 
cBovine oocytes were obtained from an abattoir. 
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polar body and metaphase spindle with a small amount of surrounding ooplasm were removed by 
negative pressure applied to an enucleation pipette (20 µm o.d., 35º bevel, spiked).  
 Once enucleated, the cytoplasts were held in modified TCM (mTCM; TCM-199 
supplemented with 10% FBS and 0.1% gentamicin) at 38.5ºC and 5% CO2 in humidified air. 
Banteng adult fibroblasts were used as nuclear donors at the third subpassage of culture (Figure 
6.1). Donor cells were serum starved (0.5% FBS) for 3 to 5 d to induce quiescence prior to NT 
procedures. Reconstruction was performed in working groups of 25 cytoplasts in a 200-µL 
elongated droplet of mTLH containing 6 µg/mL of cytochalasin D overlaid with mineral oil 
(Sigma, embryo tested).  
 One single adult banteng fibroblast (15 to 20 µm in diameter) was inserted into the 
perivitelline space of an enucleated oocyte. The fusion of karyoplast-cytoplast couplets was 
performed in a microslide fusion chamber with stainless steel electrodes separated by a 1-mm 
gap. The chamber was filled with fusion buffer (0.3 M mannitol, 0.1 mM MgSO4⋅7H2O, 0.05 
mM CaCl2, 0.5 mM HEPES and 4 mg/mL of BSA (Fraction V, Sigma). The couplets were then 
fused by two consecutive DC pulses (1.9 kV/cm for 25 µs) delivered by a BTX Electrocell 
Manipulator 200 (Genetronics, San Diego, CA). The couplets were evaluated for fusion by 
microscopic examination within a 1-h period. At this time, oocytes randomly allocated to the 
parthenogenic activation treatment group were placed in the microslide fusion chamber and 
pulsed once (1.9 kV/cm for 25 µs) to initiate activation.  
 Chemical activation of all treatment groups was performed by a 4-min exposure to 5 µM 
of ionomycin (Sigma) followed by 5 min in TL-HEPES with 30 mg/mL BSA (Fraction V, 
Sigma) and 2-h incubation in 10 µg/mL of cycloheximide (Sigma) with 6 µg/mL of cytochalasin 
D prepared in CR1aa medium.  
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Figure 6.1. Adult banteng fibroblasts. (a) Male banteng cell line, subpassage no. 2. (b) Female 
banteng cell line, subpassage no. 2. 
 
 
 
 
 
 
 
 
 
a b 
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 The embryos produced were cultured in 35-µl droplets of CR1aa medium in a modular 
incubator chamber (Billups-Rothenberg, Del Mar, CA) at 38.5ºC and 5% O2, 5% CO2 and      
90% N2 humidified atmosphere. Embryos were checked for cleavage after 3 d of in vitro culture 
and medium was then replaced with CR1aa with 5% FBS. Blastocysts were selected on 7 d of in 
vitro culture (fusion = d 0) for nonsurgical transfer. Transfers were performed 7 d after naturally 
occurring estrus (estrus = d 0) to mature, mixed breed, cycling beef cows (body condition score 6 
to 8). Each recipient received two blastocysts of embryo quality grade-1 or -2 (in a range of 1 to 
4, with grade-1 being the best quality and grade-4 being worst quality), transferred in CR1aa 
with 5% FBS medium into the uterine horn ipsilateral to the corpus luteum. Pregnancy status was 
assessed by rectal ultrasonography (Aloka 500, 5 MHz transducer, Aloka Co., Tokyo, Japan) at 
30 and 60 d post-NT. Fetal viability was assessed by detection of fetal heartbeats.  
Statistical Analysis 
 Mean cleavage rates on day 3 of in vitro culture and embryo development rate on day 7 
were compared across treatment groups by Chi-square analysis (SAS Institute, 1995). In this 
study, different mean values between treatment groups were considered statistically significant at 
the P<0.05 level. 
Results 
 This experiment was conducted in replicates to evaluate the development of NT embryos 
reconstructed with male and female banteng fibroblasts. Four replicates consisted of interspecies 
nuclear transfer using male adult banteng cell line (Treatment A) and 4 replicates consisted of 
interspecies nuclear transfer using a female adult banteng cell line (Treatment B). In addition, a 
parthenogenic control (Treatment C) was included in each of the replicates. Replicates using 
male or female cell lines were performed in alternate order. All replicates of the experiment 
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yielded blastocysts following in vitro culture (Figure 6.2). Development of interspecies embryos 
reconstructed with adult male and female banteng fibroblasts and parthenogenically activated 
oocyte control is summarized in Table 6.2. Of a total of 143 enucleated cytoplasts in Treatment 
A, 94% were successfully reconstructed with male banteng fibroblasts and 68% subsequently 
fused following two electrical pulses. Of the fused couplets, 1% lysed post-fusion, 67% of the 
embryos cleaved and 28% reached the blastocyst stage in 168 h of in vitro culture.  Of a total of 
205 enucleated cytoplasts in Treatment B, 90% were successfully reconstructed with female 
banteng fibroblasts and 77% of these fused after two electrical pulses. Of the fused couplets, 
12% lysed post-fusion, 51% of the embryos cleaved and 15% reached the blastocyst stage in 168 
h. Of a total of 103 parthenogenically activated oocytes in Treatment C, 93% of the embryos 
cleaved and 42% reached the blastocyst stage in 168 h. 
 There was no significant difference in the number of fused couplets among treatment 
groups. However, there were significantly fewer (P<0.05) lysed couplets reconstructed with male 
banteng cells (Treatment A) than in couplets reconstructed with female banteng cells (Treatment 
B). No lysed oocytes were observed in the parthenogenic activation control (Treatment C). 
Furthermore, the male adult banteng cell line used as a karyoplast donor (Treatment A) had a 
significantly greater (P<0.05) cleavage rate and blastocyst production rate than the embryos 
derived from the injection of the female adult banteng cells (Treatment B).  
 Embryo transfer and pregnancy data are summarized in Table 6.3. Of a total of 24 
blastocysts transferred into 12 synchronized recipients (2 embryos per recipient) from the 
embryos reconstructed with the male banteng cell line in Treatment A, two pregnancies (17%) 
were established with normal appearing morphology and heartbeats detectable at 30 d of 
gestation via rectal ultrasonography. The first singleton pregnancy was lost after d 40 d of  
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Figure 6.2.  Transferred interspecies NT banteng blastocysts. (a) Male cell line (Treatment A, 20 
X objective. (b) Male cell line (Treatment A, 40 X objective). (c) Female cell line (Treatment B, 
40 X objective). (d) Female cell line (Treatment B, 40 X objective). 
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Table 6.2.  Development of interspecies embryos reconstructed with male and female adult banteng fibroblasts 
 
Treatment 
group 
No. of M II1 
oocytes 
No. (%) 
enucleated 
No. (%) 
reconstructed 
No. (%) 
fused 
No. (%) 
lysed2 
No. (%) 
cleaved 
No. (%) 
BLST 
 
A (Male cell line) 
 
143 
 
143 (100) 
 
134 (94) 91 (68)a 1 (1)a 60 (67)a 25 (28)a 
B (Female cell line) 205 205 (100) 185 (90) 142 (77)a 17 (12)b 64 (51)b 19 (15)b 
C (Parthenogenic)3 103 - - 103 (100)@ 0 (0) 96 (93)c 43 (42)c 
abcValues with different superscripts in the same column are significantly different (Chi square; P<0.05). 
     1M II = metaphase-II spindle. 
     2Lysed post-activation. 
     3Parthenogenic control consisted of chemically activated bovine oocytes. 
 @Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation. 
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Table 6.3. Transfer of interspecies banteng NT embryos and pregnancy data 
Treatment 
group 
No. of 
recipients1 
No. of embryos          
transferred 
No. (%) 
pregnant2,3 
 
A (Male line) 12 24 2 (17)4 
B (Female line) 7 14 0 
C (Parthenogenic) - - - 
1Two embryos were nonsurgically transferred to the uterine horn ipsilateral to the ovary with a corpus luteum. 
2Pregnancy verified with heartbeats by rectal ultrasonography at 30 d of gestation. 
3Percentage based on the number of recipients. 
4One pregnancy was lost after 40 d of gestation and the second conceptus was lost after 65 d of gestation. 
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gestation and the second pregnancy was lost after d 65 of gestation. No pregnancies resulted 
from the transfer of 14 blastocysts transferred to 7 recipient females from the embryos 
reconstructed with the female banteng cell line in Treatment B.  
Discussion 
 The use of alternative NT techniques, such as interspecies NT, is an exciting possibility 
for species with limited availability of oocytes and recipients. An in vitro developmental block 
has been previously reported using this procedure (Yoon et al., 2001; Li et al., 2002a; Sansinena 
et al., 2002, 2003a), particularly when the species of donor karyoplasts and recipient cytoplasts 
are far apart in their taxonomic classification. An 8- to 16-cell stage in vitro developmental block 
has previously been reported for the pig (Yoon et al., 2001), horse (Li et al., 2002a; Sansinena et 
al., 2002) and llama (Sansinena et al., 2003a) when using bovine recipient cytoplasts. It has been 
suggested that although the bovine cytoplast seems capable of supporting a few mitotic divisions, 
heteroplasmy or mitochondrial incompatibilities may affect nuclear-ooplasmic events occurring 
at the time of genomic activation (Sansinena et al., 2002).   
 Correspondingly, the interspecies NT research studies that have resulted in pregnancies, 
namely the gaur (Lanza et al., 2000), the mouflon (Loi et al., 2001) and the banteng in the 
present study have used animals of the same genus but different species both as source of 
oocytes and surrogates for embryo transfers. Interspecies NT live offspring has previously been 
reported in the gaur (Lanza et al., 2000) and the mouflon (Loi et al., 2001). In the study reported 
by Lanza et al. (2000), domestic cattle (Bos taurus) oocytes were enucleated and gaur (Bos 
gaurus) adult fibroblasts were used as donor cells, producing several pregnancies and one single 
offspring that lived for a couple of days following birth. Cytogenetic analysis of cloned gaur 
fetuses revealed a normal gaur karyotype of 58, and allele-specific PCR confirmed exclusively 
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Bos taurus mtDNA in fetal tissues, indicating no detectable mitochondrial contribution from the 
donor gaur cells. With a similar approach, Loi et al. (2001) used domestic sheep (Ovis aries) 
oocytes as recipient cytoplast and mouflon (Ovis communis musimmon) donor granulosa cells as 
donor karyoplasts. Two pregnancies were established, one resulting in a live birth and a viable 
offspring. 
 In our study, no in vitro developmental block was detected using the banteng as donor 
karyoplasts and the bovine cytoplast and embryos proceeded beyond the 8- to 16-cell stage to 
achieve high blastocyst rates. Moreover, the two pregnancies established from the male cell line 
overcame the reported stage of maternal recognition in the cow (Thatcher et al., 1995), indicating 
these were actually viable embryos. Bantengs have 60 acrocentric chromosomes, similar to 
domestic cattle, except for minor rearrangement seen on banding studies (Gallagher et al., 1999), 
such as a metacentric Y-chromosome. The fact that both donor karyoplasts (banteng) and 
recipient cytoplast (domestic cattle) species have a chromosome number of 60 may indicate that 
chromosome number could be related to the in vitro developmental block found when 
interspecies NT procedures were undertaken in species with dissimilar chromosome number.  
 Several studies have reported inheritance of mitochondria and mitochondrial DNA 
(mtDNA) after NT procedures. Sheep (Evans et al., 1999) and calves (Takeda et al., 1999) 
produced by somatic cell NT have been reported to inherit their mitochondria entirely from the 
oocyte and not from the donor cell. However, other authors have indicated the presence of 
heteroplasmy after NT and the potential for mitochondrial mismatch could possibly impair 
embryo development (Nagao et al., 1998a). Steinborn et al. (2000) have reported presence of 
mtDNA heteroplasmy in cloned cattle generated from fetal and adult donor cells. More recently, 
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mtDNA was reported to be present in somatic cell NT-derived embryos by allele-specific PCR, 
direct DNA sequencing and DNA chromatography of the D-loop region (Do et al., 2002).  
 In humans, ooplasm transfer from fertile donor oocytes into oocytes from infertile 
patients has produced the birth of healthy babies (Cohen et al., 1997, 1998). Later, heteroplasmy 
was identified in 2 of 15 ooplasm transfer children using direct polymerase chain reaction (PCR) 
(Brenner et al., 2000; Barritt et al., 2001b). Correspondingly, Nagao et al (1998) reported 
decreased physical performance in congenic mice with a mismatch between the nuclear and the 
mitochondrial genome. Since foreign mitochondria are introduced when conducting interspecies 
NT procedures, it is possible that mitochondrial heteroplasmy, as well as, chromosome number 
per cell, may be key factors that affect embryonic development and in utero survivability of 
interspecies NT embryos.  
 Although two singleton pregnancies with heartbeats were established in our study, one 
was lost between 40 d of gestation and the second conceptus was lost after 65 d of gestation. 
Interspecific transfer of gaur (Bos gaurus) embryos into domestic cattle (Bos taurus) has resulted 
in pregnancies and live offspring (Stover et al., 1981; Hradecky et al., 1988; Pope et al., 1988). 
However, Hammer et al. (2001) reported poor branching of the villi and inability to penetrate 
maternal caruncular crypts sufficiently, suggesting feto-maternal incompatibility between gaur 
embryos and the uterus of domestic cattle. In addition, first trimester losses of more than 50% are 
common for NT pregnancies in cattle (Hill et al., 1999, 2000a, 2000c, 2001a, 2001b, 2002) and 
placentation abnormalities have been extensively documented for NT pregnancies (Hill et al., 
2000b, 2000c, 2001a, 2001b). Hill et al. (2000a) reported that 82% of 30 days NT fetuses did not 
survive to day 90 of gestation, with more than 80% of deaths occurring between days 30 and 60, 
with half of these occurring between 30 and 40 days and half between day 40 and 60 of 
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gestation. The reason for the loss of the two pregnancies established in the present study remains 
unclear and further research is needed in this area.  
 In addition, our study also found significant differences between male and female 
banteng cell lines, with significantly greater cleavage and blastocyst rates for those cytoplasts 
reconstructed with male adult banteng fibroblasts compared with female adult banteng donor 
cells. Early in the development of female eutherian mammals, one of the two X-chromosomes is 
transcriptionally inactivated (Xi) to ensure compensation for the X-linked products (Lee and 
Jaenisch, 1997). An untranslated RNA, encoded by the Xist (X-inactive specific transcript) gene 
that is expressed only from Xi, is necessary and sufficient for the initiation of X inactivation (Lee 
and Jaenisch, 1997). In somatic cell NT, the oocyte receives one Xi and one Xa. Aberrant 
patterns of X-chromosome inactivation have been reported in bovine clones derived from female 
cell lines (Wrenzycki et al., 2002). Although individual variations between cell lines cannot be 
overruled, it is not known whether X-chromosome inactivation and/or other epigenetic effects 
may be affected by the sex of the donor karyoplasts, and this area deserves further investigation.  
 To our knowledge, this is the first scientific report of banteng embryos and pregnancies 
produced by interspecies NT. The present study demonstrates that the bovine cytoplast supports 
mitotic cleavage of banteng karyoplasts, and is capable of reprogramming the nucleus to achieve 
blastocyst stage embryos and pregnancies in exotic bovids. 
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CHAPTER VII 
OOPLASM TRANSFER AFTER INTRESPECIES NUCLEAR TRANSFER: 
PRESENCE OF FOREIGN MITOCHONDRIA, PATTERN OF 
MIGRATION AND EFFECT ON EMBRYO DEVELOPMENT 
 
Introduction 
 The technique of somatic cell nuclear transfer involves the removal of the nuclear DNA 
of a metaphase-II-stage oocyte (enucleation) followed by the insertion of a single cell into the 
perivitelline space of an enucleated oocyte or cytoplast (reconstruction). This is followed by 
electrofusion, chemical activation and in vitro culture of embryos. Somatic nuclear transfer (NT) 
has been successfully applied in Bos taurus and Bos indicus cattle using homologous oocytes, 
resulting in establishment of pregnancies and live offspring. (Cibelli et al., 1998; Shiga et al., 
1999; Wells et al., 1999; Hill et al., 2000b, 2000c). However, the current low efficiencies of the 
NT procedure, in addition to the high gestational loss and perinatal mortality, require that 
numerous attempts are needed to produce live offspring (Wells et al., 1999; Colman, 2000). In 
exotic or endangered species, the limited availability of both oocytes and recipients precludes the 
use of traditional somatic cell NT, and an approach such as interspecies NT may be the only 
alternative to produce embryos and offspring. 
 One of the early attempts of interspecies NT using the enucleated bovine oocyte as 
recipient cytoplast was reported by Dominko et al. (1999a). In their study, karyoplasts from 
monkey, sheep, pig and rat somatic cells were injected into bovine cytoplasts, resulting in 
various degrees of early in vitro development. Although no pregnancies were reported, this study 
indicated that the bovine oocyte is capable of supporting mitotic divisions after the introduction 
of a differentiated nucleus.  
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 Further interspecies NT attempts using the bovine cytoplast and karyoplasts from other 
species include somatic cells from pigs (Yoon et al., 2001), saolas (Bui et al., 2002), elands 
(Damiani et al., 2003), horses (Li et al., 2002a; Sansinena et al., 2002), bears (Ty et al., 2003) 
and humans (Cibelli et al., 2001; Chang et al., 2003). The first interspecies NT offspring was 
reported for the gaur by Lanza et al. (2000), but unfortunately died within the first 48 h after 
birth. Using domestic sheep (Ovis aries) as recipient cytoplasts two pregnancies were established 
after interspecies NT using an exotic argali (Ovis ammon) as donor karyoplasts, but both of these 
pregnancies were lost by 59 d of gestation (White et al., 1999). Subsequentlt, domestic sheep 
(Ovis aries) oocytes used as recipients for mouflon (Ovis orientalis musimon) cells resulted in 
one live offspring (Loi et al., 2001). 
 An in vitro developmental block has been previously reported using the procedure of 
interspecies NT when the species of donor karyoplasts and recipient cytoplasts are far apart in 
their taxonomic classification (Loi et al., 2001; Bui et al., 2002; Li et al., 2002). An 8- to 16-cell 
stage in vitro developmental block has been reported for the pig (Yoon et al., 2001), horse (Li et 
al., 2002; Sansinena et al., 2002) and llama (Sansinena et al., 2003a) when using bovine recipient 
cytoplasts. Progression through the early stages of embryogenesis is regulated by maternally 
inherited gene products derived from the ooplasm. Development beyond the early stages 
becomes dependent on embryonic gene activation at a species-specific developmental stage 
(Telford et al., 1990). It has been suggested that although the bovine cytoplast seems capable of 
supporting a few mitotic divisions, heteroplasmy or mitochondrial incompatibilities may affect 
nuclear-ooplasmic events occurring at the time of genomic activation (Sansinena et al., 2002).   
Ooplasm or cytoplasmic donation (OT) is a technique recently developed in the human 
field (Cohen et al., 1997, 1998) in which a small volume of the ooplasm from the donor oocyte 
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to be injected into a recipient oocyte prior to fertilization, using the intracytoplasmic sperm 
injection technique. The mechanisms by which ooplasm transplantation can restore growth and 
viability of developmentally compromised embryos still remain unclear. Cellular components 
that might benefit development include the pool of stored mRNAs and proteins that might 
regulate oocyte function and embryo development, as well as mitochondria and other organelles.  
To this date, there have been no reports of ooplasmic transfer used in combination with 
interspecies nuclear transfer in an attempt to overcome the previously observed in vitro block. To 
our knowledge, no reports of heteroplasmy after ooplasmic transfer or patterns of migration of 
foreign mitochondria are available in animal studies.   
Therefore, the objectives of this study were to establish a repeatable procedure for 
ooplasmic transfer in combination with nuclear transfer in the cow. In addition, the presence and 
pattern of migration of foreign mitochondria after ooplasmic transfer procedure was investigated. 
Finally, the effect of the transfer of caprine ooplasm into bovine oocytes used as recipients for 
interspecies NT in the goat was examined. 
Materials and Methods 
Experiment 7.1 
Preparation of Bovine and Caprine Donor Cells 
 Adult fibroblasts were isolated from 6-mm skin biopsies taken from one mature, cycling 
mixed breed beef cow (body condition score 6, scale 1 to 9) and one mature, cycling Spanish-
type crossbred doe (body condition score 5, scale 1 to 9). The primary cell cultures were 
obtained as previously described (Reggio et al., 2001). Briefly, dermal tissue was minced using 
sterile curved scissors in a 35 x 10-mm Falcon™ petri dish (Becton and Dickinson, Lincoln 
Park, NJ). Culture medium consisting of TCM-199 (Gibco, Grand Island, NY) with 10% fetal 
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bovine serum (FBS, HyClone, Logan, UT) and 0.1% gentamicin (Gibco) was added to the petri 
dish. Tissue samples were washed by swirling the tissue suspension in a 15-mL centrifuge tube 
and allowing the tissue to settle to the bottom. The supernatant was discarded and 3 mL of fresh 
culture medium was added to the tube. This process was repeated three times, after which tissue 
was transferred to a 35-mm petri dish. All but 500 to 700 µL of excess medium was aspirated. 
Cell cultures were conducted at 38.5ºC and 5% CO2 in humidified atmosphere.  
 Once a fibroblast cell layer was established (~7 to 10 d), cells were grown in 25-cm2 
tissue culture flasks (Costar™, Cambridge, MA) until they reached 95% confluency. Cells were 
then treated with 0.25% trypsin-EDTA (Sigma, St. Louis, MO), counted with a hemocytometer 
and re-seeded at a density of 100,000 cells in 25-cm2 tissue culture flasks. After two 
subpassages, cultured cells were exposed to a cryoprotectant solution consisting of TCM-199, 
20% calf serum, 5% dimethylsulfoxide (DMSO) and frozen in aliquots of 500,000 cells/mL of 
cryoprotectant in 1.5 mL CryoTubes™ (Nunc, Fisher Scientific, Pittsburgh, PA). To prepare 
adult fibroblasts as donors for NT, cells were thawed in the water bath at 37˚C for 1 min and 
cultured in TCM-199 containing 10% FBS and 0.1% gentamicin in 25-cm2 tissue culture flasks.  
Bovine Oocyte Preparation 
 Abattoir-derived bovine oocytes were collected (Ovagenix, San Angelo, TX), matured 
overnight and shipped by air courier. After 18 to 22 h of maturation, cumulus-oocyte complexes 
were exposed to vortexing for 2 min in TCM containing 1.2 mg/mL of hyaluronidase (Sigma) to 
remove the cumulus investments. Mature, metaphase-II oocytes were selected based on the 
visualization of a first polar body, and randomly assigned to treatment groups.  
 Treatment groups consisted of ooplasmic transfer followed by nuclear transfer in the cow 
(OT-NT, Treatment A), nuclear transfer followed by ooplasmic transfer in the cow (NT-OT, 
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Treatment B) and parthenogenically activated cow oocytes served as a laboratory control 
(Treatment C) (Table 7.1).  
Ooplasmic Transfer  
 Oocytes were manipulated in modified TL-HEPES (mTLH; TL-HEPES supplemented 
with 10% FBS and 0.1% gentamicin) in two elongated, parallel 120-µL droplets overlaid with 
mineral oil, one containing the oocytes to be used as ooplasmic donors and one containing the 
oocytes to be used as ooplasmic recipients. Micromanipulations were conducted on the heated 
stage (39°C) of an inverted microscope (Nikon Diaphot) equipped with Hoffman Modulation 
Contrast objectives, Narishige micromanipulators and epifluorescent illumination. A 120-µm 
diameter (o.d.) pipette was used to hold the oocytes by negative pressure.   
 Ooplasm from the donor oocyte was aspirated into a 7 µm (o.d.) glass pipette until the 
oolema was ruptured. Ooplasm was taken from the pole opposite to the polar body to avoid the 
metaphase spindle and it was aspirated until it filled about 200 µm of the micropipette (~ 5% of 
the total volume of the oocyte). Aspirated ooplasm was then injected into the recipient oocyte. 
The oolema of the recipient oocyte was also ruptured by partial aspiration into the micropipette, 
and both donor and recipient ooplasm were deposited into the pole opposite to the metaphase 
spindle (Figure 7.1).  
Nuclear Transfer 
 Nuclear DNA was labeled with 3 µg/mL of Hoechst-33342 for 3 min. Oocytes were then 
washed in mTL-HEPES and placed in working groups of 25 oocytes in an elongated 150-µL  
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Table 7.1. Experimental design for Experiment 7.1: Nuclear transfer (NT) and ooplasm transfer 
(OT) in the cow 
 
Treatment group                                       Experimental procedure 
 
Treatment A Ooplasm Transfer  (OT) followed by Nuclear Transfer (NT)  
Treatment B Nuclear Transfer (NT) followed by Ooplasm Transfer (OT) 
Treatment C Parthenogenically activated bovine oocytes 
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Figure 7.1. Ooplasm transfer procedure for oocytes. 
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micromanipulation droplet containing 6 µg/mL of cytochalasin D (Sigma) overlaid with embryo 
tested mineral oil (Sigma). All micromanipulations were conducted on the stage of an inverted 
microscope (Nikon Diaphot) equipped with Hoffman Modulation Contrast objectives, Narishige 
micromanipulators, Uniblitz VMM-D1 shutter system (Vincent Associates, Rochester, NY) and 
epifluorescent illumination. A 120-µm diameter (o.d.) pipette was used to hold the oocytes by 
negative pressure. After a brief exposure (<5 s) to ultraviolet light to visualize nuclear DNA, the 
metaphase spindle and polar body with a small amount of surrounding ooplasm were removed by 
negative pressure applied to an enucleation pipette (20-µm o.d., 35º bevel, spiked). Once 
enucleated, the cytoplasts were held in modified TCM (mTCM; TCM-199 supplemented with 
10% FBS and 0.1% gentamicin) at 38.5ºC and 5% CO2 in humidified air.  
 Cow adult fibroblasts were used as nuclear donors at passage three of culture. Donor cells 
were serum starved (0.5% FBS) for 3 to 5 d prior to the NT procedures. Reconstruction was 
performed in working groups of 25 cytoplasts in a 200-µL elongated droplet of mTLH 
containing 6 µg/mL of cytochalasin D overlaid with embryo tested mineral oil (Sigma). A single 
adult cow fibroblast (15 to 20 µm in diameter) was inserted into the perivitelline space of an 
enucleated oocyte. Fusion of karyoplast-cytoplast couplets was performed in a microslide fusion 
chamber with stainless steel electrodes separated by a 1-mm gap and the chamber was filled with 
fusion buffer (0.3 M mannitol, 0.1 mM MgSO4⋅7H2O, 0.05 mM CaCl2, 0.5 mM HEPES and 4 
mg/mL of BSA (Fraction V, Sigma). The couplets were then fused by two consecutive DC 
pulses (1.9 kV/cm for 25 µs) delivered by a BTX Electrocell Manipulator 200 (Gentronics, San 
Diego, CA). Couplets were evaluated for fusion by microscopic examination within a 1-h period. 
At this time, oocytes randomly allocated to parthenogenic activation treatment group (Treatment 
C) were placed in the microslide fusion chamber and pulsed once (1.9 kV/cm for 25 µs) to 
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initiate activation. Chemical activation of all treatment groups was performed by a 4-min 
exposure to 5 µM of ionomycin (Sigma) followed by 5 min in TL-HEPES with 30 mg/mL of 
BSA (Fraction V, Sigma) and 2-h incubation in 10 µg/mL of cycloheximide (Sigma) with 6 
µg/mL of cytochalasin D prepared in CR1aa medium (Rosenkrans et al., 1993). Embryos were 
cultured in 35-µl droplets of CR1aa medium in a modular incubator chamber (Billups-
Rothenberg, Del Mar, CA) at 38.5ºC and 5% O2, 5%CO2 and 90% N2 humidified atmosphere. 
Embryos were checked for cleavage after 3 d of in vitro culture, the medium was then replaced 
with CR1aa with 5% FBS and blastocyst production was checked at days 7 and 9 (fusion = d 0) 
of in vitro culture.  
Statistical Analysis 
 Mean cleavage rates and embryo development rates were compared across treatment 
groups by Chi-square analysis (SAS Institute, 1985). In this study, different mean values 
between treatment groups were considered statistically significant at the P<0.05 level. 
Experiment 7.2 
Mitochondrial Staining of Donor Ooplasm 
 Oocytes to be used as ooplasmic donors were stained with 200 nM of MitoTracker Green 
FM (M-7514, Molecular Probes Inc., Eugene, OR) in mTCM (mTCM; TCM-199 with 10% fetal 
bovine serum and 0.1% gentamicin) for 45 min. Stained oocytes were washed for 30 min in 
mTCM and were then placed in micromanipulation droplets of mTLH for ooplasmic transfer. 
Ooplasmic transfer and nuclear transfer procedures were conducted as described in Experiment 
7.1. Couplets were cultured in 35-µL droplets of CR1aa medium in a modular incubator chamber 
(Billups-Rothenberg, Del Mar, CA) at 38.5ºC and 5% O2, 5%CO2 and 90% N2 humidified 
atmosphere and imaged for the presence and distribution of labeled mitochondria at 12 (pre-
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cleavage), 72 and 144 h post-fusion. Fluorescence was assessed using a Leica TCS SP2 laser 
scanning confocal microscope using a 20X objective at excitation (ex) of 490 nm and emission 
(em) of 516 nm (Figure 7.2). 
Experiment 7.3 
Surgical Goat Oocyte Retrieval 
 All does were maintained in accordance with the Institutional Animal Care and Use 
Committee Guidelines at Louisiana State University. Does were implanted subcutaneously (d 1) 
on the dorsal side of the ear with a 3-mg norgestomet implant (Synchro-Mate B, Rhone Merieux, 
Athens, GA) and then subjected (d 6) to ovarian superstimulation (i.m.) by twice daily 
administration of pFSH (Sioux Biochemical, Sioux Center, IA) in a decreasing total dose of 50 
units/doe (10, 7.5, 5, 2.5). Implants were then removed and does were aspirated 24 h after the 
final FSH injection. Cumulus-oocyte complexes (COC) were harvested as previously described 
(Reggio et al., 2001) and placed in groups of 10 to 15 oocytes in 35-µL droplets of maturation 
medium overlaid with mineral oil. Maturation medium consisted of TCM-199 supplemented 
with 10% goat serum (Sigma), 10 µg/mL of LH, 5 µg/mL of FSH and 1 µg/mL of estradiol 17β 
and COC were allowed to mature for 18 to 22 h.  
 Cumulus-oocyte complexes were vortexed for 1.5 min in TCM containing 0.6 mg/mL of 
hyaluronidase (Sigma) to aid in the removal of cumulus investments, metaphase-II oocytes were 
selected based on the visualization of a first polar body and maintained in mTCM at 38.5°C and 
5% CO2 in humidified air until they were used as ooplasmic donors.  
Bovine Oocyte Preparation 
 Abattoir-derived bovine oocytes were obtained and prepared as described in Experiment 
7.1. Metaphase-II bovine oocytes were selected and randomly assigned to treatment groups.  
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Figure 7.2. Flow chart of experimental procedures for Experiment 7.2. 
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Treatment groups for this experiment consisted of interspecies NT using enucleated bovine 
oocytes and goat adult fibroblasts as karyoplast donors followed by the transfer of goat ooplasm 
(Interspecies NT-OT, Treatment A), interspecies NT only (Treatment B) and parthenogenically 
activated bovine (Treatment C) and caprine (Treatment D) oocytes served as a laboratory control 
(Table 7.2).  
 The transfer of goat ooplasm into bovine oocytes (Figure 7.3) was conducted as described 
in Experiment 7.1. Nuclear transfer procedure was performed as described in Experiment 7.1, 
except goat adult fibroblasts were used as nuclear donors at the third subpassage of culture.  
 Chemical activation of all treatment groups was performed at approximately 24 to 26 h 
post IVM by a 4-min exposure to 5 µM of ionomycin (Sigma) followed by 5 min in TL-HEPES 
with 30 mg/mL of BSA (Fraction V, Sigma) and a 2-h incubation in 10 µg/mL of cycloheximide 
(Sigma) with 6 µg/mL of cytochalasin D prepared in CR1aa medium (Rosenkrans et al., 1993). 
In vitro culture of embryos was conducted as described in Experiment 7.1. 
Results 
Experiment 7.1 
 This experiment was conducted in replicates. In 2 replicates the sequence of events was 
OT followed by NT (Treatment A) and in 2 replicates the sequence of events was NT followed 
by OT (Treatment B). In addition, a parthenogenic control (Treatment C) was included in each of 
the replicates. All the replicates of the experiment yielded blastocysts following 7 d of in vitro 
culture. Development of embryos and parthenogenically activated oocyte control is summarized 
in Table 7.3.  
 Of a total of 48 reconstructed couplets in Treatment A (OT – NT), 65% fused following 
two electrical pulses. Of the fused couplets, 87% of the embryos cleaved, 48% reached the  
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Table 7.2. Experimental design for Experiment 7.3: Interspecies nuclear transfer (NT) using 
bovine oocytes and goat donor cells in combination with transfer of goat ooplasm (goat OT) 
 
Treatment group                                       Experimental procedure 
 
Treatment A Interspecies NT – goat OT  
Treatment B Interspecies NT 
Treatment C Parthenogenically activated bovine oocytes 
Treatment D Parthenogenically activated caprine oocytes 
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Figure 7.3. Experimental procedure of interspecies NT (cow oocyte-goat donor cell) in combination 
with OT (goat ooplasm) for Experiment 7.3. 
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Table 7.3. Development of embryos after nuclear transfer (NT) and ooplasm transfer (OT) in the cow 
 
Treatment 
group 
No. of M II1 
oocytes 
No. (%) 
fused 
No. (%) 
cleaved 
No. (%) 
BLST2 (d 7) 
No. (%) 
HBLST3 (d 9)
No. (%) nucleated 
blastomeres 
 
A (OT-NT) 48 31 (65) 27 (87) 15 (48) 10 (32) 15 (100) 
B (NT-OT) 45 33 (73) 28 (85) 13 (39) 9 (27) 13 (100) 
C (Parthenogenic)4 55 - 44 (80)@ 20 (36) 14 (25) 20 (100) 
1M II = metaphase-II spindle. 
2BLST = blastocysts. 
3HBLST = hatched blastocysts. 
4Parthenogenic control consisted of chemically activated bovine oocytes. 
@Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation. 
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blastocyst stage in 168 h and 32% hatched after 216 h of in vitro culture. Of a total of 45 
reconstructed couplets in Treatment B (NT – OT), 73% fused after two electrical pulses. Of the 
fused couplets, 85% of the embryos cleaved, 39% reached blastocyst stage in 168 h and 27% of 
the blastocysts hatched after 216 h of in vitro culture. Of a total of 55 parthenogenically activated 
bovine oocytes in Treatment C, 80 % of the embryos cleaved, 36% reached the blastocyst stage 
in 168 h and 25% hatched after 216 h of in vitro culture.  
 Presence of nuclei was confirmed in all blastocysts by Hoechts-33342 (Figure 7.4). There 
were no significant differences in the number of fused couplets among treatment groups. Also, 
no significant differences were found in embryo cleavage, blastocyst and hatching rates among 
treatment groups.  
Experiment 7.2 
 The findings from embryos imaged with confocal laser microscopy at 12, 72 and 144 h 
are summarized in Table 7.4. Of reconstructed couplets that were imaged at 12 h post-activation 
(pre-cleavage), 83% displayed a localized cluster pattern of foreign mitochondria (Figure 7.5) 
and 17% did not produce a detectable signal. Of cleaved embryos that were imaged at 72 h post-
activation, 75% displayed a cluster pattern of foreign mitochondria (Figure 7.6), 17% had a 
dispersed pattern and 8% did not produce a detectable signal. Of cleaved embryos imaged at 144 
h post-activation, 33.3% displayed a cluster pattern of foreign mitochondria, 33.33% displayed a 
dispersed pattern and 33.3% had no detectable mitochondria. The localization of a typical 
mitochondrial cluster is shown in Figure 7.7.  
 All the embryos imaged with confocal microscopy were quality-graded before they were 
mounted onto microslides. The embryos were graded on a 1 to 4 scale, with quality grade-1 
corresponding to excellent quality embryo with evenly-shaped blastomeres and no cytoplasmic  
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Figure 7.4. Bovine NT-OT hatched blastocyst (Treatment B). (a) Without Hoechst-33342 
staining (40 X objective). (b) With Hoechst-33342 staining (40X objective). 
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Table 7.4. Laser confocal results of OT-derived mitochondria stained with MitoTracker® Green FM in embryos imaged 
after 12, 72 or 144 h of in vitro culture 
 
Time of confocal imaging 
(h of IVM) 
No. of 
embryos 
Mitochondria present 
Y                   N 
Confocal results 
 
Embryo quality 
grade 
 
12 
 
12 
 
10                  2 
 
10 localized in distinct cluster  
 
N/A1 
   2 undetectable N/A1 
 
72 
 
12 
 
11                 1 
 
9 localized in a distinct cluster 
 
1 and 2 
   2 spread throughout cytoplasm 3 
   1 undetectable 4 
 
144 
 
9 
 
6                 3 
 
3 clustered in a few blastomeres 
 
1 and 2 
   3 spread throughout cytoplasm 3 
   3 undetectable 4 
 
1Embryo quality grade not available (pre-cleavage confocal microscopy observation).
 132 
 
Figure 7.5. A bovine NT-OT embryo imaged after 12 h of in vitro culture. White arrows indicate 
presence of the fluorochrome. (a) Fluorescence MitoTracker green emission. (b) Differential 
interference contrast (DIC) image. (c) Overlay. 
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Figure 7.6. Bovine NT-OT embryo imaged after 72 h of in vitro culture. The white arrow 
indicates presence of fluorochrome. 
 
 
 
 
40 µm
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Figure 7.7. Z-stack showing the localization of MitoTracker green emission from foreign 
mitochondria introduced by OT (72 h of IVC). The thickness of each section is 2-3 µm.  
 
 
 
 135 
fragments and a quality grade-4 corresponding to a poor quality embryo with uneven 
blastomeres and cytoplasmic fragments. Embryo quality grade was not available for confocal 
observations at 12 h of IVC (pre-cleavage). Of the embryos imaged at 72 and 144 h of IVC, 
grade-1 and -2 embryos displayed a cluster patter of mitochondria, whereas quality grade-3 
embryos displayed a dispersed pattern of mitochondria and quality-4 embryos did not emit a 
signal for mitochondria.  
Experiment 7.3 
 This experiment was conducted in replicates. The development of embryos and 
parthenogenically activated oocyte control is summarized in Table 7.5. Of a total of 60 
reconstructed couplets in Treatment A (cow-goat NT followed by goat OT), 52% fused 
following two electrical pulses.  
 Of the fused couplets, 55% cleaved and all embryos arrested at the 8- to 16-cell stage. Of 
a total of 55 reconstructed couplets in Treatment B (cow-goat interspecies NT only), 82% fused 
after two electrical pulses. Of fused couplets, 78% of the embryos cleaved but none of the 
embryos progressed through the 8- to 16-cell stage. Of a total of 40 parthenogenically activated 
bovine oocytes in Treatment C, 80 % of the embryos cleaved, 40% reached the blastocyst stage 
in 168 h and 22% of the blastocysts hatched after 216 h of in vitro culture. Of a total of 25 
parthenogenically activated goat oocytes in Treatment D, 88 % of the embryos cleaved, 32% 
reached the blastocyst stage in 168 h and 12% hatched after 216 h of in vitro culture.  
 Couplets from interspecies NT followed by the transfer of goat ooplasmic transfer 
(Treatment A) had a significantly lower fusion rate (P<0.05) than couplets from interspecies NT 
alone (Treatment B). In addition, the numbers of cleaved embryos from interspecies NT 
followed by goat ooplasmic transfer (Treatment A) was significantly lower (P<0.05) than the  
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Table 7.5. Development of embryos from transfer of goat ooplasm into bovine recipient oocytes of goat interspecies NT    
(Interspecies NT-OT) or interspecies NT only (Interspecies NT) 
 
Treatment 
group 
No. of M II1 
oocytes 
No. (%) 
fused 
No. (%) 
cleaved 
No. (%) 
BLST2 (d 7) 
No. (%) 
HBLST3 (d 9) 
No. (%) nucleated 
blastomeres 
 
A (Interspecies NT-OT) 60 31 (52)a 17 (55)a 0 0 17 (100) 
B (Interspecies NT) 55 45 (82)b 35 (78)b 0 0 35 (100) 
C (Parthenogenic cow) 40 - 34 (80)@ 16 (40) 9 (22) 16 (100) 
D (Parthenogenic goat) 25 - 22  (88)@ 8 (32) 3 (12) 8 (100) 
abMean values with different superscripts in the same column are significantly different (Chi square; P<0.05). 
   1MII = metaphase II spindle. 
   2BLST = blastocysts. 
   3HBLST = hatched blastocysts. 
 @Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation. 
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number of embryos cleaving from interspecies NT alone (Treatment B). However, there was no 
significant difference in the number of cleaved embryos between interspecies NT alone 
(Treatment B), parthenogenically activated cow (Treatment C) and goat oocytes (Treatment D). 
Discussion 
 Early studies in the animal field lead to the ultimate implementation of the OT technique 
in humans. Levron et al. (1996) conducted studies in mice that provided the basis for the first 
attempts of OT in humans. Since the birth of a child was announced after OT (Cohen et al., 
1997), the technique has become the subject of debate in the human field. Its application to 
overcome fertilization failures in older women has become a matter of concern due to the 
possibility of heteroplasmy of mitochondrial DNA.  
 Meirelles and Smith (1998) have produced heteroplasmic mice after transfer of cytoplasts 
followed by electrofusion and demonstrated that mitochondrial genotypes in cytoplast- and 
karyotyped-reconstructed embryos were segregated during the preimplantation period. Recently, 
Barritt et al. (2001b) attempted to determine if active mitochondria were transferred from human 
donor oocytes to recipient oocytes, and if these mitochondria persisted in preimplantation 
embryos. Their observations after 48 h showed segregation of labeled mitochondria to some, but 
not to all, blastomeres and demonstrated the recipient oocyte contained a heteroplasmic 
population of mitochondria after ooplasm transfer. Heteroplasmy was identified in 2 of 15 
ooplasm-transfer children using direct polymerase chain reaction (PCR) (Brenner et al., 2000). 
 To our knowledge, the present study is the first report of the ooplasmic transfer technique 
used in combination with the nuclear transfer procedure. In the first experiment, it was 
demonstrated that the two procedures can be successfully combined (within the same species) 
without any further effect on in vitro embryo development. Furthermore, the sequence of events 
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(OT followed by NT or vice versa) did not seem to affect subsequent cleavage, blastocyst or 
hatching rates. Although the fact that none of these embryos were transferred to recipients 
precludes any speculations about their viability, the presence of nuclei indicated the embryos 
underwent apparently normal karyokinesis in conjunction with cytokinesis. 
 The second experiment of our study confirmed the hypothesis that foreign mitochondria 
are incorporated at the time of OT. This is in agreement with other studies conducted by 
Meirelles and Smith (1998) and Barritt et al. (2001a). Our study also indicated the majority of 
the foreign mitochondria remain in a distinct cluster after 72 h of in vitro culture. However, the 
pattern of distribution after genomic activation seems harder to predict. Although some embryos 
still showed clustering of foreign mitochondria, only 33.3% exhibited a dispersed pattern 
indicating foreign mitochondria could have been relocated to other blastomeres. Constant levels 
of mtDNA have been detected in mice during development from mature oocytes to blastocyst 
stage, leading to suggestions that mitochondria do not replicate their genomes during this early 
period of development (Pikó and Taylor, 1987; Ebert et al., 1988).  
 In our study, the use of MitoTracker Green FM appeared to have no detrimental effect of 
subsequent embryo development. Because this probe appears to preferentially accumulate in 
mitochondria regardless of its membrane potential (Molecular Probes’ Product Information), it 
was chosen as a tool to identify the presence of foreign mitochondria introduced by the OT 
procedure, as well as, a means to track the redistribution of foreign mitochondria during in vitro 
culture. The use of this probe, however, does not allow for speculation about the level of activity 
of the organelles and further studies using MitoTracker Red, a probe that accumulates in the 
mitochondria according to their membrane potential, would be useful to clarify this point.   
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 It is known that the movement and redistribution of mitochondria is an important part of 
normal cell function. Subcellular organelle dynamics are strongly influenced by interactions with 
cytoskeletal filaments and their associated motor proteins (Knowles et al., 2002). In our study, 
the higher quality-grade embryos (embryo quality grades-1 and -2) displayed a pattern of 
transferred mitochondria clustered in a small portion of the cytoplasm. However, since embryos 
had to be mounted on a microslide and covered with a coverslip for confocal imaging, we cannot 
speculate whether this mitochondrial cluster was isolated in one single blastomere. It is possible 
that the redistribution of organelles within the cytoskeleton is not only a function of their 
association with cytoskeletal components, but also of their level of activity, the nuclear-
mitochondrial interactions and membrane potential and further studies are needed in this area. 
 The use of alternative NT techniques, such as interspecies NT, is an exciting possibility 
for species with limited availability of oocytes and recipients. However, an 8- to 16-cell in vitro 
developmental block has been previously reported using this procedure (Yoon et al., 2001; Li et 
al., 2002a; Sansinena et al., 2002, 2003a), particularly when the species of donor karyoplasts and 
recipient cytoplasts are far apart in their taxonomic classification. 
 Results from our third experiment indicate that the transfer of ooplasm from the same 
species as the donor karyoplast into the bovine oocytes used for interspecies NT had no effect in 
overcoming the in vitro block. However, the increased levels of heteroplasmy introduced after 
interspecies OT may explain the decreased cleavage rates observed. Previously, Nagao et al., 
(1998a) have reported decreased physical performance in congenic mice with a mismatch 
between nuclear and mitochondrial genome. It is possible that although the bovine cytoplast 
appears to be capable of supporting a few mitotic divisions after interspecies OT-NT, 
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heteroplasmy or mitochondrial incompatibilities may affect nuclear-ooplasmic events occurring 
at the time of genomic activation.   
 In conclusion, the present study demonstrates that foreign mitochondria are introduced at 
the time of OT and that these mitochondria tend to remain as a distinct cluster without relocation 
after a few mitotic divisions. To our knowledge, this is the first scientific report of OT used in 
combination with interspecies NT in an attempt to overcome the in vitro developmental block. 
Further research is needed to determine the characteristics of foreign mitochondrial dynamics as 
well as the replication of foreign mitochondria introduced into NT embryos. 
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CHAPTER VIII 
SUMMARY AND CONCLUSIONS 
 Although the first successful report (Wilmut et al., 1997) of the production of a live 
offspring from adult somatic cell nuclear transfer (NT) marked the advent of a renewed interest 
in the area, no major improvements in the efficiency of the procedure have been reported since 
then. The current efficiency of the NT procedure remains disappointingly low, with most of the 
laboratories reporting 3 to 4% viable offspring based on the initial number of oocytes.  
 Inefficiencies associated with the NT procedure include donor cell-recipient oocyte 
degree of cycle synchronization (Campbell et al., 1993, 1996a; Collas and Robl, 1991; Wells et 
al., 2003) differences among cell lines (Kasinathan et al., 2001; Collas et al., 1992a, 1992b; 
Miyoshi et al., 2003), epigenetic alterations (Reik et al., 2001; Niemann et al., 2002; Shi et al., 
2003), aberrant patterns of gene expression (Bourc'his et al., 2001; Niemann et al., 2002; Xue et 
al., 2002), placentation abnormalities (Hill et al., 1999, 2000a, 2000b, 2000c, 2001a, 2001b, 
2002) and the high perinatal morbidity/mortality (Brem and Kuhholzer, 2002b; Colman, 2000; 
Heyman et al., 2002). Since these inefficiencies require that numerous attempts are needed to 
produce live offspring, large numbers of oocytes are needed to undertake NT experiments. In 
exotic or endangered species, the limited availability of both oocytes and recipients precludes the 
use of traditional somatic cell NT, and an approach such as interspecies NT may be the only 
alternative to produce embryos and offspring.  
 In the horse, one of the largest obstacles in establishing a repeatable protocol for NT has 
been the inability to collect and mature large numbers of good quality oocytes from donor mares. 
The low number of follicles per ovary (Del Campo et al., 1995; Hinrichs, 1991; Hinrichs et al., 
1993), the difficulty recovering oocytes from follicles (Hawley et al., 1995) and the limited 
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information regarding the process of selection of oocytes for optimal meiotic and developmental 
competence (Dell'Aquila et al., 2001) have been key factors contributing to the overall 
inefficiency of the NT procedure in the equine species.  
 The low efficiency of the somatic cell NT procedure requires that large numbers of 
meiotically competent equine oocytes must be available for maturation. In vitro maturation rates 
of equine oocytes have been reported by several laboratories, and are generally lower and more 
variable than those of other domestic species (Hinrichs et al., 1993; Del Campo et al., 1995; Alm 
and Hinrichs, 1996; Squires, 1996; Choi et al., 2000a; Hinrichs and Schmidt, 2000a; Franz et al., 
2001; Hinrichs et al., 2002; Dell'Aquila et al., 2003; Marchal et al., 2003).  
 With the overall objective of increasing the number of mature, metaphase-II oocytes 
available for NT, a first experiment was conducted to evaluate the nuclear status of equine 
oocytes matured in vitro using a sequential maturation medium. A second study was conducted 
to evaluate the effect of roscovitine prematuration in oocytes from small equine ovarian follicles 
and to use these in vitro matured oocytes for equine NT procedures. Our results indicated that the 
prematuration of oocytes pooled from all follicle sizes in roscovitine with follicular fluid did not 
improve nuclear maturation rates obtained after permissive maturation. Our results also indicated 
that the pretreatment of oocytes from small follicles in roscovitine did not have a significant 
effect on the proportion of oocytes reaching the metaphase-II stage after maturation.  
 Our results are in agreement with previous studies that have shown that, although rosco-
vitine was effective in maintaining the oocytes in meiotic arrest, the nuclear maturation rates 
were not significantly affected by the preincubation treatment (Khatir et al., 1998; Mermillod et 
al., 2000; Ponderato et al., 2001; Franz et al., 2002). In addition, when roscovitine pre-incubated 
equine oocytes were used for NT in our study, no fusion of karyoplast and cytoplast was 
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observed and no subsequent cleavage was attained. Because the roscovitine-treated oocytes 
remained in culture for as long as 84 h, it is possible that membrane stability might have been 
compromised. This would explain the lack of fusion in that treatment, and more research is 
needed to clarify this point. 
 The llama, a member of the Camelidae family, has not been cloned to date. The 
application of the NT technology to the llama industry could be helpful in the propagation of 
genetically valuable animals. Also, future experiments in interspecies NT using llama oocytes as 
hosts and vicuña donor cells could potentially aid in the conservation and propagation of 
endangered species. A study was conducted with the objective to produce NT llama embryos and 
to compare their development in two different in vitro culture conditions. This resulted in the 
first scientific report of somatic cell NT, in vitro culture and transfer of NT embryos in the llama 
(Sansinena et al., 2003b). Furthermore, our results showed that although llama oocytes appeared 
darker than goat oocytes, the micromanipulation protocol previously used for the goat in our 
laboratory (Reggio et al., 2001) was effective in the enucleation and reconstruction of llama 
oocytes. It was demonstrated that llama NT transfer embryos can be produced from traditional 
NT protocols and these results have implications not only in the conservation of superior 
genetics in the llama, but also in future applications of NT technology for the conservation of 
endangered species.  
 Because large numbers of oocytes from horse and llama oocytes are expensive and 
difficult to obtain, a series of experiments was conducted to examine the aptitude of the cow 
oocyte as a ‘Universal Recipient’ for NT as well as its capability to reprogram nuclei from 
different species. At the time of the initiation of these experiments, only a few reports of 
interspecies NT were available. In one of the first studies exploring the potential of the bovine 
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oocyte as a universal recipient for NT, skin fibroblast cells from cows, sheep, pigs, monkeys and 
rats were used as sources of nuclei; undergoing progression through the cell cycle to achieve 
various degrees of development (Dominko et al., 1999a). However, this study failed to control 
for parthenogenesis and efficiency of enucleation, which raised some questions about the validity 
of their results.  
 The results of our interspecies studies showed that the bovine recipient ooplasm is 
capable of reprogramming somatic nuclei from other species. The fact that horse and llama 
interspecies embryos progressed through a few mitotic division indicated that the factors 
contained in the bovine ooplasm were capable of reprogramming the foreign nucleus and driving 
cell division. In addition, significant differences were found in the development of equine 
interspecies NT embryos, suggesting the interspecies model could be used as a tool for cell line 
cloning efficiency.  
 However, an important finding of our interspecies study was that neither horse nor llama 
interspecies NT embryos progressed to the blastocyst stage, with all embryos arresting 
consistently at the 8- to 16-cell stage in vitro. Interestingly, this stage corresponds to the timing 
of maternal to embryonic genomic take-over of development reported for the cow (Telford et al., 
1990; Memili et al., 1998). These findings suggested that, although the bovine cytoplast seemed 
capable of supporting a few mitotic divisions, heteroplasmy or mitochondrial incompatibilities 
may affect nuclear-ooplasmic events occurring at the time of genomic activation.   
 Our next interspecies NT experiment aimed at the study of the previously observed in 
vitro developmental block. It was hypothesized that nuclear-ooplasmic interactions could be 
species-specific and therefore, if more closely related donor cell and recipient oocytes were used 
(domestic cow and an endangered bovid, the banteng) the in vitro developmental block could be 
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overcome. The results of our study showed that no in vitro developmental block was detected 
using the banteng as donor karyoplasts and the bovine cytoplast and embryos proceeded beyond 
the 8- to 16-cell stages to achieve high blastocyst rates. Moreover, two pregnancies with 
heartbeats established from the male cell line indicated these were actually initially viable 
embryos. Although the two pregnancies were subsequently lost after 40 and 65 days of gestation, 
respectively, the study demonstrated that the bovine cytoplast supports mitotic cleavage of 
banteng karyoplasts, and is capable of reprogramming the nucleus to achieve blastocyst stage 
embryos and pregnancies in exotic bovids.  
 In addition, at the time of writing this dissertation, two cloned banteng births were 
announced from interspecies NT by a joint effort between a private biotechnology company 
(Advanced Cell Technology, Worcester, MA), Trans Ova (Sioux Center, IA) and the San Diego 
Zoo (San Diego, CA). One was euthanized 2 days after birth due to respiratory failure and the 
other remains alive at the San Diego Zoo. No scientific publication had been made available at 
the time of writing this dissertation. 
 Finally, a series of experiments was conducted to investigate the effect of mixed 
mitochondrial populations (heteroplasmy) on early embryonic development. Previous studies had 
reported mtDNA heteroplasmy in cloned cattle generated from fetal and adult donor cells 
(Steinborn et al., 2000). More recently, mtDNA was reported to be present in somatic cell NT-
derived embryos by allele-specific PCR, direct DNA sequencing and DNA chromatography of 
the D-loop region (Do et al., 2002). Presence of heteroplasmy after NT and the potential for 
mitochondrial a mismatch has been suggested to impair embryo development (Nagao et al., 
1998a) and decreased physical performance has been reported in congenic mice with mismatch 
between nuclear and mitochondrial genomes. Since foreign mitochondria are introduced when 
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conducting interspecies NT procedures, mitochondrial heteroplasmy as well as chromosome 
number, may be key factors that affect embryonic development and in utero survivability of 
interspecies NT embryos.  
 To evaluate the effect of combine both NT and OT procedures on in vitro embryonic 
development, an experiment was conducted injecting donor bovine ooplasm (ooplasmic transfer, 
CT) into bovine oocytes prior to being used for NT. Subsequent embryo development to the 
blastocyst stage demonstrated that the procedures of OT and NT can be successfully combined 
(within the same species) without any further effect on in vitro embryo development. 
Furthermore, the sequence of events (OT followed by NT or vice versa) did not seem to affect 
subsequent cleavage, blastocyst or hatching rate. 
 In addition, by staining the donor ooplasm prior to OT with MitoTracker, we have 
confirmed the hypothesis that foreign mitochondria are incorporated at the time of OT. This is in 
agreement with other studies (Meirelles and Smith, 1998; Barritt et al., 2001a; 2001b). Our study 
also indicated the majority of the foreign mitochondria remain in a distinct cluster after 72 h of in 
vitro culture.  
 Finally, our research has shown that the transfer of ooplasm from the same species as the 
donor karyoplast into the bovine oocytes used for interspecies NT had no effect on overcoming 
the in vitro block. Interestingly, lower cleavage rates were observed after OT and this could be 
due to the increased levels of heteroplasmy introduced after interspecies OT. It is possible that 
although the bovine cytoplast appears to be of supporting a few mitotic divisions after 
interspecies OT-NT, heteroplasmy or mitochondrial incompatibilities may affect nuclear-
ooplasmic events occurring at the time of embryonic genome activation.   
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 In conclusion, it is possible to use the bovine ooplasm to reprogram the nucleus of other 
species, however, a consistent in vitro developmental block is observed when the karyoplast and 
ooplast are far apart in their taxonomic classification. Although many other factors could affect 
the early events in interspecies NT embryos, the increased levels of heteroplasmy or incomplete 
nuclear reprogramming could be a possible explanation for the impaired nuclear-ooplasmic 
interactions. Further studies using serial NT could be explored in an attempt to overcome the in 
vitro embryo developmental block and the nuclear-ooplasmic incompatibilities found in inter-
species NT embryos.  
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APPENDIX 
LIST OF ABBREVIATIONS 
CB .................................................................................................................. Cytochalasin B 
CD.................................................................................................................. Cytochalasin D 
CHX ................................................................................................................Cycloheximide 
COC ...............................................................................................Cumulus-oocyte complex 
CSF .............................................................................................................. Cytostatic factor 
DMAP............................................................................................... 6-dimethylaminopurine 
EGF..................................................................................................Epidermal growth factor 
FBS .......................................................................................................... Fetal bovine serum 
FSH ...........................................................................................Follicle stimulating hormone 
GV................................................................................................................Germinal vesicle 
GVBD ....................................................................................... Germinal vesicle breakdown 
ICM.................................................................................................................Inner cell mass 
IGF ................................................................................................. Insulin-like growth factor 
IVC.................................................................................................................. In vitro culture 
IVF .......................................................................................................... In vitro fertilization 
IVM...........................................................................................................In vitro maturation 
LH ......................................................................................................... Luteinizing hormone 
M I....................................................................................................................... Metaphase-I 
M II ....................................................................................................................Metaphase-II 
MAP................................................................................... Mitogen-activated protein kinase 
MPF........................................................................................... Maturation promoting factor 
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mtDNA................................................................................................... Mitochondrial DNA 
NEBD....................................................................................... Nuclear envelope breakdown 
NT ................................................................................................................. Nuclear transfer 
OT ............................................................................................................... Ooplasm transfer 
PCC................................................................................. Premature chromatin condensation 
TCM................................................................................................... Tissue culture medium 
TUGA .................................................... Transvaginal Ultrasound-guided follicle aspiration 
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